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ABSTRACT
DEVELOPMENT OF COLLOIDS-BASED FOOD DELIVERY SYSTEMS TO
ENHANCE THE BENEFICIAL EFFECTS OF NUTRACEUTICALS FOR
HUMAN HEALTH
MAY 2019
B.A., GANSU AGRICUTURE UNIVERSITY, CHINA
M.A., SOUTHWEST UNIVERSITY, CHINA
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST, USA
Directed by: Professor David Julian McClements
Numerous bioactive agents within the food and pharmaceutical industries need to
be encapsulated in delivery systems to overcome problems associated with poor watersolubility, chemical instability, and low oral bioavailability. Hydrogel particles are one
kind of food-grade delivery system that offers considerable scope for tailored
functionality, which can be used for encapsulation, protection, and controlled release of
these bioactives. In current studies, hydrogel particles were formed by polysaccharides
(i.e., alginate or pectin) and protein (i.e., casein or gelatin) through complex coacervation.
Our results indicated that the encapsulation of protein or polyunsaturated lipid droplets
nanoparticles within the hydrogel particles could improve their chemical or physical
stability during storage. The lipid droplets encapsulated within the hydrogel particles
could be released under simulated oral conditions, which was triggered by a pH or
temperature change. The current study further fabricated the hydrogel particles (beads)
using alginate or carrageenan based on an injection-gelation method. We found
carrageenan beads had a relatively fragile structure that was easily disrupted in the GIT
and released the encapsulated lipid droplets and curcumin. Conversely, alginate beads
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had a robust structure that remained relatively intact throughout the GIT and retained the
lipid droplets and curcumin. The incorporation of the β-carotene-loaded lipid droplets
into hydrogel beads greatly improved its chemical stability during storage and digestion
process. The current study further fabricated the hydrogel beads with self-regulating
internal pH microclimates by encapsulating antacid agents (i.e., Mg(OH)2 or CaCO3)
inside them. A quantitative fluorescence confocal laser scanning microscopy (CLSM)
method was developed to map the local pH inside the hydrogel beads. Our results showed
that the pH inside antacid-loaded beads remained close to neutral in the mouth and
stomach, leading to retention the activity of acid sensitive agents (i.e., lactase, lipase,
insulin and probiotics) in the small intestine. The current study further studied the effect
of pH on the encapsulation, retention and release of whey proteins from alginate-based
hydrogel beads. Our results indicated that the protein encapsulation efficiency and
retention of the beads increased with decreasing fabrication pH, which was attributed to
the fact that there was a strong electrostatic attraction between the cationic protein and
anionic beads matrix (alginate molecules) at low pH conditions. We further found heatdenaturation of the protein prior to microgel formation led to the highest encapsulation
efficiency and retention, which was attributed to the formation of a cold-set protein gel
inside the beads. Simulated GIT studies indicated that protein encapsulation in the
microgels retarded its digestion in the stomach, but not in the small intestine. Overall, our
study suggest that hydrogel particles with different structures and compositions can be
designed for encapsulation, protection, and delivery of hydrophilic or lipophilic bioactive
agents, which is advantageous for the development of certain functional food products.
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CHAPTER 1
INTRODUCTION
Many pharmaceuticals, nutraceuticals, and vitamins have to be encapsulated
within delivery systems to overcome physicochemical or physiological challenges that
normally limit their efficacy, such as poor water solubility, chemical or biochemical
instability, and low or variable oral bioavailability 1. Numerous types of delivery systems
have been designed to control the retention, stability, and release of bioactive components
within the gastrointestinal tract (GIT) 2. In particular, there has been a strong emphasis on
developing delivery systems that can target or control the release of bioactives at specific
locations within the GIT (such as mouth, stomach, small intestine, or colon) because this
may improve their efficacy, as well as reduce any undesirable side effects. Food grade
delivery systems are one of the most suitable candidates for encapsulation and delivery of
bioactives because they are relatively simple and inexpensive to fabricate 3.

W/O/W
Emulsions

Hydrogel
Particle

Solid
Particles

Liposomes
O/W
Emulsions

Molecules
Figure 1. 1 A variety of bioactive molecules or particles can be trapped inside filled
hydrogel particles to alter their physicochemical properties and delivery.
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Hydrogel particles are one category of food grade delivery system that offers
considerable scope for tailored functionality (Figure 1.1). Hydrogel particles contain
biopolymer networks with a three-dimensional structure that is capable of trapping
relatively large quantities of water 4. A filled hydrogel particle contains oil droplets
trapped within the biopolymer network 5. Typically, bioactives are first dissolved in an
oil phase, and then an oil-in-water emulsion is formed by homogenizing this oil phase
with an aqueous phase containing a suitable emulsifier. The resulting oil droplets are
then trapped within the hydrogel particles during the preparation procedure. The ability to
tune the composition, dimensions, shape, and internal structure of hydrogel particles has
led to widespread interest in their utilization as delivery systems in the food,
pharmaceutical, and personal care industries.
In my projects, I was working on the formation and design of food-grade hydrogel
particles that can encapsulate bioactive agents suitable for use in the food industry, such
as oil-soluble vitamins and nutraceuticals. In particular, My research focus on the
application of hydrogel particles for controlled or targeted release of bioactive agents in
the GIT.
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CHAPTER 2
LITERATURE REVIEW

2.1 Hydrogel particle characteristics
The structural and physicochemical characteristics of hydrogel particles can be
manipulated to tailor their functional attributes for specific applications. In this section,
we therefore highlight some of the most important properties of hydrogel particles that
can be controlled during the fabrication process, e.g., particle composition, size, pore size,
and cross-linking.

2.1.1 Composition
Hydrogel particles are typically fabricated from natural polymers (such as
proteins and polysaccharides) due to their good biocompatibility and biodegradability.
The nature of the biopolymers used to assemble hydrogel particles determines many of
their functional attributes, such as stability, retention, and release properties. It is
therefore crucial to have a good understanding of the molecular, physicochemical and
physiological properties of the biopolymer molecules used to fabricate a hydrogel particle.
Typically, biopolymers can be distinguished based on their conformations in solutions
such as globular, random coil, or rod-like (Figure 2.1).

2.1.2 Polysaccharides
Polysaccharides are usually isolated from plant or microbial sources and may vary
considerably in their molecular and physicochemical properties, such as molecular
weight, branching, flexibility, charge, polarity and digestibility 6. There are a large
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number of different polysaccharides available to form hydrogels, and we only focus on a
selected number that have been widely used. In general, there are three major
mechanisms that can be used to prepare hydrogels from polysaccharides, i.e. ionotropic,
cold-set, and heat-set gelation 7.

Open Structure
High RV value

Dense Structure
Low RV value

Globular

Random coil
Rod-like

Figure 2. 1 Biopolymers may adopt different conformations in aqueous solutions, which
influences their ability to form hydrogel particles with different effective volume
fractions and volume ratios (Rv).
2.1.2.1 Pectin
Pectin can be considered to consist of a linear anionic backbone with neutral side
chains protruding from certain regions, with an overall molecular weight of around 110 to
150 kDa 8. The linear backbone is mainly comprised of α(1-4)-d-galacturonic acid
residues that may be partly esterified with methyl groups. The degree of methyl
esterification (DE) is an important factor determining the gel forming properties of
pectin. Low methoxy (LM) pectin has DE < 50%, and is typically gelled via ionotropic
gelation by adding divalent ions (e.g. calcium). High methoxy (HM) pectin has a DE > 50%
and is typically gelled by adding high levels of soluble solids (such as sugar) under acidic
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conditions 9. Pectin is not digested by gastric or small intestinal enzymes, but is easily
degraded by pectinases produced by the colonic microflora. LM pectin is more tolerant of
pH variations and calcium levels, which could make it more suitable for colonic delivery
systems formation 10. Calcium pectinates have been widely used in different formulations
for the lipophilic bioactive agents encapsulation and delivery 11-12. The integrity of
calcium pectinate beads can be reinforced by formation of polyelectrolyte coatings, e.g.,
by electrostatic deposition of cationic biopolymers (such as chitosan) onto the anionic
beads13. The charge characteristic of pectin can be selected to control lipid digestion and
bioactive release, e.g., decreasing DE reduced lipid digestion and bioactive
bioavailability 14-16.

2.1.2.2 Alginate
Alginate is a linear anionic biopolymer that is widely used to form hydrogel
particles to encapsulate lipophilic agents17-19. Alginate is a block copolymer composed of
1-4-linked residues of β-D-mannuronic acid (M) and α-L-guluronic (G) acid, with an
overall molecular weight around 60 kDa to 700 kDa 20. Alginate hydrogels are usually
formed through an electrostatic cross-linking interaction between multivalent cations
(typically Ca2+) and anionic carboxyl groups (-COO-) on G residues from different
alginate chains21. The pore size of this type of hydrogel has been reported to be between
5 and 200 nm depending on alginate and calcium concentration 22. Calcium alginate
hydrogels shrink at low pH (gastric environment) due to the loss of negative charge on
the alginate molecules when the carboxyl groups become protonated (-COOH, pKa ≈ 3.5).
On the other hand, once transferred into higher pH solutions (intestinal phase), the
alginate molecules become highly charged and the hydrogel network may swell 23. This
5

pH dependent behavior can be exploited to fabricate targeted delivery systems for GIT
applications. Alginate can be further cross-linked or mixed with other polymers such as
neutral gums, chitosan or pectin to strengthen the structure and restrict the pore of the gel
network 22. Studies indicate that the guluronic acid content of the alginate molecules
influences the release properties of alginate-based hydrogels: the amount of bioactive
component that diffused out of alginate hydrogels decreased with increasing G-content 24.

2.1.2.3 Carrageenan
Carrageenan is another type of linear anionic polysaccharide that is commonly
used to form hydrogels25. It consists of galactan monomers linked together by alternating
(1→3)- and (1→4)-β-D-glycosidic bonds, and has a negative charge due to the presence
of sulfate groups 26. Carrageenan can form hydrogels through ionotropic gelation coupled
with a cold-set mechanism. Three types of carrageenan (κ, ι and λ) are commonly used
that have different molecular and gelation properties: κ- and γ- carrageenan can undergo
coil-helix conformational transitions and form hydrogels upon cooling in the presence of
appropriate salts. Gelation of κ-carrageenan is promoted by the presence of potassium
ions, whereas γ-carrageenan gelation is promoted by the presence of calcium ions. The κtype dissolves when heated and forms strong gels that tend to be rigid and brittle, whereas
the γ-type is either hot or cold soluble and forms soft, elastic and cohesive gels. λcarrageenan does not form gels, but it can be used to thicken solutions or as an anionic
building block for structures held together by electrostatic interactions. These differences
in functional performance can be attributed to differences in molecular structure, such as
the linear density of sulfate groups and the preferred molecular conformation (helix
versus ribbon) 20, 27. After hydrogel formation, it is sometimes possible to modify
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hydrogel properties and release characteristics by covalent cross-linking, e.g., κcarrageenan hydrogel particles have been cross-linked using genipin 28.

2.1.2.4 Agar
Agar is a linear neutral polysaccharide that is capable for forming hydrogels under
appropriate conditions29. The agar molecule consists of alternating β-1,3-linked-Dgalactose and α-1,4-linked 3,6-anhydro-L-galactose units, and has an overall molecular
weight above about 100 kDa. The gelling properties of agar depend on its molecular
weight and chemical characteristics 30. Agar can be dissolved in water after heating, and
forms a hydrogel when the solution is cooled due to a coil-helix transition and hydrogen
bonding of helical regions of different molecules. It can therefore be used to form
hydrogel particles by cooling agar microspheres formed by extrusion or biopolymer
phase separation 31. Agar hydrogels tend to be transparent, rigid, and brittle. The gelation
temperature of agar (Tg ≈ 40 °C) tends to be appreciably lower than the melting
temperature (Tm ≈ 85 °C), which can be useful for forming hydrogel particles that are
stable over a range of temperatures. The melting and gelling temperatures of agar gels
have been reported to decrease in the presence of ionic surfactants, whereas nonionic
surfactants had the opposite effect 32. Thus, it may be possible to control their thermal
behavior by incorporating additives that modulate the melting and gelation temperatures.

2.1.2.5 Starch
Starch is a water-soluble polysaccharide mainly composed of two types of
biopolymers: amylose and amylopectin. Amylose is a linear biopolymer consisting of αD-glucopyranose units joined by (1 → 4) linkages, whereas amylopectin is a branched
7

biopolymer with a main chain similar to amylose, but with branches formed due to the
presence of (1 → 6) linkages 33. Certain types of starch (“digestible starch”) are rapidly
degraded in the mouth and stomach due to hydrolysis by a-amylase, whereas other types
of starch (“resistant starches”) are not hydrolyzed until they reach the colon. Hydrogel
particles have been fabricated by thermal gelatinization of digestible starch and used for
targeted delivery of oil-soluble flavors 34-36. Native starches may be modified by various
chemical, enzymatic, and physical methods to improve their functional properties, such
as addition of attachment of hydrophobic, polar, or charge groups, as well as controlled
hydrolysis or cross-linking 37. Modified starches have been widely used to form different
kinds of hydrogel particles for bioactive delivery. For example, chemically modified
starches have been used for targeted delivery of curcumin 38.

2.1.2.6 Chitosan
Chitosan is one of the few examples of positively charged polysaccharides
available to form hydrogels. It has a linear structure composed of randomly distributed
β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine units, with an overall average
molecular weight around 3.8 to 20 kDa 39. The presence of ionizable amino groups (NH3+, pKa ≈ 6.3) is the origin of the cationic charge on chitosan and plays an important
role in its ability to form hydrogels40-41. Chitosan hydrogels can be formed by
complexation with anionic biopolymers or multivalent ions (such as tripolyphosphate)42.
The hydrogel particles formed by chitosan tend to swell and dissolve at low pH (gastric
environment) but be insoluble at higher pH ranges (intestinal phase) due to changes in the
charge characteristics 43. The mechanism of pH sensitive swelling involves the
protonation of amine groups of chitosan under low pH conditions. This property means
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that it is possible to use chitosan to fabricate targeted delivery systems for gastric
applications. Chitosan-based hydrogel particles may also be a good candidate for delivery
of lipophilic bioactive agents due to their mucoadhesive properties, which may prolong
the contact time between the bioactive and absorption sites in the GIT 44.

2.1.2 Protein
Proteins are the other commonly used food biopolymer for the fabrication of
hydrogel particles. Protein-based hydrogels can be formed by various strategies including
heat-set, cold-set, and ion-set gelation. Hydrogel particles can be formed using a number
of top-down and bottom-up fabrication methods (see Section 3). After particle
fabrication, a chemical, physical, or enzymatic hardening step can be used to further
cross-link the proteins and stabilize the particle structures formed 45-48. It should be noted
that many proteins have anti-oxidant properties, which makes them particularly suitable
for encapsulation of lipophilic bioactive agents that are susceptible to oxidation, such as
carotenoids and w-3 oils.

2.1.2.1 Gelatin
Gelatin is usually obtained by acid or alkaline treatment of collagen extracted
from animal or fish sources. Gelatin can form hydrogels through two different
mechanisms leading to physical or chemical gels. Physical gels are the result of reversible
(non-covalent) cross-links formed between different gelatin molecules, which are usually
induced by cooling below the coil-to-helix transition temperature of gelatin chains 49.
Conversely, chemical gels are the result of the formation of covalent cross-links between
different gelatin molecules by chemical or enzyme reactions. Previous studies have
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shown that once gelatin is cross-linked by chemicals (e.g., gluteraldehyde) or enzymes
(e.g., transglutaminase), it loses the ability to undergo thermally reversible coil-to-helix
transitions 50. Physical gelatin gels can melt slightly below the physiological temperature
of humans. This “melt-in-the-mouth’’ property can be used to develop gelatin-based
delivery systems for targeted delivery of bioactive components in the mouth 34.

2.1.2.2 Whey protein
Whey proteins are isolated from the supernatant that remains after milk is treated
to precipitate the casein proteins. Whey protein actually contains numerous different
globular protein fractions, with the most abundant being β-lactoglobulin (β-Lg), αlactoalbumin (α-La), bovine serum albumin (BSA), and immunoglobulins with molecular
weights ranging from 14 kDa to 1,000 kDa 51. Whey proteins can form heat-set and coldset gels through different processing strategies. Heat-set gels are produced when globular
proteins are heated above their thermal denaturation temperature under conditions that
favor protein-protein interactions (i.e., pH near pI and/or high ionic strength). Cold-set
gels are formed using a two-step process. First, the globular proteins are heated above
their thermal denaturation temperature under conditions that oppose protein-protein
interactions (i.e., pH far from pI and low ionic strength), which leads to the formation of
unfolded proteins that assemble into thin filaments. Second, conditions are altered to
favor protein-protein interactions (i.e., pH near pI and/or high ionic strength), which
promotes protein gelation due to aggregation of the filaments. Cold-set gels are
particularly suitable for encapsulating lipophilic bioactive agents that are thermally
unstable52-53. Whey proteins have an isoelectric point around pH 5, and so are positively
charged below this value and negatively charged above it. They can therefore be used to
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assemble structures based on electrostatic attraction, such as coacervates and multilayers.
In addition, whey proteins are surface-active and can be used to form oil-in-water
emulsions. However, whey protein-coated lipid droplets are particularly sensitive to pH,
ionic strength, and temperature.

2.1.2.3 Casein
Caseins are a group of fairly flexible proteins isolated from milk by selective acid
or enzyme precipitation. There are four major casein fractions in bovine milk that have
somewhat different molecular structures and functional properties: aS1 (~ 44%), aS2 (~
11%), b (~ 32%) and k (~ 11%) 54. Nevertheless, all types of caseins have relatively
disordered and flexible structures, with a limited amount of secondary and tertiary
structure. Certain caseins have regions along their backbones that are either highly nonpolar or highly charged, which plays an important role in determining their ability to
associate into hydrogels and other structures. In their native state, caseins usually exist as
molecular clusters (“casein micelles”) that are typically between about 50 and 250 nm in
diameter and are partly held together by mineral ions (such as calcium phosphate). Casein
micelles may be useful for the development of delivery systems because they can
encapsulate lipophilic bioactives in their non-polar interiors, such as carotenoids,
curcumin, and oil-soluble vitamins 55-58. Caseins are amphiphilic molecules that have
good surface-activity and can therefore be used as emulsifiers to stabilize lipid droplets.
They have an isoelectric point around pH 4.6, and are positive at lower pH and negative
at higher pH. Casein molecules, casein micelles or casein-coated oil droplets tend to
aggregate strongly around their isoelectric point due to the reduction in electrostatic
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repulsion at this pH 59. Caseins are less sensitive to thermal treatments than globular
proteins (such as whey protein) due to their disordered flexible structures.

2.2 Hydrogel particle fabrication methods
The properties of hydrogel particles can be tailored for specific applications by
selecting the most appropriate fabrication method and operation conditions. A wide
range of different techniques can be utilized to fabricate hydrogel particles, which have
been reviewed in detail elsewhere 60. Some of the most suitable methods for
encapsulating lipophilic or hydrophilic bioactives are discussed below.

2.2.1 Coacervation-based gelation methods
Coacervation is a well-established technique for encapsulation of bioactive
components, and it is already widely used in the food industry for fabricating hydrogel
particles 61-62. The bioactive is trapped within an electrostatic complex formed when two
oppositely charged biopolymers associate with each other through electrostatic attraction,
and then the resulting system is gelled to form a hydrogel particle63-64. The
swelling/shrinking behavior of hydrogels based on complex coacervation depend on pH
and ionic strength since these parameters influence the sign, magnitude, and range of
electrostatic interactions. Changes in pH alter the electrical characteristics of proteins and
ionic polysaccharides, which influences the formation, stability, and properties of
coacervate-based hydrogels. For example, a protein and anionic polysaccharide associate
at pH values around and below the isoelectric point of the protein due to electrostatic
attraction (one anionic, one cationic), but they may dissociate at higher pH values due to
electrostatic repulsion (both anionic). Addition of salt weakens electrostatic attraction,
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which may also cause dissociation of coacervates. The type and amount of biopolymers
used to assemble a coacervate also determines its properties. The ratio of two
biopolymers required to form a hydrogel particle using coacervation depends on their
charge densities 65. The release characteristics of hydrogel particles can be controlled by
manipulating their composition and fabrication e.g., biopolymer type and concentration,
order of mixing, stirring conditions, temperature, pH, and ionic strength 66-70. The pH
sensitivity of hydrogel particles can be improved by cross-linking the biopolymers
molecules or by coating them with a layer of polyelectrolytes 71. The main limitations of
the coacervation method are that it is difficult to tightly control the particle dimensions
and to avoid particle coalescence and phase separation over time. Previous studies have
shown that hydrogel particles based on coacervation may vary widely in size, ranging
from less than 100 nm to greater than 100 µm 34, 72.
Recently, filled hydrogel particles have been fabricated within our laboratory
based on complex coacervation using various combinations of biopolymers, e.g. alginatechitosan, pectin-casein, gelatin-starch, gelatin-pectin, and alginate-casein 62, 73-75. The
encapsulation of lipids within coacervate-based hydrogel particles has been shown to
delay their digestion by pancreatic lipases, which may be useful to controlled delivery
systems for gastrointestinal applications 76.

2.2.2 Thermal-denaturation gelation methods
Studies have shown that protein hydrogels can be formed by heating a solution of
globular proteins above its thermal denaturation temperature under controlled solution
conditions, e.g. protein concentration, pH, ionic strength, and holding temperature/time
77-78

. The proteins expose non-polar groups on their surfaces after they are denatured,
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which increases the hydrophobic attractive between them. The protein molecules will
tend to associate with each other and form nanoparticles when the hydrophobic attraction
is strong enough to overcome any electrostatic repulsion, but not too strong to promote
extensive aggregation. The size of the hydrogel particles formed can be controlled by
altering the initial biopolymer concentration, holding time, holding temperature, pH and
ionic strength 79. Mixed biopolymer hydrogel particles have been formed by controlled
thermal treatment of electrostatic complexes containing globular proteins and ionic
polysaccharides. These particles were formed by heating a solution of globular proteins
above their thermal denaturation temperature at a specific pH and then complexing with
an ionic polysaccharide 70, 77, 80-81, or by directly heating a solution of protein–
polysaccharide complexes above the protein's thermal denaturation temperature at a
specific pH 82.

2.2.3 Emulsification-based gelation methods
Emulsification-based methods typically rely on the formation of a water-in-oil
(W/O) emulsion or microemulsion containing biopolymer molecules dissolved in the
internal aqueous phase, and then gelling the internal aqueous phase 83. Typically, an
aqueous phase containing the biopolymer and an oil phase containing a lipophilic
surfactant are homogenized together to form a W/O emulsion. Any bioactive
components are usually incorporated into the aqueous phase prior to homogenization.
After the W/O emulsion has been formed the internal aqueous phase is gelled using a
method that is appropriate for the biopolymer used. For example, a heat-set biopolymer
could be gelled by heating, a cold-set biopolymer by cooling, or an ion-set biopolymer by
adding an appropriate organic salt or acid to the oil phase. Once the internal aqueous
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phase has gelled, the resulting hydrogel particles have to be isolated from the surrounding
oil phase, which can be achieved by centrifugation, filtration, and washing with an
organic solvent. Finally, the washed hydrogel particles can be dispersed into an aqueous
solution. This method can also be used to form filled hydrogel particles by preparing an
O/W/O emulsion, gelling the aqueous phase, and then isolating the filled hydrogel
particles from the external oil phase. One of the major advantages of the emulsificationbased methods is that relatively small hydrogel particles with well-defined sizes can be
produced. Hydrogel nanoparticles (10 to 1000 nm) can be formed using W/O
microemulsions as templates, whereas hydrogel microparticles (100 nm to 100 µm) can
be formed using W/O emulsions.

2.2.4 Injection-based gelation methods
Injection or extrusion methods are commonly used to form hydrogel particles
from food-grade biopolymers 84-86. In this case, a biopolymer solution containing the
bioactive agent is initially placed into an injection system, such as a syringe (Figure 2.2).
The biopolymer solution is then injected into another “hardening” solution under
conditions that promote gelation of the biopolymer molecules. The hardening solution
used depends on the gelation mechanism of the biopolymers. A cold or hot hardening
solution could be used to promote cold-set or heat-set gelation of biopolymers. A
hardening solution containing calcium ions could be used to promote ion-gelation of
anionic biopolymers, such as alginate, pectin, or carrageenan. Enzyme or chemical crosslinking agents could be included to promote hydrogel formation through covalent bonds.
The size of the hydrogel particles formed can be manipulated by controlling the needle
diameter, flow rate, and solution viscosity.
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Calcium alginate beads are commonly formed using the injection method. For
example, filled hydrogel particles have been formed by mixing lipid droplets with an
alginate solution, and then injecting this mixture into a hardening solution containing
calcium ions. An in vitro digestion study indicated that calcium alginate beads were
particularly effective at retarding the digestion of the encapsulated lipids, with the extent
of inhibition increasing with increasing bead size and decreasing pore size 76. The
functional properties of calcium alginate beads can be further modulated by coating them
with another polyelectrolyte, such as chitosan 87-88.

Bioactive &
Biopolymer
Solution

Hardening
Solution
Figure 2. 2 Schematic representation of injection method used to produce hydrogel beads.
A solution containing bioactive and biopolymer is injected into a hardening solution.
2.2.5 Shearing-based gelation methods
Fluid gels have been defined as suspensions of hydrogel particles formed by
application of a flow field to a gelling biopolymer solution. Typically, the bioactive and
biopolymer are dissolved within an aqueous solution, the system is stirred continuously,
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and then gelation is induced using an appropriate method (e.g., altering temperature,
changing pH, or adding a gelling agent). The dimensions of the particles produced are
typically around 4 to 100 µm, and depend on the shear rate relative to the gelation rate 89.
Studies of hydrogel particles formed using this method have shown that their size, shape,
and strength can be controlled by varying biopolymer type and concentration, gelation
mechanism, and shearing conditions e.g., rate, duration, and type 90-91. This creates an
attractive opportunity to fabricate hydrogel particles with specific functional attributes 92.
For example, fluid gels have been designed to act as pourable viscoelastic fluids suitable
for the oral delivery of bioactives to individuals with difficulties swallowing 92.

2.2.6 Spray drying and spray chilling-based methods
Hydrogel particles can also be formed using spray drying and spray chilling
methods 20, 93. In spray drying, an aqueous solution containing the bioactive component
and the biopolymer is forced through a small nozzle into a hot chamber. The nozzle
converts the biopolymer solution into small fluid drops that are rapidly converted into
solid particles due to water evaporation caused by the hot air. The solid particles are then
collected by filtration or centrifugal forces94. Typically, the solid particles formed have
dimensions of around 10 to 100 µm, and have to be carefully designed to ensure good
powder functionality (e.g., flowability, dispersion, and dissolution). Hydrogel particles
can be formed by dispersing the powder into an aqueous solution containing a suitable
gelling agent. The size of the hydrogel particles formed depends on the relative rates of
dissolution versus gelation 20. Spray chilling can often be carried out using a similar
apparatus as used for spray drying, however the chamber is usually cooled rather than
heated 93. In this case, the bioactive and a cold-set biopolymer are dissolved in an
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aqueous solution held at a temperature above the gelation temperature. The biopolymer
solution is then sprayed out of a nozzle into a cooled chamber, which promotes gelation
of the biopolymers and leads to formation of hydrogel particles that can be collected by
centrifugal forces or filtration.

2.2.7 Other methods
The fabrication methods discussed above are some of those that are most
commonly used to form food-grade hydrogel particles suitable for encapsulation and
delivery purposes. Nevertheless, there are also many other methods that might be
utilized for specialist applications, such as molding, microfluidic, and electrospraying
methods. A number of review articles have been published detailing the application of
these methods for hydrogel particle fabrication 20, 31.

2.3 Body-particle interactions
Hydrogel particles can be designed to retain, protect, and deliver bioactive
components to specific regions within the gastrointestinal tract 95. For example, they
might be used to release desirable flavor molecules within the mouth or to retain bitter
bioactive molecules in the mouth but release them in the stomach. Alternatively, they
may be designed to protect labile bioactive components from the harsh conditions in the
stomach, but release them within the small intestine or colon. Knowledge of the different
physicochemical and physiological conditions within the different regions of the GIT is
required to design effective delivery systems that can retain and release bioactive
components at specific sites (Figures 2.3 and 2.4).
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Small intestinal

Mouth
Potential release trigger:
• Dilution
• Mixing
• pH
Stomach
• Temperature
Potential
release
• Enzyme degradation
trigger:
(amylase)
• Enzyme degradation
(lipase, protease)
• pH
(highly acidic)
• Time
(1-2 hours)

Potential release trigger:
• Enzyme degradation
(lipase, protease)
• Bile salts/phospholipids
• pH, ionic strength
Colon
• Time
Potential
release trigger:
(1-2 hours)
• Bacterial Fermentation
• pH
• Time
(12-24 hours)

Figure 2. 3 Potential release trigger of bioactive released from hydrogel particles in
mouth, stomach, small intestinal and colon.

2.3.1 Mouth
Numerous variables need to be taken into account when designing hydrogel
particles to retain or release bioactive components in the mouth, including oral
temperature, saliva composition and flow rate, pH and ionic strength, frictional forces,
mixing conditions, duration, and enzyme activity 96-97. Typically, fluid foods spend a
shorter time in the mouth and are not subjected to intense mechanical forces during
mastication, and are therefore often less susceptible to alterations induced by oral
processing than solid foods 98. The utilization of hydrogel particles to control the release
of drugs within the mouth has been investigated by pharmaceutical researchers 99, and
much of the information obtained from these studies is useful for food applications. Some
food researchers have also examined the utilization of hydrogel particles to control the
release of lipophilic bioactive food components in the mouth100-101.
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Malone and co-workers fabricated a range of different filled hydrogel particles to
control the release of lipophilic flavors in the mouth through different mechanisms 34.
Calcium-alginate particles remained intact within the mouth during mastication and
therefore released the flavors primarily through a diffusion-controlled mechanism. Agar
particles broke down in the mouth due to fragmentation by mechanical forces and
therefore released the particles primarily by a degradation-controlled mechanism. Gelatin
particles and gelatin–gum complexes were susceptible to a combination of melting and
fragmentation triggers, while starch particles were susceptible to a combination of aamylase and fragmentation triggers. Factors such as hydrogel particle size, oil content,
and partition coefficient affected the rate of flavor release 34. Our laboratory has
fabricated hydrogel particles based on complex coacervation of casein and alginate that
dissociated and released encapsulated lipid droplets under simulated oral conditions due
to a pH change 75.

Food
Intact and
Impermeable

Mouth

Retention
Stomach

Small
Intestine

Colon

Disintegrated
or Swollen
Release

Figure 2. 4 Delivery systems may be designed to remain intact under one set of
conditions, but breakdown under another set of conditions.
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2.3.2 Stomach
In some cases it is desirable to have a delivery system that remains intact within
the stomach so that it can protect an encapsulated bioactive component from degradation
by acids or enzymes, whereas in other cases it is more desirable to release it in the
stomach to enhance its bioactivity 102. Hydrogel particles encounter a number of harsh
physicochemical and physiological conditions within the dynamic stomach environment
103

. They are mixed with highly acidic gastric fluids (pH 1 to 3) that have a relatively high

mineral content (e.g., calcium, potassium, and sodium salts) and contain various types of
digestive enzyme (e.g., proteases, lipases, and amylases) and surface-active substances
(e.g., phospholipids and proteins). In addition, they are subjected to dynamic mechanical
forces and fluid flows due to the motility of the gastric chamber 104-105.
Alginate gel bead was fabricated with the vegetable oil hold inside the hydrogel
beads. In vitro digestion results indicated that release rate of drug from these hydrogel
beads in artificial gastric juice was inversely related to the percentage of oil, which was
due to the buoyancy characterization of the gel beads at presence of oil inside the gel
particles 106. Other study suggested that oil-entrapped calcium pectinate gel beads also
showed a buoyancy characterization in stomach phase, which made them an excellent
candidate of gastro-retention delivery system for lipophilic agents 107. Calcium alginate
beads have been shown to remain intact under stomach conditions, and are therefore
capable of protecting bioactive components in the gastric environment 76. On the other
hand, various types of protein-based hydrogel particles have been shown to degrade
under simulated gastric conditions, and may therefore be suitable for releasing bioactive
components in the stomach 108-109.

21

2.3.3 Small intestine
After entering the duodenum, any hydrogel particles remaining in the chyme will
be mixed with alkaline small intestinal fluids containing bile salts, phospholipids,
digestive enzymes, and various salts. Pancreatic enzymes (a complex mixture of
proteases, amylases, and lipases) and other digestive enzymes produced by the small
intestine act in concert to degrade any digestible macronutrients in the hydrogels: proteins
are converted to peptides and amino acids by proteases; starches are converted to
oligosaccharides and glucose by amylases; triacylglycerols are converted to free fatty
acids (FFA) and monoacylglycerols (MAG) by lipases 104. It is often desirable to have
bioactive components released from hydrogel particles in the small intestine so as to
increase their bioavailability. This is particularly important for highly lipophilic
bioactives (such as oil soluble vitamins, caroteonids, curcuminoids, and long chain fatty
acids) that normally have low bioavailability because of their limited solubility in
gastrointestinal fluids. These components need to be released from the hydrogel particles
within the small intestine, and then solubilized within mixed micelles formed by bile salts,
phospholipids, and lipid digestion products. The mixed micelles then transport the
encapsulated bioactive components to the surfaces of the epithelium cells where they are
absorbed 110.
Li and co-workers fabricated filled hydrogel particles by trapping protein-coated
lipid droplets inside chitosan/calcium alginate hydrogel particles 76. A simulated GIT
model showed that the hydrogels could control the lipid digestion rate: relatively small
hydrogel beads (d < 50 µm) caused a moderate delay in lipid digestion, while large
hydrogel beads (d > 100 µm) delayed appreciably delayed digestion 76. Mun and co-
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workers showed that β-carotene bioaccessibility was increased after being encapsulated
in starch-based filled hydrogels, which was attributed to the ability of the lipid droplets to
form mixed micelles and the hydrogels to increase the surface area of lipid exposed to
digestive enzymes by inhibiting droplet aggregation 111.

2.3.4 Colon
If they are designed for colonic delivery, then the bioactive components within
hydrogel particles must pass through the mouth, stomach, and small intestinal without
being released or absorbed. Most macronutrients (lipids, proteins, and starches) are
digestible within the upper GIT and therefore they are largely unsuitable for the
development of hydrogel particles suitable for use as colonic delivery systems.
Conversely, dietary fibers are not digested within the upper GIT but are digested within
the lower GIT due to enzymes secreted by colonic bacteria, and are therefore suitable
building blocks for this type of delivery system 112. Nevertheless, the delivery systems
must still be carefully designed so that the bioactive agents remain retained and protected
within the hydrogel particles throughout the upper GIT. This usually means that they
should remain intact and impermeable within the mouth, stomach, and small intestine
fluids. The ability of bioactive agents to be delivered to the colon by dietary fiber based
hydrogels is due to the fact that the concentration of microbes present in the colon is
much higher than that in other regions of the GIT 113. Several dietary fibers had been
investigated for colon-specific hydrogel particles such as pectin 114, alginate 115, dextran
116

, guar gum 117 and chitosan 118 .
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2.4 Conclusions
Structurally-designed hydrogel particles have been developed to encapsulate,
protect, and release a wide range of bioactive components in the pharmaceutical industry.
Hydrogel particles are now being explored for similar types of application in the food
industry. In this case, food-grade biopolymers, such as proteins and polysaccharides, are
used to fabricate the hydrogel particles rather than synthetic polymers or chemicallymodified biopolymers. The biopolymers should be selected according to the
characterization of encapsulated agents and the delivery target of the hydrogel matrix.
For example, protein should be involved in the ω-3 fatty acids loaded hydrogels design.
The dietary fiber is a good candidate used in the colon target hydrogel particles
fabrication. In addition, the hydrogel particles must be fabricated utilizing processing
operations that are inexpensive, robust, and scalable, which provides additional
challenges. Hydrogel particles are being developed to protect bioactive components
from degradation within foods and specific regions of the gastrointestinal tract, but then
release them at an appropriate site of action.
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CHAPTER 3
ENCAPSULATION, PROTECTION, AND RELEASE OF BIOACTIVE LIPIDS
USING HYDROGEL PARTICLES

3.1 Encapsulation and protection of bioactives using hydrogel particles
3.1.1 Introduction
Epidemiological, clinical, and experimental studies indicate that fish oil, which
contains n-3 polyunsaturated fatty acids (n-3 PUFA) such as eicosapentaenoic acid (EPA,
20:5 n-3) and docosahexaenoic acid (DHA, 22:6, n-3), can protect against the
development of chronic diseases such as heart disease, brain disease, arthritis, and certain
types of cancer (Riediger, Othman, Suh & Moghadasian, 2009, Ruxton, Reed, Simpson,
Millington & Ruxton, 2007, Yashodhara, Umakanth, Pappachan, Bhat, Kamath & Choo,
2009). In the USA, where a western-style diet is predominant, the average fish intake is
currently well below the recommended two to three servings per week 119. There is
therefore a concerted effort to enrich various food and beverage products with n-3 PUFA
so as to improve their healthfulness. However, there are a number of challenges
associated with incorporating these bioactive lipids into foods. Firstly, PUFAs are highly
non-polar molecules with low water-solubility and therefore have to be encapsulated
within emulsion-based delivery systems if they are going to be introduced into aqueousbased products 5, 120. Second, PUFAs are highly susceptible to chemical degradation due
to lipid oxidation, which leads to a reduction in product quality and acceptability, and
therefore they have to be protected against this form of chemical degradation 121-125.
Third, it is important that PUFAs are fully absorbed within the upper gastrointestinal (GI)
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tract after oral ingestion so that they can demonstrate their beneficial health effects 126.
Consequently, there is a need to develop effective food-grade delivery systems to
encapsulate, protect, and release PUFAs.
There is growing interest in the utilization of proteins and peptides (referred to
collectively as “polypeptides” for convenience) as functional ingredients in foods because
of their beneficial health effects, such as antioxidant, antimicrobial, and anti-hypertension
activities 127-130. Typically, the activity of polypeptides depends on their threedimensional structures and specific amino acid sequences 130. Polypeptide activity may
therefore be altered in food products during manufacture, storage, or transportation, due
to changes in solution or environmental conditions that alter protein structure, such as pH,
ionic strength, ingredient interactions, or temperature 131. In addition, their activity may
be altered after they are ingested and pass through the gastrointestinal tract (GIT) because
they are exposed to digestive enzymes (proteases and peptidases) and environmental
conditions (pH, ionic strength, and ingredient interactions) that may alter their structure
132

. Within the GIT, digestive enzymes and highly acidic gastric conditions may

hydrolyze polypeptide chains at particular bond locations, thereby generating new
peptides 133. This process may be undesirable if it leads to loss of the bioactivity of an
ingested polypeptide, or it may be desirable if it leads to the generation of new peptides
with improved bioactivity. Consequently, it is often important to design food matrices
that can control the gastrointestinal fate of polypeptides within foods and within the GIT
so as to improve their bioactivity profiles 132, 134.
In the current study, we fabricated filled hydrogel particles containing n-3 PUFA
droplets embedded within a dietary fiber matrix formed by complex coacervation. We
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used low-methoxy (LM) amidated pectin as an anionic biopolymer and casein as a
cationic biopolymer to form hydrogel particles. The casein was enzymatically crosslinked using transglutaminase to improve the stability of the biopolymer matrix. The
effect of hydrogel particle encapsulation on the chemical stability of emulsified
polyunsaturated lipids (fish oil) were investigated. Furthermore, we investigated the
possibility of encapsulating protein nanoparticles within polysaccharide-based hydrogel
particles, and studied the influence of solution and environmental conditions on their
properties. Initially, protein nanoparticles were formed from a hydrophobic protein (zein)
using an antisolvent precipitation method, and utilizing a protein-based emulsifier (whey
protein) to stabilize them. These composite protein nanoparticles were then encapsulated
within microgels formed by acidifying a polysaccharide/protein mixture
(alginate/caseinate) to induce electrostatic complexation, leading to the formation of a
hydrogel matrix that trapped the protein nanoparticles inside. The main focus of this
study was to examine the influence of solution conditions (pH and ionic strength) on the
stability and properties of the protein nanoparticle-loaded microgels. This information is
useful for establishing their potential application in food products, and their potential
behavior within the gastrointestinal tract

3.1.2 Materials and methods
3.1.2.1 Materials
Powdered sodium caseinate was obtained from the American Casein Company
(MP Biomedicals LLC) and was used without further purification. As stated by the
manufacturer, the protein and moisture content of the powder were 91.4% and 5.0%,
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respectively. Zein (Lot# SLBD5665V) and sodium alginate (Lot 50K0180) were
purchased from Sigma–Aldrich (St. Louis, MO, USA). Whey protein isolate (WPI)
powder was obtained from Davisco Foods International Inc. (Le Sueur, MN,
USA). Alginic acid (sodium salt) (Lot# 180947) was purchased from the Sigma
Chemical Company (St. Louis, MO). Low methoxyl amidated pectin (Genu Pectin
(Citrus), LM-104 AS-Z) was donated by CP Keloco (Lille Skensved, Denmark) and was
used without further purification. The degree of esterification (DE) was approximately 27%
as provided by the manufacturer. The protein cross-linking enzyme transglutaminase
(Activa TI) was donated by Ajinomoto Food Ingredients (Chicago, Illinois). According to
the manufacturer, the activity of this enzyme was 100 units per gram of powdered
preparation. Fish oil was obtained from DSM Nutritional Products Ltd. (Basel,
Switzerland). This oil contained 101 mg of EPA/g of oil, 148 mg of DHA/g oil, and a
total w-3 PUFA content of 312 mg/g of oil.
All chemicals used, including technical grade Nile red dye (CAS #7385-67-3) and
fluorescein isothiocyanate isomer I, were purchased from Sigma-Aldrich (St. Louis, MO).
Double distilled water was used to prepare all solutions and emulsions.

3.1.2.2 Conventional emulsion preparation
A 10% (w/w) oil-in-water (O/W) emulsion stabilized by sodium caseinate (NaC)
was prepared as a stock emulsion. An emulsifier solution was prepared by dispersing 1%
(w/w) NaC powder in 10 mM phosphate buffer (pH 7) with continuous stirring at 700
rpm for 2 hours (40 oC). A coarse emulsion was then prepared by blending fish oil (10%
w/w) and emulsifier solution (90% w/w) using a high speed blender for 2 min (Tissue
Tearor Model 985370-395, Biospec Products Inc., Bartles- ville, OK). The droplet size in
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this coarse emulsion was further reduced by passing it three times through a highpressure homogenizer (Microfluidics Microfluidizer M-110P, Newton, MA USA) at
12,000 psi.

3.1.2.3 Protein nanoparticles preparation
Protein nanoparticles were fabricated from zein using an antisolvent precipitation
method. Initially, zein (26.4 mg/mL) was dissolved in ethanol solution (80% v/v). Then,
25 mL of aqueous ethanol solution was rapidly injected into 75 ml of whey protein
solution (0.25% WPI, PBS, pH 6.5) that was continuously stirred at 1200 rpm using a
magnetic stirrer (IKA R05, Werke, GmbH). The resulting colloidal dispersion was then
stirred for another 30 min at the same speed. The ethanol remaining in the final colloidal
dispersions was evaporated using a rotary evaporator (Rotavapor R110, Büchi Corp.,
Switzerland), and the same volume of pH 6.5 PBS was added to compensate for the lost
ethanol.

3.1.2.4 Unfilled hydrogel particle preparation
The method used to form the hydrogel microspheres was adapted from Chung et
al (2012) with some slight modifications. This method involves inducing thermodynamic
incompatibility at a pH where the biopolymers have similar charges (e.g., pH 7), and then
adjusting the pH to a value where the biopolymers have opposite charges (e.g., pH 4.5) to
induce coacervation. This procedure promotes the formation of casein-rich microspheres
surrounded by a pectin shell. Initially, 3% (w/w) NaC and 3% (w/w) pectin solutions
were prepared by dissolving weighed amounts of biopolymers into phosphate buffer (pH
7). 2 M sodium hydroxide was used to adjust the biopolymer solution to pH 7. Equal
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weights of the two stock solutions were then mixed together using stirring. The pH of this
mixture was adjusted to 7 (if necessary) using 2 M sodium hydroxide. This mixture was
then acidified to pH 4.5 using 1 M citric acid at a rate of 1 drop/10 s with continuous
stirring at 500 rpm. The hydrogel particles were then cross-linked by adding a solution of
transglutaminase (0.1 g/ml 10 mM PBS, pH 4.5) at a level of 10 units of enzyme
activity/per gram of protein. The solution was then incubated at 40 oC for 2 hours with
constant stirring at 500 rpm. At the end of the incubation period, the reaction was stopped
by heating the samples in an 85 oC water bath for 5 minutes. Control (not cross-linked)
particles were exposed to the same incubation and inactivation conditions as enzyme
treated particles.
For the protein nanoparticles encapsulation, another hydrogel particles were
prepared using caseinate and alginate. Firstly, 2 M sodium hydroxide was used to adjust
caseinate (2%) and alginate (2%) solutions to pH 7. Then these two stock solutions and
phosphate buffer were mixed together at different volume ratios under continuous stirring
to form final compositions of 0.33% sodium caseinate/1.33% alginate (mass ratio 1:4).
The mixtures were then acidified to pH 5 using 1 M citric acid at a rate of 1 drop/10 s
with continuous stirring at 500 rpm to promote complex formation.

3.1.2.5 Filled hydrogel microsphere preparation
Stock solutions of 6% casein and 3% pectin were prepared separately in 10 mM
phosphate buffer at pH 7 and stirred until fully dissolved. 2 M sodium hydroxide was
used to adjust the dissolved biopolymer solution to pH 7. After pH adjustment, 10% (w/w)
oil-in-water emulsion, 6% casein, and 10 mM phosphate buffer were mixed together to
obtain a system containing 3% casein and 2% fat. Then equal volumes of droplet-
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biopolymer mixture and pectin were mixed (500 rpm) and the solution was adjusted to
pH 7.0 (if necessary). The obtained mixture was finally acidified to pH 4.5 using 1 M
citric acid at a rate of 1drop/10 s with continuous string at 500 rpm to promote complex
coacervation. The same procedure was also used as described in 2.2.1 to form cross-liked
filled hydrogel microspheres.
2 M sodium hydroxide was used to adjust caseinate solutions, alginate solutions,
and protein nanoparticle dispersions to pH 7. After pH adjustment, 6.6 mg/mL protein
nanoparticle dispersion and 2% sodium caseinate solution were mixed together at a 1:1
volume ratio. Then, this system was mixed (500 rpm) with 2% alginate solution at a
volume ratio of 1:2. Finally, the resulting mixture was acidified to pH 5 using 1 M citric
acid with continuous stirring at 500 rpm to promote complex formation. The final
composition of the resulting system was 1.1 mg/mL protein nanoparticles, 0.33% sodium
caseinate, and 1.33% alginate.

3.1.2.6 Microstructure analysis
The microstructure of all systems was examined using optical and confocal
scanning laser microscopy with a 60 × objective lens and 10 × eyepiece (Nikon DEclipse C1 80i, Nikon, Melville, NY, U.S.). A small aliquot of sample was placed on a
microscope slide and covered with a cover slip prior to analysis. For the confocal
microscopy, samples were dyed prior to particle formation. The oil phase in the filled
hydrogel particles was dyed with Nile red solution (1 mg/mL ethanol) by adding 0.1 mL
of Nile red solution to 2 mL of oil, covering, and stirring overnight. The dyed oil was
then used to form an emulsion as described in Section 2.2.1. The NaC phase was dyed
with fluorescein thiocyanate isomer I (FITC) solution (1 mg/mL dimethyl sulfoxide)
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prior to measurements by adding 0.1 mL of FITC dye solution to 2 mL of sample. The
excitation and emission spectrum for Nile red were 543 nm and 605 nm, respectively
while for FITC they were 488 nm and 515 nm, respectively. The microstructure images
for confocal microscopy were taken and analyzed using image analysis software (NISElements, Nikon, Melville, NY).

3.1.2.7 Determination of lipid oxidation
The chemical stability of the filled hydrogel particles and non-encapsulated lipid
droplets was evaluated by monitoring the formation of hydroperoxides over the course of
7 days storage. The hydroperoxides of different systems were extracted using
chloroform/methanol solution: 1 ml of emulsion or filled hydrogel microsphere
suspension was vigorously vortexed three times with 7.5 ml of chloroform: methanol (2:1
vol/vol) followed by centrifugation for 5 min at 1300g. Then 0.2 ml of the
chloroform/methanol extract (lower layer) was carefully removed and mixed with 2.8 ml
of methanol/1-butanol (2:1 vol/vol). Depending on the concentration of hydroperoxides,
the chloroform/methanol extract was diluted with solvent such that the final absorbance
of the reacted sample remained below 1.0 cm-1. This mixture (3.0 ml) was then reacted
with 15 µL of 3.94 M ammonium thiocyanate and 15 µL of ferrous iron solution
(prepared by reacting 0.132 M barium chloride and 0.144 M ferrous sulphate). The
mixture was vortexed and allowed to react for 20 min at room temperature in the dark
before the absorbance of the sample was measured at 510 nm using a spectrophotometer.
The concentration of hydroperoxides was determined based on a standard curve of
cumene hydroperoxide (0–20 µM).
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3.1.2.8 Stability of environmental conditions
The particle size and microstructure of the colloidal dispersions were determined
after they were exposed to various environmental conditions.
Effect of pH: Freshly prepared colloidal dispersions were mixed with equal
volumes of 10 mM phosphate buffer with pH values ranging from 3.0 to 7.0. The samples
were then adjusted to the desired pH values with 1 mol/L NaOH or HCl.
Effect of salt: Protein nanoparticles were mixed with equal volumes of phosphate
buffer at pH 6.5 containing sodium chloride (50–400 mM NaCl). While, nanoparticleloaded microgels were mixed with equal volumes of phosphate buffer at pH 5.0
containing sodium chloride (0.5–2 M NaCl). If necessary, the samples were then adjusted
to pH 6.5 or pH 5.0 with 1 mol/L NaOH or HCl.

3.1.2.9 Statistical analysis
All experiments were carried out on two or three freshly prepared samples. The
results are expressed as means ± standard deviations (SD). Data were subjected to
statistical analysis using SPSS software (version 18.0). Means were subject to Duncan's
test and a P-value of <0.05 was considered statistically significant.

3.1.3 Results and discussion
3.1.3.1 Microstructure
The microstructure of the particles in the different delivery systems was measured
using confocal scanning laser microscopy. The lipid droplets were dyed using Nile red
(stained red) and the casein was dyed using FITC (stained green). The confocal images
show that small lipid droplets were distributed throughout the casein-rich phase. In the
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emulsion, the casein was distributed throughout the aqueous phase, indicating that it was
not all adsorbed to the lipid droplet surfaces (Figure 3.1 a). In the unfilled hydrogel
particles, casein-rich microspheres were distributed throughout a black background,
indicating that most of the casein was present within the hydrogel particles. The location
of pectin within the hydrogel particle suspensions could not be determined since it was
not specifically dyed by a fluorochrome. However, based on the negative particle charge,
we expect that some pectin molecules formed a coating around the casein-rich
microspheres. In the presence of lipid droplets, the confocal images indicate that almost
all of the lipid droplets (red) were embedded inside the casein-rich hydrogel microspheres
(Figure 3.1c). Samples containing larger microspheres were prepared using moderate
stirring conditions during fabrication of the filled hydrogel particles so as to better
observe their internal structure. The images of these larger particles clearly indicate that
lipid droplets (red) were encapsulated within casein-rich microspheres (green) (Figure
3.1d). This result is in agreement with the static light scatting data mentioned above.
Both the filled and non-filled hydrogel microspheres had a uniform small diameter
(around 3 to 5 µm). These filled hydrogel particles are smaller than those typically
produced using conventional coacervation methods, which may an advantage for some
commercial applications within the food industry.
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(a)

(b)

(c)

(d)

Figure 3. 1 Confocal micrographs (60× magnifications) of (a) 1% oil-in-water emulsion,
(b) hydrogel particles fabricated without fat, (c) filled hydrogel particles and (d) filled
hydrogel particles fabricated with moderate stirring. The oil phase (red) was stained with
Nile red while the protein phase (green) was stained with FITC.
3.1.3.2 Lipid oxidation in filled hydrogel particles and emulsions
One of the major challenges associated with the fortification of foods with omega3 fatty acids is their high susceptibility to lipid oxidation during storage 105, 122-123. The
rate and extent of lipid oxidation of emulsified lipids can often be overcome using well-
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designed colloidal delivery systems. We therefore compared the oxidative stability of the
lipid (fish oil) droplets in filled hydrogel microspheres and conventional emulsions
(Figure 3.2). We measured the concentration of primary reaction products
(hydroperoxides) in conventional emulsions and filled hydrogel microspheres during 7
days storage. The hydroperoxide concentration in the conventional emulsions increased
sharply after 4 days storage and then remained high during further storage. On the other
hand, the hydroperoxide concentration remained relatively low from 0 to 7 days storage
for the lipid droplets encapsulated within filled hydrogel microspheres. These results
were somewhat different from a previous study, which reported that filled casein-rich
microspheres and casein-stabilized emulsions had fairly similar oxidation rates, but filled
hydrogel microspheres had much better stability than Tween-stabilized emulsions 73.
These differences may be due to the different fabrication methods and materials used to
form the filled hydrogel microspheres in both studies. Casein is known to have
antioxidant properties due to its ability to scavenge free radicals and chelate pro-oxidant
transition metals, such as iron or copper 135. The confocal fluorescence images discussed
earlier indicated that casein was concentrated within the hydrogel microspheres, and
therefore there would be a high local concentration of this antioxidant protein in the
vicinity of the lipid droplets. This casein-rich matrix may have been able to scavenge free
radicals and bind transition metals thereby inhibiting their interaction with the lipid
droplets inside the hydrogel microspheres. Overall, these results suggest that
encapsulating fish oil droplets within a hydrogel matrix containing high concentrations of
antioxidant proteins may be a more effective means of inhibiting lipid oxidation than
simply having a thin layer of casein molecules around each lipid droplet.
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3.1.3.3 Influence of pH on stability
Colloidal delivery systems utilized within foods and beverages may experience
appreciably different pH environments depending on the nature of the product. In
addition, they may be exposed to considerable variations in pH as they pass through the
human gastrointestinal tract after ingestion. Consequently, it is useful to understand the
influence of pH on the properties of any colloidal delivery system intended for use in
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Figure 3. 2 Concentration of hydroperoxides formed from fish oil during 7 days storage
in simple oil-in-water emulsions and in filled hydrogel particles
3.1.3.3 Influence of pH on stability
Colloidal delivery systems utilized within foods and beverages may experience
appreciably different pH environments depending on the nature of the product. In
addition, they may be exposed to considerable variations in pH as they pass through the
human gastrointestinal tract after ingestion. Consequently, it is useful to understand the
influence of pH on the properties of any colloidal delivery system intended for use in
commercial food and beverage products.

3.1.3.3.1 Protein-nanoparticles
The tendency for aggregation to occur is highlighted in measurements of the
influence of pH on the particle size and microstructure of the protein nanoparticle
suspensions (Figures 3.3 to 3.5). At high pH values (6.5 to 7), the particles were
relatively small (d32 < 1 µm), had a monomodal distribution, and were evenly distributed
throughout the sample. At intermediate pH values (pH 5.5. to 4), the particle size was
relatively big (d32 > 10 µm) and large irregular shaped aggregates were observed in the
microscopy images. At low pH values (3 to 3.5), there was an appreciable increase in
particle size detected by light scattering, and also evidence of some large aggregates in
the microscopy images (Figures 3.3 to 3.5). It is possible that these aggregates formed
as the suspensions were moved from high pH to low pH, and were not fully broken down
under acidic conditions. The reason for the difference in appearance of the protein
nanoparticle suspensions at low and high pH values also indicated that the nature of the
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particles present had changed due to an alteration in the strength of the electrostatic
interactions in the system.
1000
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Figure 3. 3 Effect of pH on mean particle diameters (d32) of protein nanoparticles and
filled hydrogel particles. Different letters mean significant differences (p < 0.05) of the
particle diameter at different pH values.
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Figure 3. 4 The pH-dependence of the particle size distribution of (a) protein
nanoparticles and (b) protein nanoparticle-filled hydrogel particles.
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Figure 3. 5 Confocal fluorescence micrographs of (a) protein nanoparticles and (b)
protein nanoparticle-filled hydrogel particles after incubation at different pH values.
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3.1.3.3.2 Filled microgels
We then examined the influence of pH on the properties of the proteinnanoparticle filled microgels. The light scattering measurements indicated that the
dimensions of the microgels remained relatively constant from pH 3 to 6, with a
monomodal particle size distribution (Figures 3.3 and 3.4b). However, the particle size
distribution became bimodal at pH 6.5 and 7, with a population of particles around 180
nm and another population around 4 µm. We hypothesize that the microgels dissociated
at these higher pH values because the alginate and caseinate molecules both had strong
negative charges and so there was a strong electrostatic repulsion between them.
Consequently, the microgels may have released the protein nanoparticles, which would
account for the population of small particles observed in the particle size distributions at
these pH values (Figure 3.4b). This observation was supported by the confocal
microscopy images of the influence of pH on the microstructure of the system (Figure
3.5b). At pH 3 to 5, the microgels remained as discrete intact particles, i.e., the images
showed discrete regions of high fluorescence intensity (protein-rich particles) surrounded
by a black (protein-free) background. At pH 5.5, there was evidence that some of the
protein had leaked out of the microgels, i.e., the images showed discrete regions of high
fluorescence intensity (protein-rich particles) surrounded by a green (protein-rich)
background. At pH 7, it appeared that the microgels had almost completely disintegrated
and the protein was evenly distributed throughout the system. In these systems, we
hypothesize that the protein nanoparticles had been released from the microgels and
formed a stable colloidal dispersion. This hypothesis is based on the fact that a
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population of small particles was observed in the light scattering data (Figure 3.4b), , and
the protein was evenly spread throughout the samples.

3.1.4 Conclusion
This study has shown that protein nanoparticles and polyunsaturated lipid droplets
can be successfully incorporated into biopolymer microgels formed from electrostatic
complexation of casein and alginate. Incorporating polyunsaturated lipid droplets within
the hydrogel microspheres effectively inhibited lipid oxidation, which may be important
for stabilizing these healthy lipids in food and beverage products. In addition, we found
The protein nanoparticles were retained within the microgels at low pH values (3 to 5.5)
with no aggregation formed. Overall, our results suggest that encapsulation of protein or
polyunsaturated lipid droplets nanoparticles within microgels may be a viable method of
improving their chemical or physical stability, which have important implications for the
development of food-grade delivery systems to fortify foods and beverages with
bioactive protein and lipids.
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3.2 Release of bioactives using hydrogel particles: pH-triggered release
3.2.1 Introduction
Various types of lipophilic active agents need to be incorporated into aqueousbased products, protected during storage, and then released in the mouth after ingestion,
e.g., certain oil-soluble drugs 136-137, antimicrobials for oral health 138-139, and food flavors
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. Lipophilic actives usually have to be solubilized within an emulsified oil phase before

they can be successfully incorporated into aqueous-based products. It is often important
to be able to control the release profile of lipophilic components within the mouth after
ingestion, e.g., for controlled flavor release in the food industry 34, 101, 141. In some
situations, a rapid or burst release profile is required, but in other cases a prolonged or
delayed release is preferred 142. It is therefore important to develop delivery systems that
can encapsulate lipophilic active agents, protect them within products, but then release
them within the mouth. A number of studies have encapsulated lipophilic actives within
solid particles produced by drying oil-in-water emulsions 143-146. The resulting delivery
systems are in a powdered form that is particularly suitable for application within lowmoisture products. However, there is also a need for delivery systems that can be
incorporated into high-moisture products (such as beverages, dressings, sauces, and
desserts). For these applications it is possible to encapsulate lipophilic actives within
hydrogel particles formed from food-grade biopolymers 34, 101. These hydrogel particles
may be specifically designed to control the release profile of lipophilic actives within the
mouth.
Hydrogel particles can be formed using various fabrication methods, including
extrusion, templating, molding, thermodynamic incompatibility, and coacervation, with
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each method having certain advantages and disadvantages for particular applications 20, 79.
Complex coacervation is a relatively simple method that relies on the formation of
electrostatic complexes between polymers that have opposite charges 147-148.
Coacervation refers to the phase separation of a liquid phase into a polymer-rich phase
(coacervate) and a polymer-poor phase 149-152. Coacervation is already widely used in the
food and pharmaceutical industries to encapsulate active ingredients 145, 153-154. Filled
hydrogel microspheres based on complex coacervation can be used as aqueous-based
delivery systems, and can be considered to be examples of O/W1/W2 type structured
emulsions 79. Lipid droplets are trapped within hydrogel microspheres (W1), which
themselves are suspended within a continuous aqueous phase (W2). In recent studies, we
have successfully fabricated fish oil loaded hydrogel particles based on complex
coacervation of caseinate and LM-pectin 155. Encapsulation of fish oil within filled
hydrogel particles improved their stability to lipid oxidation compared to conventional
emulsions.
The design of delivery systems that can control the release of encapsulated actives
within the mouth relies on an understanding of their oral processing 156-158. Aqueousbased delivery systems containing relatively small particles do not require chewing
before swallowing. Nevertheless, they are still exposed to changes in environmental
conditions within the mouth that may alter their release properties, such as changes in
temperature, enzyme activity, dilution, pH, ionic strength, flow profiles, and interactions
159-161

. A number of these factors may be used as potential triggers to release encapsulated

active components within the mouth.
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In this work, we fabricated filled hydrogel particles by trapping emulsified lipids
within complex coacervates formed from two food-grade biopolymers: alginate and
casein. Casein is a milk protein with a flexible structure known to have strong antioxidant
properties 155, and may therefore be used to stabilize encapsulated polyunsaturated lipids
from oxidation during storage 155. Alginate is an anionic linear polysaccharide that is
commonly used as a building block in the formation of hydrogel particles 6. The ability of
hydrogel particles to control the release of encapsulated lipid droplets within the mouth
was evaluated using simulated oral conditions. We hypothesized that lipid droplets could
be retained within hydrogel particles during storage, but released under simulated oral
conditions using pH as a trigger. The results of this study provide valuable information
for the rational design and fabrication of delivery systems for lipophilic agents that need
to be released in the mouth.

3.2.2 Materials and methods
3.2.2.1 Materials
Powdered sodium caseinate was obtained from the American Casein Company
(MP Biomedicals LLC) and was used without further purification. As stated by the
manufacturer, the protein and moisture content of the powder were 91.4% and 5.0%,
respectively. Corn oil was purchased from a local supermarket and used without further
purification. Alginic acid (sodium salt) (Lot# 180947, viscosity of 1% alginic acid in
water is 15–20 cp) was purchased from Sigma–Aldrich (St. Louis, MO). All chemicals
used were analytical grade and purchased from Sigma-Aldrich (St. Louis, MO). Double
distilled water was used to make all solutions.

45

3.2.2.2 Conventional emulsion preparation
A 10% (w/w) oil-in-water (O/W) emulsion stabilized by sodium caseinate (NaC)
was prepared as a stock emulsion. An emulsifier solution was prepared by dispersing 1%
(w/w) NaC powder into 10 mM phosphate buffer (pH 7) with continuous stirring at 700
rpm for 2 hours (40 oC). A coarse emulsion was then prepared by blending corn oil (10%
w/w) and emulsifier solution (90% w/w) together using a high-speed blender for 2 min
(Tissue Tearor Model 985370-395, Biospec Products Inc., Bartles- ville, OK). The
droplet size in this coarse emulsion was further reduced by passing it 3 times through a
high-pressure homogenizer (Microfluidics Microfluidizer M-110P, Newton, MA USA) at
12,000 psi.

3.2.2.3 ζ-potential measurements
The electrical charge (ζ-potential) of caseinate and alginate at different pH values
(2 to 7) was measured using a particle electrophoresis instrument (Zetasizer Nano ZA
series, Malvern Instruments Ltd. Worcestershire, UK). Samples were diluted using 10
mM phosphate buffer (at the same pH as the sample) prior to analysis to keep the
instrument attenuation value between 5 and 10. All measurements were made on at least
two freshly prepared samples and each sample was measured in duplicate.

3.2.2.4 Turbidity measurements
The turbidities of dispersions containing caseinate and alginate were determined
using a UV–visible spectrophotometer at 600 nm (Ultrospec 3000 pro, Biochrom Ltd.,
Cambridge, UK). The samples were contained within 1 cm path length optical cells, and
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phosphate buffer was used as a control. Turbidity measurements were carried out on at
least two freshly prepared samples.

3.2.2.4 Unfilled and filled hydrogel microsphere preparation
Initially, 1% (w/w) NaC and 2% (w/w) alginate solutions were prepared by
dissolving weighed amounts of biopolymers into phosphate buffer (pH 7). 2 M sodium
hydroxide was used to adjust the dissolved biopolymer solution to pH 7. Then these two
stock solutions and phosphate buffer were mixed together at different volume ratios
under continuous stirring to form final compositions of 0.33% casein/1.33% alginate
(mass ratio 1

4) and 0.75% casein/0.25% alginate (mass ratio 3:1). The pH of the

biopolymer mixtures was adjusted to 7.0 (if necessary) using 2 M sodium hydroxide. The
mixtures were then acidified to pH 5 using 1 M citric acid at a rate of 1 drop/10 s with
continuous stirring at 500 rpm. The influence of pH on the characteristics of the hydrogel
particles formed was studied by adding different amounts of 1 M citric acid or sodium
hydroxide.
Stock solutions of 2% casein and 2% alginate were prepared separately in 10 mM
phosphate buffer at pH 7 and stirred until fully dissolved. 2 M sodium hydroxide was
used to adjust the dissolved biopolymer solution to pH 7. After pH adjustment, 6% (w/w)
oil-in-water emulsion and 2% casein were mixed together to obtain a system containing 1%
casein and 3% fat. Then this droplet-biopolymer mixture was mixed (500 rpm) with 2%
alginate solution at a volume ratio of 1:2. The obtained mixture was finally acidified to
pH 5 using 1 M citric acid with continuous string at 500 rpm to promote complex
coacervation. The final composition of the resulting system was 1% fat, 0.33% casein,
and 1.33% alginate.
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3.2.2.5 Particle size measurements
The particle size of hydrogel particles at different pH (2-7) was determined using
static light scattering (Mastersizer 2000, Malvern Instruments, Worcestershire, United
Kingdom). This instrument infers the size of the particles from measurements of their
angular scattering pattern. All measurements were made on at least two freshly prepared
samples. Samples were diluted in 10 mM phosphate buffer (pH 2-7) by adding small
aliquots into a measurement chamber. A refractive index of 1.33 was used for the
aqueous phase, 1.472 for the oil phase and hydrogel particle phase. Particle size
measurements are reported as surface-weighted mean diameter (d32).

3.2.2.5 Simulated Oral Conditions
Simulated saliva fluid (SSF), containing mucin and various salts, was prepared
according to a previous study 162. A 5 mL-aliquot of the filled hydrogel particle solution
was mixed with 5 mL of SSF, so that the final mixture contained 0.5% (w/w) oil. The pH
of the mixture was adjusted to 6.8 and it was incubated at 37 °C for 10 min with
continuous agitation at 100 rpm. The particles size distribution and microstructure were
measured immediately after incubation.

3.2.2.6 Microstructure analysis
The microstructure of all systems were examined using confocal scanning laser
microscopy with a 60 × objective lens and 10 × eyepiece (Nikon D-Eclipse C1 80i,
Nikon, Melville, NY, U.S.). A small aliquot of sample was placed on a microscope slide
and covered with a cover slip prior to analysis. For the confocal microscopy, samples
were dyed prior to particle formation. The oil phase in the filled hydrogel particles was
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dyed with Nile red solution (1 mg/mL ethanol) by adding 0.1 mL of Nile red solution to 2
mL of oil, covering, and stirring overnight. The dyed oil was then used to form an
emulsion as described in Section 2.2.1. The sodium caseinate phase was dyed with
fluorescein thiocyanate isomer I (FITC) solution (1 mg/mL dimethyl sulfoxide) prior to
measurements by adding 0.1 mL of FITC dye solution to 2 mL of sample. The excitation
and emission spectrum for Nile red were 543 nm and 605 nm, respectively while for
FITC they were 488 nm and 515 nm, respectively. The microstructure images for
confocal microscopy were taken and analyzed using image analysis software (NISElements, Nikon, Melville, NY).

3.2.2.7 Statistical analysis
All experiments were carried out in triplicate using freshly prepared samples. The
mean and standard deviations were calculated from these values using SPASS.

3.2.3 Results and discussion
3.2.3.1 Electrical characteristics of biopolymer molecules
The formation of hydrogel particles by complex coacervation is an
electrostatically driven process, and so it is important to measure the electrical
characteristics of the biopolymers used. The pH dependence of the ζ-potential of the two
biopolymers was therefore determined using an electrophoresis method i.e., by measuring
the direction and velocity of molecular movement in a well-defined electrical field. The
charge on the caseinate molecules went from negative at pH 7.0 (≈ -27 mV) to positive at
pH 2.0 (≈ +18 mV), with a point of zero charge around pH 4.6 (Fig. 3.6). The point of
zero charge is in good agreement with the reported isoelectric point (pI) of caseinate
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molecules 163. The ζ-potential of alginate changed from strongly negative (≈ -68 mV) at
pH 7 to slightly negative (≈ -9 mV) at pH 2 (Fig. 3.6). Thus, the magnitude of the
negative charge on the alginate molecules was appreciably lower under acidic conditions
than neutral conditions, which can be attributed to the fact that the anionic carboxylic (–
COO-) groups on the mannuronic and guluronic acid groups became partially protonated
(–COOH) in this pH range (pK ≈ 3.5). Fig. 3.6 also shows the ζ-potential obtained for the
mixed caseinate-alginate system at different pH values. The charge on the mixed system
was between those of the individual caseinate and alginate values, which suggested that
alginate was electrostatically bound to caseinate molecules over the pH range studied.
Nevertheless, in mixed systems it is difficult to precisely determine whether the measured
charge is from a complex or from individual molecules.
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Figure 3. 6 Dependence of pH on the ζ-potential for 0.1 wt% caseinate and 0.1 wt%
sodium alginate in 10 mM phosphate buffer.
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In this study, hydrogel particles were assembled/dissembled by modulating
solution conditions so as to induce complex coacervation of the two biopolymers. Based
on the electrical characteristics of the two biopolymers we would expect them to
associate with each other at low-to-intermediate pH values because they have opposite
charges, but to dissociate at high pH values because they have similar charges (Fig. 3.6).
Thus, we would anticipate that hydrogel particles could be assembled by complex
coacervation in the pH regime where both biopolymers had opposite charge. Nevertheless,
the characteristics of hydrogel particles formed under conditions where electrostatic
attraction occurs is known to be highly dependent on interaction strength and
stoichiometry 147. We therefore used turbidity, light scattering, and microscopy
measurements to obtain information about the influence of pH and biopolymer
composition on the nature of the electrostatic complexes formed.

3.2.3.2 Aggregation characteristics of mixed biopolymer systems
Initially, the formation of protein-polysaccharide complexes was studied by
measuring the change in turbidity as a function of pH at two different biopolymer mass
ratios. Initially, we characterized the behavior of a biopolymer mixture where the protein
was in excess, i.e., caseinate-to-alginate mass ratio in the final mixture was 3:1 (Fig.
3.7a). At pH 7, the turbidity of the mixed biopolymer solution was relatively low (≈0.016
cm-1), which can be attributed to a relatively strong electrostatic repulsion between the
anionic alginate and anionic caseinate under neutral pH conditions (Fig. 3.7). When the
pH was decreased, there was initially a gradual increase in turbidity around pH 5.6, and
then a much steeper increase around pH 3.7. The turbidity exhibited a maximum value at
pH 3.1, and then decreased appreciably when the pH was adjusted to lower values.
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(a)
(b)
Figure 3. 7 Turbidity at 600 nm as a function of pH for the system of caseinate/alginate
at different biopolymers volume mixing ratios: (a) 0.1% sodium caseinate (NaC) and 0.1%
sodium alginate (NaA), 3:1, (b) 0.1% casein and 0.2% alginate, 1:2.
Critical pH values corresponding to the formation of different structures for the
caseinate-alginate mixtures are also given in Fig. 3.7a. In general, complex coacervation
involves two main pH-induced structuring events associated with the formation of
soluble and insoluble complexes 164. The formation of soluble complexes (“coacervates”)
occurs at a pH (denoted “pHC”) corresponding to the first experimentally detectable
increase in turbidity during a pH titration from a region where the biopolymers have
similar charges and do not form complexes. This is followed by a second structureforming event (denoted “pHΦ1”), associated with the formation of insoluble complexes
(“precipitates”) and a large rise in turbidity. In our study, complex coacervation began
around pH 5.6 (pHC), and insoluble complex formation began around pH 3.65 (pHΦ1)
(Fig.3.7a). These results indicate that complex coacervation began under conditions (pH
5.6) where both the caseinate and alginate molecules had net negative charges (Fig. 3.7).
Previous studies have also shown that coacervates can be formed under conditions where

52

a protein and anionic polysaccharide have similar net negative charges, due to
electrostatic attraction between anionic groups on the polysaccharides and cationic
patches on the protein surfaces 147, 165-166.
We also studied the aggregation behavior of a biopolymer mixture in which the
polysaccharide was dominant, i.e., a caseinate-to-alginate mass ratio of 1:4 (Fig. 3.7b).
Qualitatively, the behavior of this biopolymer mixture was similar to that where protein
was dominant: as the pH was reduced, the turbidity initially remained low, then increased
slightly, then increased steeply to a maximum value, and then fell. The two different
casein-to-alginate mixing ratios used (3:1 and 1:4) gave similar pHC values (pH ≈ 5.6),
but the pHΦ1 values shifted to lower pH values with decreasing mixing ratio (Fig. 3.7b).
These results are in agreement with other studies that showed that the protein-topolysaccharide mixing ratio had little effect on pHC 167-168. The turbidity measurements
indicate that the protein and polysaccharide used in this study may form either soluble or
insoluble complexes depending on the pH. In the following section, we examined the
influence of biopolymer ratio on the microstructure of the complexes formed.

3.2.3.3 Microstructural characteristics of hydrogel particles
To identify suitable conditions for forming hydrogel particles, we measured the
particle size distribution of biopolymer mixtures containing different ratios of casein and
alginate (Fig. 3.8). These samples were prepared by adjusting the mixed biopolymer
solutions from pH 7 to 5 to induce electrostatic complex formation. This final pH was
selected based on the turbidity versus pH profiles of the biopolymer mixtures (Fig. 3.7),
which showed that coacervates could be formed under these conditions, i.e., pHI < pH <
pHC. At a casein-to-alginate ratio of 3:1 very large hydrogel particles were detected by
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static light scattering (d ≈ 700 µm). Presumably, hydrogel particles formed under these
conditions were highly prone to coalescence, and were therefore unsuitable for use as
delivery systems. On the other hand, at a casein-to-alginate ratio of 1:4 small uniform
hydrogel particles were detected (d ≈ 4 µm). Caseinate solutions are highly prone to
aggregation near their isoelectric point (pI ≈ 4.6), and therefore there may have been
insufficient alginate present to prevent some protein aggregation from occurring in the
mixed systems containing high protein levels (3:1). Conversely, in the mixed system
containing high alginate levels (1:4) there may have been sufficient anionic
polysaccharide molecules present to inhibit aggregation between protein molecules
thereby forming more stable complexes. Another possible explanation is that the protein
molecules were on the outside of the electrostatic complexes for the 3:1 system thereby
promoting aggregation, but the alginate molecules were at the exterior for the 1:4 system
thereby inhibiting aggregation. For this reason, we only used the 1:4 mass ratio of
caseinate-to-alginate in the following experiments.
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Figure 3. 8 Particle size distribution of hydrogel particles formed at pH 5 by different
mixing ratios: 1% casein and 1% alginate at volume ratio of 3:1(concentration ratio: 3:1)
and 1% casein and 2% alginate at volume ratio of 1:2 (concentration ratio: 1:4).
3.2.3.4 Influence of pH on hydrogel particle integrity
Hydrogel particles may be exposed to various pH conditions in food products and
after ingestion when they pass through the various stages of the gastrointestinal tract 169170

. Knowledge of the influence of pH on the properties of hydrogel particles is therefore

important for their commercial application, and for creating delivery systems designed to
release encapsulated lipids in response to a particular pH trigger (such as the oral
environment). We therefore used confocal scanning laser microscopy and static light
scattering to study the influence of pH on the microstructure and dimensions of the
hydrogel particles.
Initially, hydrogel particles were formed by adjusting a 1:4 caseinate-to-alginate
mixture from pH 7 to 5 to induce complex coacervation. The change in particle size and
microstructure was then measured when this system was adjusted to lower or higher pH
values. The observed changes can be divided into three distinct pH regions according to
the structures formed. At pH 4 to 5, stable hydrogel particles were formed which had
fairly uniform dimensions with diameters around 2 to 4 µm. Most of the particles had a
spherical shape, which can be attributed to the presence of sufficient alginate to stabilize
the casein molecules 171. These hydrogel particles may be suitable for incorporation into
commercial products that have aqueous phases in this intermediate pH range (such as
yogurts). When the system was increased into the range pH 6 to 7 the hydrogel particles
completely dissociated, as indicated by the confocal images, which showed that the
continuous phase became a uniform green color suggesting that the caseinate molecules
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were evenly distributed throughout the system rather than located within hydrogel
particles (Fig. 3.9). The origin of this effect can be attributed to the change in the
electrical characteristics of the two biopolymers. At high pH values, both the caseinate
and alginate molecules have relatively high negative charges and therefore there will be a
strong electrostatic repulsion between them. The increase in particle size measured by
light scattering at high pH values suggests that there may have been some biopolymer
aggregation, even though hydrogel particles were not formed. For example, there may
have been some bridging of caseinate and alginate molecules through electrostatic
attraction of cationic patches on the protein and anionic groups on the polysaccharide.
When the pH of the mixed biopolymer system was reduced from pH 5 to 3 there
was a large increase in mean particle diameter determined by light scattering, and
extensive protein aggregation observed by confocal microscopy (Fig. 3.9). This
phenomenon can also be attributed to changes in the electrical characteristics of the two
biopolymers. When the pH is reduced below the isoelectric point of the caseinate, the two
biopolymers have opposite charges, which leads to a strong electrostatic attraction
between them. Consequently, the biopolymers become more closely packed and larger
aggregates are formed. Extensive protein aggregation also occurred at pH 2, but the size
of the aggregates was smaller than those formed at pH 3 (Fig. 3.9), which probably
occurred because the anionic groups on the alginate molecules became partially
protonated causing a reduction in their negative charge and therefore weaker electrostatic
attraction 172. Insolubilization and/or precipitation of alginate would also be induced at
pH value lower than the pKa of carboxyl groups. An understanding of the influence of
pH on the properties of the hydrogel particles is useful for developing delivery systems
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for oral applications. Our results indicate that the caseinate-alginate hydrogel particles
should be stable at pH 4 to 5, but should dissociate at pH 7 thereby releasing any
encapsulated components.
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Figure 3. 9 Influence of pH (2-7) on the particle size (d32) of hydrogel particles.
(Confocal micrographs show the hydrogel particles at pH 3, 5, 7 respectively in the up
right, protein phase in green was stained with FITC).
3.2.3.5 Influence of simulated oral conditions on lipid droplet release
For certain applications it is desirable to have filled hydrogel particles that remain
intact within food products, but then release encapsulated lipid droplets within the mouth
after ingestion. We therefore prepared hydrogel particles at pH 5 containing encapsulated
lipid droplets, and then exposed them to simulated oral conditions (SSF, pH 6.8, 37 ºC).
The particle size distribution and microstructure of the filled hydrogel particles before
and after being exposure to oral conditions was determined by static light scattering and
confocal microscopy (Figs. 3.10 and 3.11). In addition, the particle size distribution and
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microstructure of the lipid droplets in the initial emulsion were also measured (Figs.
3.10and 3.11)
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Figure 3. 10 Particle size distribution of filled hydrogel particles before and after mouth
digestion.
The particle size distribution of the lipid droplets in the initial emulsion had a
single broad peak at a particle diameter of about 0.2 µm (Fig. 3.10), and the droplets were
evenly distributed throughout the system (Fig. 3.11). Thus, the initial protein-coated lipid
droplets were relatively small and stable to aggregation. It should be noted that the
aqueous phase surrounding the lipid droplets had a relatively strong green color, which
suggests that there was an appreciable amount of non-adsorbed casein in the initial
emulsions. Prior to exposure to oral conditions (pH 14), the particle size distribution of
the filled hydrogel particles showed a single peak around 3 µm (Fig. 3.10), which was
fairly similar to that observed in the absence of lipid droplets (Fig. 3.9). This suggests
that incorporation of lipid droplets into the hydrogel particles did not cause a major
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change in their overall dimensions. The confocal microscopy images indicated that all of
the lipid droplets and casein molecules were initially trapped inside the hydrogel particles,
i.e., the red (lipid) and green (protein) fluorescence dyes were located together in
spheroid shapes surrounded by black (Fig. 3.11). This finding is also supported by the
light scattering data which indicated that there was no small peak corresponding to free
lipid droplets in the particle size distribution of the filled hydrogel particles at pH 5 (Fig.
3.10). After exposure to the oral phase, the particle size distribution of the filled hydrogel
particles and lipid droplets were fairly similar (Fig. 3.10), which suggested that the
hydrogel particles had dissociated and released the lipid droplets. As mentioned earlier,
the origin of this effect is likely to be the dissociation of the complex coacervates at
neutral pH because of the strong electrostatic repulsion between the negatively charged
protein and polysaccharide molecules 173.

(a)

(b)
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(c)
Figure 3. 11 Confocal micrographs of (a) oil emulsion, (b) filled hydrogel particles
before digestion and (c) after mouth digestion. The oil phase (red) was stained with Nile
red while the protein phase (green) was stained with FITC.
3.2.3 Conclusions
In this study, hydrogel particles containing encapsulated lipid droplets were
fabricated based on complex coacervation of caseinate and alginate. Relatively small and
stable hydrogel particles could be formed at pH values around the isoelectric point of the
protein (pH 4 to 5), even under conditions where both biopolymers had net negative
charges. This effect can be attributed to electrostatic attraction between anionic groups
on the alginate and cationic groups on the caseinate molecules. The biopolymer mixing
ratio was also an important factor in forming stable hydrogel particles. At a relatively
high protein-to-polysaccharide ratio very large unstable aggregates were formed that
were unsuitable as delivery systems, but at a high polysaccharide-to-protein ratio small
stable hydrogel particles were formed. These hydrogel particles remained stable from pH
4 to 5, but aggregated at lower pH due to increased electrostatic attraction or
insolubilization and/or precipitation of alginate, and dissociated at higher pH due to
60

increased electrostatic repulsion. Using simulated oral conditions, we showed that filled
hydrogel particles could be made to release encapsulated lipid droplets within the mouth.
These results have important implications for the development of food-grade delivery
systems that may protect encapsulated lipophilic active agents in products, but release
them in the mouth. One limitation of the delivery systems developed in this study, is that
the hydrogel particles are only stable over a narrow range of pH conditions (pH 4 to 5),
which would limit the number of food or beverage products they could be incorporated
into. This problem could be overcome by using different combinations of biopolymers or
different cross-linking approaches.
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3.3 Release of bioactives using hydrogel particles: temperature-triggered release
3.3.1 Introduction
There is increasing interest within the food and biomedical industries to
incorporate lipophilic bioactive agents into functional food and medical food products,
e.g., vitamins, nutraceuticals, pharmaceuticals, antimicrobials, flavors, and colors 174-177.
However, the poor water-solubility and chemical stability of many lipophilic bioactive
agents makes them difficult to incorporate into food matrices. The low solubility of these
bioactive agents in aqueous environments means they tend to phase separate, whereas
their chemical instability means they may degrade within the product prior to
consumption, thereby reducing their efficacy. It is therefore necessary to design foodgrade delivery systems to improve the dispersibility and chemical stability of lipophilic
bioactive agents in food matrices 178.
Flavor perception (taste and aroma) throughout the eating process is a key factor
in determining the desirable sensory attributes of many food products 140, 179-180. It is often
important to control the release profile of lipophilic flavors within the mouth to provide
the desired overall sensory experience 181. Other types of lipophilic bioactive agents may
also need to be released within the mouth after consumption of medical or functional
foods. e.g., some oil-soluble drugs 182-183, and antimicrobials for oral health 138-139. It is
therefore important to food-grade effective delivery systems that can: encapsulate
efficacious levels of lipophilic bioactive agents; easily be incorporated into food or
beverage matrices; protect the bioactive agents from chemical degradation during storage;
release them within the mouth after ingestion (often at a controlled rate).
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For many applications, delivery systems are needed that can be incorporated into
high-moisture food matrices, such as those in beverages, yogurts, dressings, sauces,
creams, soups, dips, and desserts. A variety of different emulsion-based delivery systems
have been developed to encapsulate lipophilic bioactive agents, including emulsions,
nanoemulsions, multiple emulsions, multilayer emulsions, filled hydrogel particles, and
solid lipid nanoparticles 105, 184-189. Each of these delivery systems has their own
advantages and disadvantages in terms of cost, ease of preparation, in-product stability,
product compatibility, ingredient utilization, and functional performance.
In this study, we focus on the utilization of filled hydrogel particles, which consist
of lipid droplets trapped within hydrogel microspheres. Initially, the lipophilic bioactive
agents are dissolved in an oil phase, and then an oil-in-water emulsion or nanoemulsion is
formed using an appropriate homogenization method 190. The hydrogel microspheres can
be formed using a number of different fabrication methods depending on the final
characteristics of the particles required, including extrusion, templating, molding,
thermodynamic incompatibility, and complexation 79. Electrostatic complexation is a
relatively straightforward method that can easily be implemented commercially, since it
simply relies on the formation of complexes between polymers in solution that have
opposite charges 148, 191. Filled hydrogel particles can be designed to control the
protection and release of lipophilic bioactive agents by controlling the composition and
structure of the hydrogel matrices. The properties of hydrogel particles formed using
electrostatic complexation can be modulated by selecting biopolymers with different
molecular characteristics (such as electrical properties, molecular weight, and structure)
and by modulating preparation conditions (such as pH, salt, and stirring).
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The design of delivery systems that can control the release of encapsulated
bioactive agents within the mouth depends on an understanding of oral processing 156-158.
Numerous factors can potentially influence the behavior of delivery systems within the
oral cavity, including: warming or cooling in the mouth; saliva composition, volume and
flow rate; mixing, disruption and frictional forces; and pH changes. In a recent study, we
fabricated hydrogel particles by trapping lipid droplets within electrostatic complexes
formed by sodium caseinate and alginate at pH 5 192. We showed that these lipid droplets
could be retained within hydrogel particles during storage, but released from the hydrogel
matrix under conditions simulating oral processing. In that system, the main driving
force for hydrogel disruption and droplet release was the pH change in the mouth. Under
storage conditions (pH 5), the electrostatic complexes were stable due to electrostatic
attraction between anionic pectin and cationic patches on the caseinate molecules.
However, under oral conditions (pH 7), the complexes dissociated due to electrostatic
repulsion between the anionic pectin and anionic caseinate molecules. These results
suggested that filled hydrogel particles based on electrostatic complexation of two
oppositely charged biopolymers might be useful for oral delivery of lipophilic bioactive
agents.
The purpose of the current study was to develop filled hydrogel particles that
would release encapsulated lipid droplets primarily through a temperature trigger. These
hydrogel particles were prepared by incorporating lipid droplets into electrostatic
complexes formed from two food-grade proteins: gelatin and sodium casein. The filled
hydrogel particles formed can be considered to be an oil-in-water-in-water (O/W1/W2)
emulsion that contains oil droplets (O) trapped within hydrogel microspheres (W1), which

64

are themselves suspended within a continuous aqueous phase (W2). A potential advantage
of using caseinate to form the hydrogel particles is that it can stabilize encapsulated
polyunsaturated lipids against oxidation, which has been attributed to its antioxidant
capacity 193. On the other hand, a potential advantage of using gelatin for fabricating oral
delivery systems, is that it can form gels that melt in the mouth, i.e., undergo a gel-to-sol
transition around body temperature. The information obtained from this study could be
useful for the rational design of emulsion-based delivery systems that release
encapsulated lipophilic bioactive agents within the mouth.

3.3.2 Materials and methods
3.3.2.1 Materials
Corn oil was purchased from a local supermarket and used without further
purification. Sodium caseinate powder was obtained from the American Casein Company
(MP Biomedicals LLC). As stated by the manufacturer, this ingredient had a protein
content of 91.4% and moisture content of 5.0%. Type A gelatin (100 bloom, extracted
from pork skin) was kindly donated by GELITA American Company (Sergeant Bluff,
IA). Double distilled water was used to prepare all solutions.

3.3.2.2 Methods
3.3.2.2.1 Emulsion preparation
An oil-in-water (O/W) emulsion stabilized by sodium caseinate (NaC) was
prepared as a stock emulsion. Initially, an aqueous emulsifier solution was prepared by
dispersing 1% (w/w) NaC powder into 10 mM phosphate buffer solution (pH 7) with
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continuous stirring at 700 rpm for 2 hours (40 oC). A coarse emulsion was then prepared
by blending corn oil (10% w/w) and emulsifier solution (90% w/w) together using a highshear mixer for 2 min (Model 985370-395, Tissue Tearor, Biospec Products Inc.,
Bartlesville, OK). The size of the droplets in the resulting coarse emulsion was further
reduced by passing it three times through a high-pressure homogenizer (Microfluidics
Microfluidizer M-110P, Newton, MA USA) at 12,000 psi. The final emulsion was then
diluted to 6% (w/w) for the further experiments.

3.3.2.2.2 ζ-potential measurements
The electrical characteristics (ζ-potential) of solutions of caseinate, gelatin, and
their mixture were measured at different pH values (pH 5 to 10) using a particle
electrophoresis instrument (Zetasizer Nano ZA series, Malvern Instruments Ltd.
Worcestershire, UK). Samples were diluted using 10 mM phosphate buffer (at the same
pH as the sample) prior to analysis so that the instrument attenuation value was within the
optimum range (5 to 10). All measurements were made on at least two freshly prepared
samples and each sample was measured in duplicate.

3.3.2.2.3 Turbidity measurements
The turbidities of dispersions containing caseinate and gelatin were determined
using a UV–visible spectrophotometer at 600 nm (Ultrospec 3000 pro, Biochrom Ltd.,
Cambridge, UK). The samples were contained within 1 cm path length optical cells, and
phosphate buffer was used as a control. Turbidity measurements were carried out on at
least two freshly prepared samples. The turbidity of biopolymer solutions (pH 5.8) with
increasing temperature was analyzed using an UV/visible spectrophotometer at 600 nm
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(Ultraspec 3000 pro, Biochrom Ltd., Cambridge, UK). Temperature scanning was carried
out from 20 to 60 °C at a heating rate of 1 °C per minute.

3.3.2.2.4 Unfilled and filled hydrogel microsphere preparation
Stock solutions of 2% sodium casein and 1% gelatin were prepared separately in
10 mM phosphate buffer at pH 7 and stirred until fully dissolved. 2 M sodium hydroxide
was used to adjust the dissolved biopolymer solutions to pH 10. After pH adjustment, 6%
(w/w) caseinate-stabilized oil-in-water emulsion (prepared in the section 2.2.1) and 2%
caseinate solution were mixed together (1:1 volume ratio) with continuous stirring at 200
rpm to obtain a system containing 1% sodium casein and 3% oil. The resulting mixture of
caseinate-coated lipid droplets and sodium casein was then mixed with a 1% gelatin
solution (1:2 volume ratio) to form filled hydrogel particles. The final mixture was then
acidified to pH 5.8 using 1 M citric acid with continuous string at 500 rpm to promote
electrostatic complexation. The final composition of the resulting system was 1% fat,
0.33% sodium casein, and 0.67% gelatin.

3.3.2.2.5 Particle size measurements
The particle size of the various samples was determined using static light
scattering (Mastersizer 2000, Malvern Instruments, Worcestershire, United Kingdom).
This instrument infers the particle size distribution from measurements of the angular
scattering pattern. Samples were diluted in 10 mM phosphate buffer by adding small
aliquots into a measurement chamber. A refractive index of 1.33 was used for the
continuous phase (water) and 1.472 for the disperse phase (oil or hydrogel). Particle size
measurements are reported as the surface-weighted mean diameter (d32).
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3.3.2.2.6 Rheological measurements
A higher total biopolymer concentration was required to produce samples that
were viscous enough to make reliable rheology measurements. Consequently, 3% (w/w)
NaC and 3% (w/w) gelatin solutions were used to fabricate hydrogel particles using a
similar approach to that described in Section 2.2.4. The rheology of the hydrogel particle
suspensions was characterized using a dynamic shear rheometer with a cup-and-bob
measurement cell (Kinexus, Malvern, Worcestershire, UK). The effect of thermal
treatment on the apparent shear viscosity was determined by temperature scanning from
25 to 60 and then to 25 °C at a scan rate of 1 °C/min-1. A constant shearing rate (10 s-1)
and test time (1 min) was used for all measurements.

3.3.2.2.7 Simulated Oral Conditions
Simulated saliva fluid (SSF), containing mucin and various salts, was prepared as
described in an earlier study 162. A 5 mL-aliquot of the filled hydrogel particle solution
was mixed with 5 mL of SSF, so that the final mixture contained 0.5% (w/w) oil. The
resulting mixture was then adjusted to pH 6.8 and incubated at 37 °C for 10 min with
continuous agitation (100 rpm). This time is longer than the time a food would typically
spend in the mouth, but was used to ensure consistent measurements between samples.
The particle size distribution and microstructure were then measured immediately after
incubation under these conditions.

3.3.2.2.8 Microstructure analysis
The microstructure of the samples was examined using confocal scanning
fluorescent laser microscopy with a 60 × objective lens and 10 × eyepiece (Nikon D-
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Eclipse C1 80i, Nikon, Melville, NY, U.S.). A small aliquot of sample was placed on a
microscope slide and covered with a glass cover slip prior to analysis. Samples were
stained with a fluorescent dye prior to particle formation. The oil phase in the filled
hydrogel particles was dyed with Nile red by adding 0.1 mL of Nile red solution (1
mg/mL ethanol) to 2 mL of oil, covering, and stirring overnight. The dyed oil was then
used to form an emulsion as described in Section 2.2.1. The sodium caseinate phase was
dyed with fast green (0.4% w/v in deionised water) after one night cold storage at 5 °C.
The excitation and emission spectrum for Nile red were 543 nm and 605 nm, respectively
while for fast green they were 488 nm and 515 nm, respectively. The microstructure
images were acquired and then analyzed using image analysis software (NIS-Elements,
Nikon, Melville, NY).

3.3.2.2.9 Statistical analysis
All experiments were carried out in triplicate using freshly prepared samples.
Means and standard deviations were calculated from a minimum of three measurements
using SPSS (IBM, USA). Means were subjected to Duncan's test and a P-value of <0.05
was considered statistically significant.

3.3.3 Results and discussion
3.3.3.1 Electrical characteristics of single and mixed biopolymer solutions
The hydrogel particles used in this study were assembled by electrostatic
complexation of gelatin and caseinate. Knowledge of the electrical characteristics of
these biopolymers is therefore useful for the rational design and fabrication of the filled
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hydrogel particles. For this reason we measured the pH dependence of the ζ-potential of
the two biopolymers and their mixture using electrophoresis (Figure 3.12).
The charge on the solution containing individual gelatin molecules went from
negative at pH 10.0 (≈ -5 mV) to positive at pH 5.0 (≈ +4 mV), with a point of zero
charge around pH 6. This value was appreciably different from the isoelectric point of
gelatin reported by the manufacturer (around pI ≈ 8-9), which we attributed to some
binding of ions in the buffer solution to charged groups on the gelatin molecules. We
therefore measured the pH dependence of the ζ-potential for gelatin dissolved in distilled
water. The results indicated that the zero point charge of gelatin in water was indeed
around pH 8 (data not shown). One possible explanation for this difference is that
phosphate anions (PO4-) from the buffer solution adsorbed to cationic groups on the
gelatin molecule, thereby altering its net charge characteristics. For the solution
containing only caseinate, the charge was negative (-22 to -36 mV) over the entire pH
range (pH 5 to 10), which can be attributed to the fact that the caseinate molecules were
always above their isoelectric point (pI = 4.6). We also measured the ζ-potential of a
biopolymer mixture (1:2 w/w caseinate:gelatin), since this biopolymer ratio was used to
prepare the hydrogel particles (discussed later). The charge on the mixed system was
between those of the individual caseinate and gelatin values, which suggested that the
two biopolymers formed a complex over the entire pH range studied. It is likely that
cationic groups on the gelatin molecules bound to anionic groups on the caseinate
molecules (and vice versa).
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Figure 3. 12 The pH-dependence of the ζ-potential of 0.1 wt% caseinate, 0.1 wt% gelatin,
0.1% mixed biopolymers (0.033 wt% caseinate + 0.067 wt% gelatin) in 10 mM
phosphate buffer and 0.1 wt% gelatin in water.
Though the net charge point of the mixture was shown around pH 5.4. In mixed
biopolymer systems, it is difficult to precisely determine the electrical characteristics of
the complexes themselves as the net particle charge determined by the electrophoresis
instrument may be a result of the signal from individual biopolymer molecules as well as
from the complexes. Turbidity measurements were therefore used to provide further
information about the influence of pH on electrostatic complex formation.

3.3.3.2 Influence of pH on complex formation
The turbidity of a solution depends on the size and concentration of the
complexes it contains 194. Turbidity measurements therefore present a simple but
powerful tool for monitoring the electrostatic complexation of biopolymers. Typically,
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soluble complexes are formed when the electrostatic interactions are fairly weak and the
net charge is relatively high, whereas coacervates are formed when the electrostatic
interactions are stronger and the net charge is low 191, 195-196. Turbidimetric titrations were
therefore performed to obtain qualitative information about the interaction of the sodium
casein and gelatin.
Transparent and homogeneous mixtures were obtained when the two biopolymers
were mixed above pH 8, which suggests that no electrostatic complexes large enough to
scatter light were formed (Figure 3.13). The electrophoresis measurements indicated
that both biopolymers had negative charges in this pH range (Figure 3.12), which would
have inhibited the formation of large hydrogel particles due to electrostatic repulsion. The
first small increase in turbidity in the biopolymer mixtures was considered to be the
critical pH (pHc) where primary soluble complexes were formed, which was around pH 9
(Figure 3.13). This pH value is slightly above the reported isoelectric point of this type
of gelatin. Consequently, the electrostatic complexes may have formed due to the
binding of negative groups on the caseinate molecules to positive patches on the gelatin
surfaces. A sharp rise in turbidity was detected when the pH was decreased below about
6, which is often designated as the critical coacervation pH i.e., pHϕ 197. There was a
maximum in the turbidity around pH 4.8, after which the turbidity decreased steeply with
further acidification. This decrease in turbidity is probably a result of dissociation of the
electrostatic complexes. Below the isoelectric point of caseinate (pI ≈ 4.6), both proteins
will have a net positive charge, and therefore there will be an electrostatic repulsion
between them.
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Based on these results, we used a pH of 5.8 to prepare the particles, since this led
to the formation of electrostatic complexes that still had an appreciable negative charge
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(Figure 3.12), and were therefore more stable to aggregation and phase separation.
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Figure 3. 13 The pH-dependence of the turbidity (600 nm) of mixed biopolymer
solutions containing 0.333 % caseinate and 0.667% gelatin (biopolymer ratio = 1:2).
3.3.3.3 Influence of temperature on complex properties
Gelatin solutions undergo a sol-to-gel transition during heating due to changes in
the molecular conformation of the gelatin molecules, i.e., a helix-to-coil transition 198.
Hydrogel particles based on electrostatic complexation were fabricated by mixing a 1%
sodium casein solution and a 1% gelatin solution at a volume ratio of 1:2 at pH 5.8 (final
composition = 0.33% sodium casein and 0.67% gelatin). A range of different
biopolymers ratios were tested in preliminary studies, and this ratio gave the most stable
complex particles and was therefore used to prepare the hydrogel particles. The effect of
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temperature scanning on the stability of the hydrogel complexes was determined by
measuring their turbidity during heating from 25 to 60 °C, and then cooling back to 25 ºC
(Figure 3.14). The initial turbidities of the caseinate-gelatin complex solutions at pH 5.8
and ambient temperature were high (around 0.82 cm-1), which meant that hydrogel
particles were relatively stable under these conditions. The turbidity of the hydrogel
particles remained relatively constant from 25 to 31 °C, decreased steeply from 31 to
38 °C, and then reached a fairly constant value at higher temperatures. These results
suggested that the structure of caseinate-gelatin complexes were appreciably altered by
heating, which may be important for the development of temperature-triggered delivery
systems. The dissolution of the caseinate-gelatin complexes appeared to be closely
associated with the melting characteristics of the gelatin molecules. Indeed, previous
researchers have reported that the gel-melting temperature of gelatin is just below body
temperature, i.e., < 35 °C 198.

Turbidity Increase (cm-1)

1
Increasing temperature

0.8

Decreasing temperature

0.6
0.4
0.2
0
20

30

40

50

Temperature (oC )

60

Figure 3. 14 Influence of temperature on turbidity of hydrogel particles (0.333% casein
and 0.667% gelatin) during heating and cooling.
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Heating-cooling scans were carried out to determine whether the complexes
dissociation behavior was thermally reversible or irreversible. In these experiments the
change in turbidity with temperature was recorded when the heated hydrogel particles
were cooled back to 25 °C. The turbidity of the biopolymer mixture remained relatively
low when the samples were cooled back to their initial temperature (25 °C), which may
have occurred because of thermal hysteresis i.e., the gelation temperature is appreciably
lower than the melting temperature 198. Whether the gelatin molecules remained attached
to the caseinate molecules after cooling is currently unknown, and would be an
interesting area for future studies.

3.3.3.4 Influence of temperature on rheology of hydrogel suspensions
The shear rheology of hydrogel particle suspensions was measured as a function
of temperature, i.e. heating from 25 to 60 °C and then cooled to 25 °C (Figure 3.15).
There was a slight decrease in the apparent shear viscosity of the samples after being
heated from 25 to 33 °C, followed by a step decrease from 34 °C to the end of the
measurements. These results suggested that heating the gelatin-hydrogel particles above a
critical temperature led to network breakdown. This critical temperature was close to the
hydrogel particle dissociation temperature determined using the turbidity measurements
(Figure 3.14), and this phenomenon may again be due to melting of the gelatin around
these temperatures. These results are in agreement with a previous study that reported
that the viscosity of suspensions of chondroitin 6-sulfate and gelatin decreased with
increasing temperature 199.
Heating-cooling scans showed that the viscosity of hydrogel particle suspensions
increased slightly with decreasing temperature and did not return back to the initial value
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after cooling back down to 25 °C. These results might again be attributed to the thermal
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hysteresis effect of gelatin mentioned earlier.
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Figure 3. 15 Influence of temperature on the viscosity of hydrogel particles fabricated by
mixing 3% casein and 3% gelatin solutions.
Taken together, the turbidity and viscosity results indicated that the caseinategelatin hydrogel particles were stable at room temperature, but dissociated above a
particular temperature (close to body temperature). These hydrogel particles may
therefore be suitable for developing food-grade delivery system for lipophilic bioactive
agents that respond to a temperature-trigger in the oral cavity.
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3.3.3.5 Influence of simulated oral conditions on lipid droplet release
For many applications it is desirable to have delivery systems that will remain
intact within food products, but then release the encapsulated active agents in the mouth
after ingestion. The melt-in-the-mouth behavior of gelatin hydrogels make them
particularly suitable for this type of application 34. We therefore fabricated gelatin-based
hydrogel particles containing encapsulated lipid droplets, and then exposed them to
simulated oral conditions (SSF, pH 6.8, 37 ºC). The particle size distribution and
microstructure of the filled hydrogel particles before and after being exposure to
simulated oral conditions was determined by static light scattering and confocal
microscopy (Figures 3.16 and 3.17). In particular, fast green was used to stain caseinate
so that they appeared green in the confocal images, while the gelatin remained black. In
addition, the particle size distribution and microstructure of the lipid droplets in the initial
emulsion were also measured as a control (Figures 3.16 and 3.17).
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Figure 3. 16 Particle size distribution of filled hydrogel particles before and after mouth
processing.
After the filled hydrogel particles were passed through the simulated mouth phase
the particle size distribution became fairly similar to that of the initial emulsion, which
suggests that the lipid droplets had been released from the dissociated hydrogel particles,
but the emulsion remained stabilized by sodium caseinate. Control experiments were
carried out keeping all conditions the same, except that room temperature was used rather
than 37 ºC. The particle size distribution and microstructure results indicated that the
lipid droplets remained within the hydrogel particles after exposing to the oral conditions
at this lower temperature. These results suggested that the temperature change in the
mouth was the major factor promoting hydrogel dissociation and the release of the lipid
droplets.
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(a)

(b)
(c)
Figure 3. 17 Confocal micrographs of (a) filled hydrogel particles before digestion and (b)
after mouth processing and (c) oil emulsion. The oil phase (red) was stained with Nile red
while the protein phase (green) was stained with fast green.
3.3.4 Conclusions
The objective of this study was to develop delivery systems for lipophilic
bioactive agents based on electrostatic complexation of biopolymers that would release
the bioactive agents due to a temperature-trigger under oral conditions. Gelatin and
caseinate were used to fabricate the hydrogel particles. Relatively stable filled hydrogel
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particles were formed at pH 5.8 with the majority of the lipid droplets being trapped
inside the hydrogel phase. Optical and rheological measurements indicated that the
structure of the hydrogel particles was disrupted when they were heated above a critical
temperature (around body temperature), which was attributed to the melting properties of
gelatin. After simulated oral processing, the lipid droplets were shown to be released
from the hydrogel particles and dispersed into the surrounding continuous phase. The
temperature change in the mouth was identified as the main trigger mechanism for
hydrogel dissolution. These results have important implications for the development of
food-grade delivery systems that may protect encapsulated lipophilic active agents in
food products, but release them in the mouth.
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CHAPTER 4
ENCAPSULATION, PROTECTION, AND RELEASE OF BIOACTIVE AGENTS
USING HYDROGEL BEADS

4.1 Encapsulation of curcumin in polysaccharide-based hydrogel beads: Impact of
bead type on lipid digestion and curcumin bioaccessibility
4.1.1 Introduction
Turmeric is a commonly used pigment, spice, and nutraceutical in foods due to its
intense yellowish color, unique flavor profile, and biological activities 200-201. Curcumin is
the major bioactive agent in turmeric, and it consists of three closely related lipophilic
molecules that have a number of phenolic groups and conjugated double bonds 201-202.
The potential pharmaceutical activity of curcumin has been established for numerous
diseases, including multiple myeloma, rheumatoid arthritis, cystic fibrosis, inflammatory
bowel disease, and colon cancer 201-203. Previous research suggests that the health
benefits of curcumin are associated with a number of biological activities, including antioxidative, anti-inflammatory, anti-microbial, anti-parasitic, anti-mutagenic, and antitumor activities 203-205. Another benefit of curcumin is that it has a low toxicity even when
ingested at relatively high doses. Consumer demand for health-promoting foods
containing fewer synthetic additives has made curcumin of particular interest as a natural
nutraceutical ingredient 206.
However, there are a number of physicochemical characteristics of curcumin that
currently limit its incorporation into many functional food products, such as its intense
color, strong flavor, low water-solubility, and chemical instability 207. Moreover,
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curcumin is rapidly metabolized within the gastrointestinal tract (GIT), which limits its
potential beneficial biological effects 206, 208. Some of these limitations can be overcome
by appropriate food product selection, e.g., appearance and flavor problems can be
overcome by incorporating curcumin into highly colored and spicy products. Other
limitations can be overcome by encapsulating curcumin within food-grade colloidal
delivery systems or by mixing it with colloidal excipient systems 209-215. A colloidal
delivery system consists of small particles (typically comprised of lipids, phospholipids,
surfactants, and/or biopolymers) that contain the curcumin 134. On the other hand, a
colloidal excipient system consists of small particles that are mixed with another food
containing curcumin 216. These small particles are specifically designed to boost the
bioavailability of curcumin. Colloidal delivery systems can be designed to facilitate the
incorporation of curcumin into commercial food products, while both colloidal delivery
and excipient systems can be designed to improve curcumin’s chemical/biochemical
stability and to control its fate within the GIT.
Previous studies have demonstrated the potential of improving the bioavailability
of curcumin using colloidal delivery systems 217-222 or colloidal excipient systems 215-216,
223

. Emulsion-based systems are particularly useful for this purpose because their

composition and structures can be designed to alter the bioaccessibility, absorption, and
transformation of lipophilic bioactives 177. In particular, the lipid phase in emulsions can
be designed to rapidly digest within the small intestine and form mixed micelles capable
of solubilizing and transporting lipophilic bioactives 224-225. In addition, emulsions are
already integral parts of many commercial food and beverage products 226, and so
emulsion-based delivery or excipient systems can easily be incorporated into a wide
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range of foods and beverages. One of the main limitations of conventional oil-in-water
emulsions for this purpose is that they only have limited scope for controlling the stability
and release of any encapsulated bioactive agents because the lipid droplets are only
coated by a thin layer of emulsifier molecules. This limitation can be overcome by
trapping the lipid droplets inside hydrogel beads (“microgels”).
Hydrogel beads suitable for utilization in the food industry are usually fabricated
from food-grade biopolymers, such as proteins and/or polysaccharides 227-229. These
beads can be fabricated using numerous approaches, including injection, coacervation,
thermodynamic incompatibility, antisolvent precipitation, templating, and molding
methods 79. The injection-gelation method is one of the simplest and most widely used
approaches for the encapsulation, protection, and delivery of food-grade bioactive
components such as nutrients, nutraceuticals, and vitamins. In this method, a biopolymer
solution containing the bioactive component is injected into another ‘‘hardening’’
solution under conditions that promote the gelation of the injected biopolymer. This
procedure results in the formation of a hydrogel bead with the bioactive components
trapped inside. The nature of the hydrogel matrix surrounding the bioactive can be
designed to improve its physical and chemical stability, as well as to control its GIT fate.
In the present study, curcumin was initially solubilized within the lipid phase of
an oil-in-water nanoemulsion. The curcumin-loaded lipid droplets were then used as
delivery systems themselves, or they were incorporated into hydrogel beads fabricated
from either carrageenan or alginate. The filled hydrogel beads were formed by mixing
the lipid droplets with a polysaccharide solution (alginate or k-carrageenan), and then
injecting the resulting mixture into a solution of positively charged ions (Ca2+ or K+,
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respectively). The cations act as salt bridges to promote gelation of the anionic
polysaccharides molecules. Carrageenan and alginate were used to form the hydrogel
beads because they are already widely utilized as food-grade ingredients. Furthermore,
these two polysaccharides were used because they are expected to form hydrogel beads
with different functional attributes. Alginate is a block copolymer composed of 1–4linked residues of β-d-mannuronic acid (M) and α-l-guluronic (G) acid. Carrageenan
consists of galactan monomers linked together by alternating (1 → 3)- and (1 → 4)-β-dglycosidic bonds with a negative charge due to the presence of sulfate groups within the
molecules. The hydrogel beads formed by the polysaccharides with these different
structures may show different gastrointestinal fate of the encapsulated curcumin during
digestion. The potential gastrointestinal fate of the different curcumin delivery systems
was studied using a simulated GIT (mouth, stomach, and small intestine). In particular,
the influence of the different hydrogel beads on the bioaccessibility of encapsulated
curcumin was compared. The information obtained in this study may facilitate the
rational design of hydrogel beads to modulate the bioavailability of encapsulated
lipophilic nutraceuticals.

4.1.2 Materials and methods
4.1.2.1 Materials
Corn oil was purchased from a local supermarket and used without further
purification. The following chemicals were purchased from the Sigma Chemical
Company (St. Louis, MO): alginic acid (sodium salt) (Lot# 180947, viscosity of 1%
alginic acid in water is 15–20 cp); curcumin (C1386-10G, purity ≥ 65%); mucin from
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porcine stomach (M2378-100G); pepsin from porcine gastric mucosa (P7000-25G);
lipase from porcine pancreas pancreatin (L3126-100G); porcine bile extract (B8631100G); Tween 80 (P1754-1L); and Nile Red (N3013-100MG). Carrageenan was kindly
donated by FMC Biopolymer (Viscarin SD 389, Philadelphia, PA). All chemicals used
were analytical grade. Double distilled water was used to make all solutions.

4.1.2.2 Preparation of oil-in-water emulsions
Initially, an aqueous phase was prepared by mixing 1% (w/w) Tween 80 with a
buffer solution (5 mM phosphate buffer saline (PBS), pH 6.5) and stirring for at least 2 h.
The emulsifier solution were then stored overnighted at 4 °C to ensure complete
dissolution. Excipient emulsions stabilized by Tween 80 were prepared by homogenizing
10% (w/w) corn oil with 90% (w/w) aqueous emulsifier solution using a high-speed
blender for 2 min (M133/1281-0, Biospec Products, Inc., ESGC, Switzer- land). The
droplet size in this coarse emulsion was reduced by passing it through a high-pressure
homogenizer (Microfluidizer, M110Y, Microfluidics, Newton, MA) with a 75 µm
interaction chamber (F20Y) at an operational pressure of 12,000 psi for 3 passes. The
resulting excipient emulsions were stored in a refrigerator at 4 °C before use.

4.1.2.3 Preparation of curcumin-loaded emulsion
The curcumin was solubilized within the lipid phase of the emulsions using a
method described previously 223. Curcumin (9 mg) was weighed into a beaker and then
excipient emulsion (10% oil, 30 mL) was added, and then held at 100 °C for 10 min. This
amount of emulsion was utilized because it has the ability to completely dissolve the
curcumin based on the measured equilibrium solubility of curcumin reported in corn oil
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at ambient temperature ≈ 3.2 ± 0.1 mg/mL 217. The resulting curcumin-loaded emulsion
was stored in the refrigerator (4°C) prior to hydrogel bead fabrication.

4.1.2.4 Preparation of curcumin-loaded emulsion
Aqueous k-carrageenan and alginate (2.5% w/w) solutions were prepared by
dissolving powdered polysaccharide ingredients in distilled water and then stirring
continuously at 60 °C for an hour, and then reducing the temperature to 35 °C.
Polysaccharide solutions and curcumin-loaded emulsions were then mixed together (1:4,
mass ratio) for 2 h with continuous stirring to form a solution that contained 8% emulsion
(w/w) and 0.5 % polysaccharide (w/w). Curcumin-loaded carrageenan hydrogel beads
were prepared using a syringe to drip curcumin-loaded emulsion/k-carrageenan mixtures
into 10 mL 5% potassium chloride solution with continuous stirring. Similarly,
curcumin-loaded alginate hydrogel beads were formed by dripping curcumin-loaded
emulsion/alginate mixtures into 5% calcium chloride solution. The hydrogel beads
formed were incubated with the cations (K+ or Ca2+) for a 1 h at ambient temperature to
promote cross-linking. The beads were then collected by filtration and subsequently
washed with distilled water and phosphate buffer to remove any excess ions from their
surfaces.

4.1.2.5 Gastrointestinal tract model
Curcumin delivery systems with the same total lipid concentration (5%) and total
volume (15 mL) were prepared by diluting the original systems with buffer solution (5
mM PBS, pH 6.5). The samples were then passed through a static GIT model that
simulated the mouth, stomach, and small intestine phases. This method has been
described in detail in our previous study 230, and so is only briefly summarized below.
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Initial System: 15 mL of the initial systems were placed into a glass beaker in an
incubator shaker at a rotation speed of 100 rpm for 15 min at 37 °C for preheating
(Innova Incubator Shaker, Model 4080, New Brunswick Scientific, Edison, NJ). Three
different initial curcumin-loaded delivery systems were tested: (i) lipid droplets, (ii) filled
alginate beads, and, (iii) carrageenan beads.
Mouth phase: 15 mL of simulated saliva fluid (SSF) containing 0.03 g/mL mucin was
preheated to 37 °C and then mixed with the initial samples. After being adjusted to
pH 6.8, the mixture was incubated in an incubator shaker for 10 min at 37 °C to mimic
agitation in the mouth.
Stomach phase: 30 mL of the “bolus” sample resulting from the mouth phase was
mixed with 30 mL of simulated gastric fluid containing 0.0032 g/mL pepsin preheated to
37 °C and then the pH was adjusted to 2.5. This mixture was incubated in the incubator
shaker for 2 h at 37 °C to mimic stomach conditions.
Small intestine phase: 60 mL of “chyme” sample from the stomach phase was
placed into a 150 mL glass beaker that was placed into a water bath at 37 °C and then
adjusted to pH 7.00. 3 mL of simulated intestinal fluid was added to the reaction vessel,
followed by 7 mL of bile salt solution with constant stirring. The pH of the reaction
system was adjusted back to 7.00. 5 mL of lipase solution was then added to the sample
and an automatic titration unit (Metrohm, USA Inc.) was used to monitor the pH and
maintain it at pH 7.0 by titrating 0.25 mM NaOH solution into the reaction vessel for 2 h
at 37 °C. The amount of free fatty acids released was calculated from the titration curves
as described previously 231.
4.1.2.6 Determination of particle characterization
The particle size distribution of the samples was measured using a static light
scattering device (Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire,
UK). Initial, mouth, and small intestine samples were diluted with phosphate buffer
(5 mM, pH 7.0) and stomach samples were diluted with acidified water (pH 2.5) to avoid
multiple scattering effects. The refractive index of the oil phase used in the calculations
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was 1.472. The average particle sizes are reported as the surface-weighted mean diameter
(d32). The hydrogel beads could not be analyzed by static light scattering because they
were too large and rapidly sedimented or creamed inside the measurement chamber. We
therefore used image analysis software (Image J, version 1.49) to characterize the particle
size distribution of the hydrogel beads based on images of the samples. The images of the
beads after each digestion stage were obtained using a regular camera at the fixed height,
and at least 20 samples were selected to determine the particle size characterization of the
hydrogel beads.

4.1.2.7 Microstructure analysis
The microstructure of samples after passing each digestion process was studied in
this section. The microstructure of the all the samples were examined using confocal
scanning laser microscopy with a 60 × objective lens (Nikon D-Eclipse C1 80i, Nikon,
Melville, NY, U.S.). For the confocal microscopy, each sample was dyed prior to
confocal microscopy observation. The corn oil was dyed with Nile red solution (1 mg/mL
ethanol) by adding 0.1 mL of Nile red dye solution to 2 mL of sample and storage at 5 °C
overnight. The excitation and emission spectrum for Nile red were 543 nm and 605 nm,
respectively. The microstructure images for confocal microscopy were taken and
analyzed using image analysis software (NIS-Elements, Nikon, Melville, NY).

4.1.2.8 Determination of curcumin concentration, bioaccessibility, and
transformation
After the samples had passed through the simulated GIT, 25 g of digesta from the
small intestine phase was collected and centrifuged (18,000 rpm, Thermo Scientific,
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Waltham, MA) at 25 °C for 30 min. The clear supernatant was collected and assumed to
be the “micelle fraction” in which the curcumin was solubilized. Aliquots of 3 mL of
micelle fraction were mixed with 3 mL of chloroform, vortexed, and centrifuged at 1,750
rpm for 10 min at ambient temperature. The bottom layer containing the solubilized
curcumin was collected, while the top layer was mixed with an additional 3 mL of
chloroform and the same procedure was repeated. The two collected chloroform layers
were mixed together and then diluted to an appreciate concentration to be analyzed by a
UV-visible spectrophotometer at 419 nm. The concentration of curcumin was calculated
from the absorbance using a standard curve.
The bioaccessibility of curcumin (i.e., the fraction in the small intestine that was
solubilized in the mixed micelle phase) was calculated from this data: B* = 100 ×
CMicelle/CDigesta, where CMicelle and CDigesta are the curcumin concentrations in the micelle
faction and in the total digesta collected after the small intestine phase, respectively. The
transformation of curcumin (i.e., the fraction remaining in a non-transformed state in the
small intestine) was calculated: T* = 100 × CDigesta/CInitial, where CInitial is the curcumin
concentration in the small intestine phase calculated based on the initial amount added,
which was calculated based on the curcumin concentration in initial sample before
digestion and the theoretical dilution process during the digestion. The effective
bioavailability (i.e., the fraction of ingested curcumin present in the mixed micelle phase)
was also calculated: BA = 100 × CMicelle/CInitial. The bioaccessibility and transformation
of curcumin in the filled hydrogel beads could not be calculated because it was not
possible to extract all of the curcumin from the hydrogel beads, so CDigesta could not be
measured.
4.1.2.9 Statistical analysis
All experiments were performed on at least two freshly prepared samples. The
results are reported as averages and standard deviations, and the differences among
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treatments were calculated based on an analysis of variance (ANOVA) and a post-hoc
Duncan test with a confidence level of 95 %. These analyses were carried out using
statistical analysis software (SPSS, IBM Corporation, Armonk, NY, USA).
4.1.3 Results and discussion
4.1.3.1 Preparation of the curcumin-loaded emulsions and filled hydrogel beads
In this study, three different curcumin delivery systems were prepared: lipid droplets;
filled alginate beads; and filled carrageenan beads (Fig. 4.1). The filled hydrogel beads
were formed by injection of a mixture of the lipid droplets and anionic biopolymer into a
crosslinking cationic mineral solution. In general, several parameters may influence the
physicochemical and structural properties (e.g., size, shape, porosity, and hardness) of
hydrogel beads fabricated by the injection method, including biopolymer concentration,
cation concentration, needle diameter, injection flow rate, and hardening time. After
some preliminary experiments to optimize the preparation conditions, we fabricated the
hydrogel beads by injecting a 0.5 % polysaccharide solution (alginate or carrageenan)
into a 5% cationic mineral solution (Ca2+ or K+) using a syringe with a needle diameter of
0.5 mm at a rate of one drop per 2 s. After injection, the hydrogel beads were incubated
in the cationic mineral solutions for an hour at ambient temperature to promote
polysaccharide cross-linking. The alginate beads fabricated using this method had a
spherical shape with a smooth surface, and had diameters ranging from about 2 to 3 mm
(Fig. 4.1 and Table 4.1). Conversely, the carrageenan beads formed using the same
method had an irregular shape and had rough surfaces with a larger mean particle
diameter (around 3 to 4 mm). The difference in the properties of the hydrogel beads can
be attributed to differences in the gelation mechanisms of the two different
polysaccharides. The hydrogel matrix within the alginate beads is formed by calcium ion
crosslinking of guluronic acid blocks within the alginate chains 232, whereas that in the
carrageenan beads is formed by potassium ion crosslinking of sulfate groups along the
carrageenan chains 233. The fact that the alginate beads had a more spherical and
smoother structure suggests that the crosslinking of the alginate molecules by calcium
ions occurred more rapidly than the crosslinking of the carrageenan molecules by
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potassium ions. Thus, the initial spherical shape of the polysaccharide solution injected
into the cation solution was maintained more readily for the fast-gelling alginate system.
This may have been because the multivalent calcium ions were more efficient at
crosslinking that the monovalent potassium ions. We hypothesized that the difference in
initial structure and properties of the hydrogel beads formed by the two different
polysaccharides would alter their behavior within the simulated GIT, e.g., their
susceptibility to enzyme penetration, and their stability to mechanical forces or pH
changes.

Figure 4. 1 Appearance of different curcumin-delivery systems prepared in buffer
solution (5 mM PBS, pH 6.5), from left to right: lipid droplets; Filled alginate beads, and
Filled carrageenan beads. Unfilled alginate beads (far right) are shown as a reference.

It is interesting to note that unfilled alginate and carrageenan beads sedimented to
the bottom of the test tubes, whereas the filled beads creamed to the top (Fig. 4.1). This
difference in behavior can be attributed to the influence of lipid droplets on the effective
density of the hydrogel beads 173: unfilled beads are denser than water, whereas filled
beads are less dense than water. This effect occurs because lipids have a lower density
than water, whereas biopolymers have a higher density. The buoyancy characteristics of
filled hydrogel beads makes them good candidates for stomach targeting delivery systems
as they may spend a longer time within the gastric cavity 106.
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4.1.3.2 Influence of GIT conditions on particle size and microstructure
The particle size distribution (Fig. 4.2), general appearance (Fig.4.3), and
microstructure (Fig. 4.4) of the curcumin-loaded lipid droplets and filled hydrogel beads
were measured during passing through the simulated GIT.
Table 4. 1 The mean particle diameters of three curcumin delivery systems after each
digestion stage in a simulated GIT: Lipid droplets; Filled alginate beads; and, Filled
carrageenan beads.
Mean Particle Diameter (µm)
Sample

Initial

Mouth

Stomach

Intestine

Lipid Droplets

0.13 ± 0.01

0.14 ± 0.01

0.15 ± 0.01

0.22 ± 0.01

Filled alginate
beads

2604 ± 75

2857 ± 166

2555 ± 204

1796 ± 58

Filled carrageenan
beads

3107 ± 159

824 ± 640

372 ± 344

848 ± 184

Curcumin-loaded lipid droplets. The mean particle diameters (d32) of the curcuminloaded lipid droplets were fairly similar for the initial samples (0.13 µm) and the samples
that had been exposed to the mouth (0.14 µm) and stomach (0.15 µm) phases (Table 4.1).
In addition, the particle size distributions of the initial, mouth, and stomach samples were
also fairly similar (Fig. 4.2). These results suggest that the lipid droplets were stable to
coalescence in the simulated saliva and gastric fluids, which can be attributed to the fact
that they were coated with a non-ionic surfactant (Tween 80) that inhibits droplet
coalescence through steric repulsion. Other studies have also reported the good
coalescence stability of lipid droplets coated by non-ionic surfactants under simulated
mouth and stomach conditions 234-235. Despite the fact little droplet coalescence was
observed by light scattering, the confocal microscopy images indicated that there was
some aggregation of the lipid droplets within the mouth and stomach phases (Fig. 4.4),

92

which may have been due to depletion flocculation caused by the presence of nonadsorbed mucin molecules in the simulated saliva 236. These non-adsorbed mucin
molecules generate an osmotic attraction between the lipid droplets that forces them
together. These large particles were not seen in the particle size distributions because the
samples had to be diluted for the light scattering measurements, which would have
caused dissociation of any flocs held together by depletion forces. After passing through
the small intestine phase, the particle size distribution of the samples initially containing
curcumin-loaded lipid droplets became bimodal (Fig. 4.2a). This suggests that there was
a wide range of different-sized colloidal particles present in the digesta after exposure to
small intestinal fluids containing lipase and bile salts. These colloidal particles may have
been mixed micelles (micelles and vesicles), undigested lipid droplets, and/or insoluble
calcium salts.

(a)
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(b)
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(c)
Figure 4. 2 Particle size distribution of different samples: (a) Lipid droplets, (b) Filled
carrageenan beads, and (c) Filled alginate beads after each digestion stage.

Filled hydrogel beads. The particle size and microstructure of the filled hydrogel
beads in the different regions of the GIT depended on the type of polysaccharide used
(Figs. 4.2 to 4.4). For the alginate beads, the general shape of the particle size distribution
remained fairly similar from initial-to-mouth-to-stomach, exhibiting a major population
of large particles with diameters around 2,500 µm (Table 4.1, Fig. 4.2c). In addition,
observation of the general appearance of the alginate beads indicated that they remained
intact after exposure to the different GIT phases (Fig. 4.3). There was an appreciable
decrease in the mean particle diameter of the alginate beads when they were moved from
the simulated stomach to small intestine (Table 4.1). Previous studies have also reported
that calcium alginate beads shrink under highly acidic gastric conditions 76, 237, which can
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be attributed to a reduction in the electrostatic repulsion between the alginate molecules
below the pKa value of the carboxyl groups. The closer packing of the biopolymer
molecules within the hydrogel beads under stomach conditions may be useful for
protecting encapsulated components from the harsh gastric environment. Interestingly,
there appeared to be an increase in the turbidity of the aqueous solution surrounding the
hydrogel beads in the small intestine (Fig. 4.3b), which suggests that there were colloidal
particles present large enough to scatter light. These particles may have been undigested
lipid droplets or mixed micelles released from the hydrogel beads. Indeed, confocal
microscopy images of the aqueous phase collected from outside of the hydrogel beads
indicated that they contained some lipid-rich particles (data not shown).
4.1.3.3 Influence of delivery system type on lipid digestion
An automatic titration (pH stat) method was used to evaluate the effect of delivery
system type on the rate and extent of lipid digestion. The fraction of free fatty acids
(FFAs) released from the samples during the small intestine phase was calculated from
measurements of the volume of NaOH that had to be titrated into the reaction chamber to
maintain a constant pH (7.0). The nature of the delivery system clearly had a pronounced
impact on the rate and extent of lipid digestion (Fig. 4.5). The free lipid droplets were
rapidly digested during the first 10 minutes with over 60% of the FFAs being released,
followed by a more gradual digestion for the remainder of the incubation time.
Conversely, the rate of FFAs released was much slower for the filled hydrogel beads, and
depended on polysaccharide type. For the filled alginate beads, no lipid digestion
occurred during the first 30 minutes, then there was a relatively slow rate of lipid
digestion at longer times, with only 33% of the FFAs being released by the end of the 2
hour digestion period. For the filled carrageenan beads, lipid digestion started
immediately and occurred throughout the incubation period, but it was relatively slow
compared to the free lipid droplets, with only 46% of FFAs released by the end of the
small intestine phase. These results indicate that encapsulation of the lipid droplets
within the hydrogel beads retarded lipid digestion, with the degree of lipase inhibition
depending on hydrogel type. Similar results have been reported in earlier studies of lipid
digestion in hydrogel beads 76.
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Figure 4. 3 Images of different curcumin-loaded beads after each digestion stage: (a)
Filled alginate beads, and (b) Filled carrageenan beads.
There are a number of reasons that encapsulation may have inhibited lipid digestion.
Firstly, lipid digestion can only occur if pancreatic lipase is able to adsorb to the surfaces
of the lipid droplets and come into close proximity with its substrate, i.e., triacylglycerol
and diacylglycerol molecules 238. For the free lipid droplets, the pancreatic lipase is able
to rapidly move from the aqueous phase to the lipid droplet surfaces and initiate lipolysis.
For the filled hydrogel beads, lipase and the other GIT components required for digestion
(such as co-lipase and calcium) have to penetrate into the beads and diffuse through the
hydrogel matrix before they can reach the lipid droplet surfaces. In particular, these
components must diffuse through the network of cross-linked biopolymer molecules that
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makes up the interior of the hydrogel beads 76. The time taken for lipase molecules to
reach the lipid droplets within the interior of the beads increases as the pore size of the
hydrogel matrix decreases, the diameter of the beads increases, or the surface area of the
beads decreases 76, 239. The lag time observed before any lipid digestion occurred for the
alginate beads may have been because the hydrogel matrix shrank under gastric
conditions thereby decreasing the bead pore size and inhibiting penetration of lipase.
However, the pore size expanded once the beads were placed into the small intestinal
fluids, thereby allowing the lipase molecules to penetrate. This hypothesis is supported
by the fact that the mean diameter of the alginate beads was smaller in the gastric fluids
than in the intestinal fluids (Table 4.1). After the lag phase, the relatively slow rate of
lipid digestion observed in the alginate beads, may have been because they were larger
than the carrageenan beads. As mentioned earlier, the alginate beads maintained their
general structure throughout the GIT, whereas the carrageenan beads were largely
disrupted by the small intestine phase. The slow rate of digestion for the alginate beads
may also have been because they had a smaller pore size than the carrageenan beads,
which would inhibit lipase diffusion. A second potential reason for retarded lipid
digestion in the filled hydrogel beads is that the long chain FFAs generated at the
surfaces of the lipid droplets have to be removed otherwise the lipolysis reaction will be
retarded 240-241. Typically, FFAs are removed from the droplet surfaces by being
incorporated into mixed micelles with bile salts and phospholipids, or by forming
insoluble salts with calcium ions 242. The removal of FFAs away from the lipid droplet
surfaces may therefore be limited because bile salts, phospholipids, and calcium cannot
easily penetrate through the cross-linked biopolymer network inside the hydrogel beads.
In addition, the diffusion of the FFAs themselves out of the hydrogel beads may also be
inhibited by the presence of the biopolymer network. These results clearly show that
encapsulating lipid droplets in hydrogel beads can modulate the rate and extent of their
digestion.
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Figure 4. 4 Microstructures of three samples including free emulsion, emulsion in
alginate beads and emulsion in carrageenan beads exposed to different regions of a
simulated GIT. Scale bar is 20 µm.
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Figure 4. 5 Amount of fatty acids released from three samples including free emulsion,
emulsion in alginate beads and emulsion in carrageenan beads measured in a pH-stat
in vitro digestion model.
4.1.3.4 Influence of delivery system type on curcumin release
The amount of curcumin released into the mixed micelle phase clearly depended on
the nature of the delivery system used to encapsulate it: free droplets > filled carrageenan
beads > filled alginate beads (Fig. 4.6). For the free oil droplets, it was possible to
calculate the bioaccessibility (73%), transformation (78%), and effective bioavailability
(57%) from the initial, digesta, and micelle curcumin concentrations (Section 2.7). The
effective bioavailability of the curcumin in the filled alginate beads (12%) and
carrageenan beads (15%) was also determined. Pure curcumin typically has a very low
bioavailability because of its poor chemical stability and low solubility in gastrointestinal
fluids 202, 206. Our results suggest that encapsulation of curcumin within free lipid droplets
led to a relatively high effective bioaccessibility. This enhanced bioavailability can be
attributed to two main physicochemical factors. First, when curcumin is present within
the interior of the lipid droplets it is protected from chemical degradation induced by
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aqueous phase components, which leads to a relatively high amount remaining in an
active form in the small intestine (high T*). Second, the digestion of the lipid droplets
leads to the formation of mixed micelles that can solubilize the hydrophobic curcumin
molecules (high B*). Previous studies in our laboratory have also reported that
nanoemulsions can increase curcumin bioaccessibility and transformation through these
mechanisms when used as either delivery systems 217 or excipient systems 216, 223.
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Figure 4. 6 Bioaccessibility (%) of curcumin in three samples including lipid droplets,
filled alginate beads, and filled carrageenan beads after in vitro digestion.
The relatively low effective bioavailability of the curcumin in the filled hydrogel
beads can largely be attributed to the fact that not all of the lipid phase was digested for
these systems. Consequently, some of the curcumin remained within the undigested lipid
droplets trapped inside the hydrogel beads and was therefore not released. In addition,
there will have been less mixed micelles available in the aqueous phase to solubilize any
curcumin molecules released: (i) because of the relatively low extent of lipid digestion;
and, (ii) because the diffusion of any FFAs and monoacylglycerols formed within the
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beads may have been hindered by the hydrogel matrix. There appeared to be a good
correlation between the extent of lipid digestion at the end of the small intestine phase
and curcumin release, i.e., they followed the same trend: free droplets > filled
carrageenan beads > filled alginate beads.
Overall, these results have a number of important practical implications. First, it is
important to ensure that any hydrogel beads used to encapsulate and protect curcumin
within food products do not inhibit its release within the GIT. Otherwise, any potential
health benefits associated with consuming curcumin may not be fully realized. Second, it
may be possible to control the release of curcumin in different regions of the GIT by
encapsulating it within hydrogel beads. For example, if it was important to release
curcumin in the colon then it could be encapsulated within hydrogel beads that retained it
in the mouth, stomach, and small intestine, but released it in the colon. Alternatively, if
one wanted to mask the taste of curcumin, but still ensure that it was absorbed in the
upper intestine, it could be incorporated into hydrogel beads that retained it in the mouth,
but released it in the stomach or small intestine.
4.1.4 Conclusions
In the present study a simulated GIT was used to study the influence of different
types of delivery systems on lipid digestion and curcumin release: free lipid droplets;
filled carrageenan beads; and, filled alginate beads. In all systems, the crystal form of
curcumin was first dissolved in a digestible lipid phase, which was then converted into an
oil-in-water nanoemulsion. In the case of the filled hydrogel beads, the curcumin-loaded
lipid droplets were then trapped within a hydrogel matrix using an injection-gelation
method. The alginate beads had a uniform spherical shape with diameters ranging from 2
to 3 mm, whereas the carrageenan beads had irregular shapes and diameters around 3 to 4
mm. Differences in hydrogel bead morphology were attributed to differences in the initial
rate of biopolymer gelation during the injection process. Simulated GIT studies indicated
that free lipid droplets were digested more rapidly and fully than those encapsulated
within hydrogel beads. In addition, they showed that the rate and extent of lipid digestion
in filled hydrogel beads depended on polysaccharide type, which was partly attributed to
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differences in their integrity within the GIT. Alginate beads remained relatively intact
throughout the GIT, while the carrageenan beads partly disintegrated. The extent of
curcumin release into the mixed micelle phase in different samples followed the
following order: free droplets > filled carrageenan beads > filled alginate beads. Our
results have important implications for designing hydrogel beads to increase the oral
bioavailability of lipophilic bioactives.
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4.2 The physicochemical stability and in vitro bioaccessibility of β-carotene in
alginate-based hydrogel beads
4.2.1 Introduction
Carotenoids are naturally occurring groups of pigments widely present in various
fruits and vegetables to play essential roles in photosynthesis and photo-protection
reactions. β-Carotene, one of the major carotenoids, is regarded as a natural carotenoid
precursor of vitamin A. Because of its antioxidant and non-antioxidant activities, βcarotene have showed biological activities to reduce the risk of certain chronic diseases
including cardiovascular disease, cataracts, age-related macular degeneration and cancers
when ingestion of sufficient levels. Growing concern on healthy diet has encouraged
many food companies to fortify their products with this bioactive ingredient. However,
the pure hydrogen-carbon skeleton structure and high unsaturation degree of β-carotene
greatly restrict its incorporation into many commercial foods and beverages. β-carotene
has been reported to have low water-solubility, high melting point, and poor chemical
instability 243-244. Moreover, β-Carotene can be rapidly metabolized like most of
lipophilic bioactive agents within the gastrointestinal tract (GIT), which limits its
potential beneficial biological effects.
Colloidal delivery systems are one of the most convenient methods for incorporating
lipophilic bioactive ingredients into food products. They usually consist of small particles
(typically comprised of lipids, phospholipids, surfactants, and/or biopolymers) that
contain the lipophilic bioactive agents. These small particles can be designed to facilitate
the incorporation of bioactive agents into commercial food products, improve
chemical/biochemical stability and control their fate within the GIT. A typical bioactiveloaded colloidal system can be simply prepared by solubilizing the lipophilic bioactive
components within an oil phase and then homogenising it with an aqueous phase
containing an emulsifier to form the oil-in-water emulsions. Previous studies have
reported that emulsion-based systems were particularly suitable for encapsulation and
delivery of carotenoids such as lutein 245, lycopene 246 and β-Carotene 247-248. The
bioavailability of carotenoids was greatly increased after encapsulation in emulsion-based
systems 249. One of the major limitations of conventional oil-in-water emulsions is that
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they have limited scope for controlling the stability of lipophilic bioactives because the
bioactives-loaded lipid droplets are coated only with a thin layer of emulsifier molecules,
which hardly guarantee the encapsulated bioactives suffer from the harsh environment
conditions. In particular, carotenoids have a conjugated polyunsaturated hydrocarbon
chain, which makes them highly prone to degradation due to autoxidation promoted by
light, heat, singlet oxygen, transition metals, free radicals and highly acidic condition 247.
This limitation can be overcome by trapping the lipid droplets inside hydrogel beads
(“microgels”). Carotenoids may have a more stable environment after encapsulation in a
polymer matrix, which creating a single compartment and thus protecting them from
degradation.
Hydrogel beads are usually fabricated from food-grade biopolymers such as proteins
and/or polysaccharides. These beads can be fabricated from numerous approaches such as
injection, coacervation, thermodynamic incompatibility, antisolvent precipitation,
templating, and molding methods 79. The injection-gelation method is one of the simplest
and most widely used approaches for the encapsulation, protection, and delivery of foodgrade bioactive components. In this method, a biopolymer solution containing the
bioactive component is injected into another ‘‘hardening’’ solution under conditions that
promote the gelation of the injected biopolymer. This procedure results in the formation
of a hydrogel bead with the bioactive components trapped inside. The nature of the
hydrogel matrix surrounding the bioactive can be designed to improve its physical and
chemical stability, as well as to control its GIT fate. In general, hydrogel beads with a
particle size greater than 1.0 mm in diameter are prepared using a syringe with a needle
or a pipette. Smaller size beads (less than 1 mm in diameter) could be fabricated using an
extrusion device (Encapsulator). The beads with relatively small size may have several
advantages over the traditional large ones on appearance, rheology and mouthfeel. The
sizes of these beads can be further adjusted by several factors including the polymers and
ion concentration, instrument parameters and hardening time.
In the present study, a high-pressure homogenisation method was used to prepare
nanoemulsions containing β-carotene. The β-carotene-loaded lipid droplets were then
used as delivery systems themselves, or they were incorporated into hydrogel beads
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fabricated from alginate. The filled hydrogel beads were fabricated by mixing the lipid
droplets with an alginate solution, and then injecting the resulting mixture into an ion
solution (Ca2+) with the extrusion device (Encapsulator). Two different alginate
concentrations (0.5% and 1%) were used because they are expected to form hydrogel
beads with different physical and functional attributes. The stability of β-carotene
encapsulated within oil-in-water nanoemulsions and filled hydrogel beads was studied
during the storage. In particular, the influence of the different delivery systems
(nanoemulsion and filled hydrogel beads) encapsulation on the bioaccessibility of
encapsulated β-carotene was compared using a gastrointestinal (GI) model that simulates
the mouth, stomach and small intestine. The information obtained from this study should
be useful for the development of bead-based functional food products fortified with
lipophilic bioactive ingredients that may improve human health and wellness.
4.2.2 Materials and methods
4.2.2.1 Materials
Whey protein isolate (WPI) was kindly provided by Davisco Foods International Inc.
(Le Sueur MN). The WPI was reported to contain 97.9 wt.% protein, 0.2 wt.% fat. Corn
oil was purchased from a local supermarket and used without further purification. The
following chemicals were purchased from the Sigma Chemical Company (St. Louis, MO):
β-carotene; alginic acid (sodium salt); mucin from porcine stomach; pepsin from porcine
gastric mucosa; lipase from porcine pancreas pancreatin; porcine bile extract; and Nile
Red. All chemicals used were analytical grade. Double distilled water was used to make
all solutions.
4.2.2.2 Preparation of β-carotene-loaded emulsions
Initially, an aqueous phase was prepared by mixing 1% (w/w) WPI with a buffer
solution (5 mM phosphate buffer saline (PBS), pH 7) and stirring for at least 2 h. The
emulsifier solution was stored overnighted at 4 °C and filtered before use to ensure the
complete dissolution of any large particles. The β-carotene-loaded lipid droplets were
prepared by dispersing β-carotene (0.1%, w/w) in corn oil by heating (55°C, 10 min) and
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then ultrasonic processing (2min). This procedure was repeated several times to ensure
the complete dissolution of β-carotene in the oil phase. The coarse emulsion was prepared
by homogenizing 10% (w/w) corn oil with 90% (w/w) aqueous emulsifier solution using
a high-speed blender for 2 min (M133/1281-0, Biospec Products, Inc., ESGC, Switzerland). The droplet size in this coarse emulsion was further reduced by passing it through a
high-pressure homogenizer (Microfluidizer, M110Y, Microfluidics, Newton, MA) with a
75 µm interaction chamber (F20Y) at an operational pressure of 12,000 psi for 3 passes.
The resulting β-carotene-loaded emulsions were stored in a refrigerator at 4 °C before use.
4.2.2.3 Encapsulation of β-carotene in alginate beads
Different concentration of aqueous alginate solutions were prepared by dissolving
powdered alginic acid (1% and 2%, w/w) in distilled water and stirring continuously at
60 °C for an hour, and then reducing the temperature to 35 °C. Alginate solutions and βcarotene-loaded emulsions were then mixed together (1:1, mass ratio) for 2 h with
continuous stirring to form a solution that contained 5% emulsion (w/w) and
polysaccharide (0.5% and 1%). The β-carotene-loaded hydrogel beads were prepared
using a commercial encapsulation unit (Encapsulator B-390, BUCHI, Switzerland) with a
120µm nozzle to inject the β-carotene/alginate solution into 10% calcium chloride
solution. The formed hydrogel beads were incubated with the Ca2+ for 1 h at ambient
temperature to promote cross-linking. The beads were then collected by filtration and
subsequently washed with distilled water and phosphate buffer to remove any excess ions
from their surfaces. The formed beads were then storage in refrigerator to dehydration
and then the total weight was determined to facilitate the further measurements.
4.2.2.4 Measurement of β-carotene stability
The physicochemical stability of β-carotene encapsulated in the free emulsion and
filled hydrogel particles were tested: 4 ml 5% emulsion samples and filled hydrogel
beads (5% oil) were transferred into glass tubes and stored in the dark at 55°C for 12 days
(pH 7). The β-carotene was isolated from a nanoemulsion and hydrogel beads using
solvent extraction methods: each sample was extracted by the chloroform and alcohol
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(volume fraction 1:1) solution at least two times. For the filled hydrogel beads, saturated
ethylene diamine tetraacetic acid (EDTA) solution was used to dissolve the beads and
release the encapsulated β-carotene. The transparent lower organic phase containing the
β-carotene was collected and transferred to a cuvette, and then its absorbance was
measured at 450 nm using a UV–visible spectrometer. A pure chloroform and alcohol
solution was used as a blank. A corn oil nanoemulsion containing no added β-carotene
was also analyzed as a control. The β-carotene content was determined using a standard
curve created from solutions with varying amounts of known β-carotene. All
measurements were repeated three times.
4.2.2.5 Gastrointestinal tract model
β-carotene delivery systems (free emulsion and filled hydrogel beads) with the same
total lipid concentration (2%) and total volume (7.5 mL) were prepared by diluting the
original systems with buffer solution (5 mM PBS, pH 7). The samples were then passed
through a static GIT model that simulated the mouth, stomach, and small intestine phases.
This method has been described in detail in our previous study 230, and so is only briefly
summarized below.
Initial System: 7.5 mL of the initial systems were placed into a glass beaker in an
incubator shaker at a rotation speed of 100 rpm for 15 min at 37 °C for preheating
(Innova Incubator Shaker, Model 4080, New Brunswick Scientific, Edison, NJ). Three
different initial β-carotene-loaded delivery systems were tested: (i) lipid droplets, (ii)
filled alginate beads (0.5 % alginate) (iii) filled alginate beads (1 % alginate).
Mouth phase: 7.5 mL of simulated saliva fluid (SSF) containing 0.03 g/mL mucin was
preheated to 37 °C and then mixed with the initial samples. After being adjusted to
pH 6.8, the mixture was incubated in an incubator shaker for 10 min at 37 °C to mimic
agitation in the mouth.
Stomach phase: 15 mL of the “bolus” sample resulting from the mouth phase was
mixed with 15 mL of simulated gastric fluid containing 0.0032 g/mL pepsin preheated to
37 °C and then the pH was adjusted to 2.5. This mixture was incubated in the incubator
shaker for 2 h at 37 °C to mimic stomach conditions.
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Small intestine phase: 30 mL of “chyme” sample from the stomach phase was
placed into a 150 mL glass beaker that was placed into a water bath at 37 °C and then
adjusted to pH 7.00. 1.5 mL of simulated intestinal fluid was added to the reaction vessel,
followed by 3.5 mL of bile salt solution with constant stirring. The pH of the reaction
system was adjusted back to 7.00. 2.5 mL of lipase solution was then added to the sample
and an automatic titration unit (Metrohm, USA Inc.) was used to monitor the pH and
maintain it at pH 7.0 by titrating 0.25 mM NaOH solution into the reaction vessel for 2 h
at 37 °C. The amount of free fatty acids released was calculated from the titration curves
as described previously 231.
4.2.2.6 Determination of particle characterization
The particle size distribution of the samples after passing each digestion process was
measured using a static light scattering device (Mastersizer 2000, Malvern Instruments
Ltd., Malvern, Worcestershire, UK). Initial, mouth, and small intestine samples were
diluted with phosphate buffer (5 mM, pH 7.0) and stomach samples were diluted with
acidified water (pH 2.5) to avoid multiple scattering effects. The refractive index of the
oil phase used in the calculations was 1.472. The average particle sizes are reported as the
surface-weighted mean diameter (d32) for emulsion samples and volume-weighted mean
diameter (d43) for beads.
4.2.2.7 ζ-potential measurements
The electrical charge (ζ-potential) of the samples after passing each digestion
process was measured using a particle electrophoresis instrument (Zetasizer Nano ZA
series, Malvern Instruments Ltd. Worcestershire, UK). Initial, mouth, and small intestine
samples were diluted with phosphate buffer (5 mM, pH 7.0) and stomach samples were
diluted with acidified water (pH 2.5) prior to analysis to keep the instrument attenuation
value between 5 and 10. All measurements were made on at least two freshly prepared
samples and each sample was measured in duplicate.
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4.2.2.8 Microstructure analysis
The microstructure of samples after passing each digestion process was studied in
this section. The microstructure of the all the samples were examined using confocal
scanning laser microscopy with a 20 × objective lens (Nikon D-Eclipse C1 80i, Nikon,
Melville, NY, U.S.). For the confocal microscopy, each sample was dyed prior to
confocal microscopy observation. The corn oil was dyed with Nile red solution (1 mg/mL
ethanol) by adding 0.1 mL of Nile red dye solution to 2 mL of sample and storage at 5 °C
overnight. The excitation and emission spectrum for Nile red were 543 nm and 605 nm,
respectively. The microstructure images for confocal microscopy were taken and
analyzed using image analysis software (NIS-Elements, Nikon, Melville, NY).
4.2.2.9 Determination of β-carotene concentration, bioaccessibility, and
transformation
After the samples had passed through the simulated GIT, 20 g of digesta from the
small intestine phase was collected and centrifuged (18,000 rpm, Thermo Scientific,
Waltham, MA) at 4 °C for 30 min. The β-carotene in digesta and micelle phase was
extracted based on the methods described in section 2.4. The EDTA solution was used to
dissolve the hydrogel beads and release the encapsulated β-carotene. The clear
supernatant after extraction was collected and assumed to be the “micelle fraction” in
which the β-carotene was solubilized. Aliquots of 2 mL of micelle fraction were mixed
with 2 mL of chloroform and 2 mL of alcohol, vortexed several times, and centrifuged at
3500 rpm for 5 min at ambient temperature. The collected chloroform layers were diluted
to an appreciate concentration to be analyzed by a UV-visible spectrophotometer at 450
nm. The concentration of β-carotene was calculated from the absorbance using a standard
curve.
The bioaccessibility of β-carotene (i.e., the fraction in the small intestine that was
solubilized in the mixed micelle phase) was calculated from this data: B* = 100 ×
CMicelle/CDigesta, where CMicelle and CDigesta are the β-carotene concentrations in the micelle
faction and in the total digesta collected after the small intestine phase, respectively. The
transformation of β-carotene (i.e., the fraction remaining in a non-transformed state in the
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small intestine) was calculated: T* = 100 × CDigesta/CInitial, where CInitial is the β-carotene
concentration in the small intestine phase calculated based on the initial amount added.
The effective bioavailability (i.e., the fraction of ingested β-carotene present in the mixed
micelle phase) was also calculated: BA = 100 × CMicelle/CInitial.
4.2.2.10 Statistical analysis
All experiments were performed on at least two freshly prepared samples. The
results are reported as averages and standard deviations, and the differences among
treatments were calculated based on an analysis of variance (ANOVA) and a post-hoc
Duncan test with a confidence level of 95 %. These analyses were carried out using
statistical analysis software (SPSS, IBM Corporation, Armonk, NY, USA).
4.2.3 Results and discussion
4.2.3.1 filled hydrogel beads formation and β-carotene stability
In current study, β-carotene was loaded into two delivery systems including
nanoemulsion and filled alginate beads. The filled hydrogel beads were formed by
injection of mixture of the emulsion and alginate solution into Ca2+ solution using an
extrusion device (Encapsulator). Base on preliminary experiments, the size of these beads
could be determined by several parameters including the biopolymer and cation
concentration, infusing gas pressure, vibrational frequency, electrode voltage, nozzle size
and the distance between the nozzle and the surface of the crosslinking solution. Two
different alginate concentrations (0.5% and 1%) were chosen to fabricate the hydrogel
beads using the same operating conditions (frequency 800 Hz, electrode 800 V, pressure
450 mbar). As shown in Fig. 4.7 and Table 4.2, the beads formed with different alginate
concentration showed significant different size and appearance characterization: the 0.5%
alginate-based beads with diameters around 285 µm creamed to the top of the test tube,
whereas the 1% alginate-based beads with diameters around 660 µm sedimented to the
bottom. These beads formed with different concentration of alginate may have different
physical structure and properties. It can be expected that the difference in initial structure
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and properties of the beads would alter the stability and in vitro digestion fate of
encapsulated β-carotene.

Figure 4. 7 The appearance of the β-carotene loaded emulsion in different alginate-based
beads. Left to right: 1% alginate based beads and 0.5% beads

Table 4. 2 The mean particle diameter of three samples including free emulsion,
emulsion in 0.5% alginate beads and emulsion in 1% alginate beads after each digestion
stage.
Mean particle
Diameter (µm)

Initial

Mouth

Stomach

Intestine

Free emulsion

0.15±0.01

0.29±0.02

33.3±3.2

6.6±1.1

0.5% bead

284.8±5.2

469.7±27.5

364.1±18.1

405±8.6

1% bead

660.6±26.4

879.7±33.5

718.4±22.8

837.3±31.5

β-carotene was widely reported to be sensitive to thermal and oxidative degradation
during storage because of its highly unsaturated structure 250-251. The effect of filled
hydrogel beads encapsulation on the stability of β-carotene was thus examined in this
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section. Fig.4.8 shows the relative β-carotene content in the different delivery systems
including nanoemulsion, hydrogel beads formed by 0.5% alginate (0.5% beads) and
hydrogel beads formed by 1% alginate (1% beads) during storage. The relative βcarotene content fell from an initial value of 100% after preparation to 0.2%, 37.6% and
55% for nanoemulsion, 1% beads and 0.5% beads respectively, after storage at 55 °C for
12 days. These results indicated that the β-carotene in nanoemulsions was highly unstable
to chemical degradation stored at elevated temperatures, and hydrogel beads
encapsulation could significantly improve its stability. There may be two reasons
attributed to the hydrogel beads protection effect: firstly, the assembled size of the
emulsion droplets was larger in hydrogel beads than those in the free emulsions, which
meant a smaller surface area for chemical reaction of β-carotene degradation. The other
reason is that beads encapsulation provides a physical barrier of wall polymers for the βcarotene, which limits the diffusion of oxygen, pro-oxidant or free radicals into the
particle core to interact with β-carotene. It is interesting to note that the retention rate of
β-carotene in 0.5% beads was higher than that in 1% beads. This is presumably due that
these beads fabricated by 0.5% alginate have relatively smaller particle and also pore size,
which provide the encapsulated β-carotene more protection by inhibiting less diffusion of
oxygen, pro-oxidant and free radicals. The visual appearance of different samples before
and after storage was also measured and shown in Fig. 4.9. It can be observed that βcarotene normally had an intense orange-yellow colour, but this colour completely faded
to white when it underwent chemical degradation in nanoemulsion. The alginate-based
beads encapsulation showed a good retention of the yellow colour of β-carotene after
storage. These results suggested that alginate-based hydrogel beads encapsulation could
improve the stability of β-carotene.
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Figure 4. 8 Degradation rates of β-carotene loaded in different delivery systems
(nanoemulsion and hydrogel beads) during storage at 55 °C.
4.2.3.2 Influence of GIT conditions on particle charge
In this section, changes in the charge characteristics of the samples were determined
as they passed through the different stages of the GIT model to provide information about
alterations in interfacial properties.
The ζ-potential of the initial samples of free emulsion, 0.5% beads and 1% beads
were -47.6, -9 and -9.5, respectively (Fig. 4.10). The strong negative charge on the free
emulsion can be due to the presence of the whey protein isolate (WPI) molecules at the
droplet surfaces. WPI is above its isoelectric point (pI = 5.1) at the initial solution
conditions (pH 7), and therefore shows a negative charge. The beads were negatively
charged for both alginate concentrations, which attributed to the anionic carboxylic (–
COO−) groups on the mannuronic and guluronic acid groups of alginate molecules. The
concentration of alginate showed little influence on the magnitudes of the electric charges.
These results were also in accordance with the previous study 252.
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Figure 4. 9 The appearance of the β-carotene loaded in different delivery systems
(nanoemulsion and hydrogel beads) before and after stability measurements. Left to right:
the β-Carotene-loaded samples before and after storage.

After subjecting to simulated mouth conditions, there was a gently decrease in the
magnitude of the negative charge on free emulsion (-40.9), while a slightly increase on
these alginate-based beads (-11.2 for 0.5% beads, -15.6 for 1% beads). These changes
were presumably due to electrostatic screening by mineral ions present within the
simulated saliva, or it may have been due to interactions of the mucin molecules with the
samples surfaces (WPI and alginate). There was an appreciable decrease in the magnitude
of the electrical charge when all the samples were passing through stomach phase. It
might be attributed to the low pH and high ionic strength in stomach phase, which
resulted in the electrostatic screening effect on the electrical charge of the samples. It
could be observed that free emulsion droplets were slightly negatively under gastric
conditions, suggesting that they were not only coated by emulsifier whey proteins.
Presumably some of the proteins was digested and displaced, and that some of the mucin
molecules from the simulated saliva could also adsorb to the emulsion droplet surfaces 253.
The relative small magnitude of negative charge of alginate beads could be attributed to a
loss of negative charge on the carboxyl groups at pH values around their pKa value (≈3.5).
The anionic carboxylic (–COO−) groups of alginate molecules became partially
protonated (–COOH) in the stomach phase (pH around 2.5). After small intestine
digestion, all the samples showed relatively high negative charges (around -23). Previous
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study has attributed that to the presence of various types of anionic particles in the
digestion mixture phase such as micelles, vesicles, calcium salts and undigested lipids
and proteins 253. These anionic species may have come from the original emulsions (e.g.,
peptides, free fatty acids, or phospholipids) or from the gastrointestinal fluids (e.g., bile
salts and phospholipids).
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Figure 4. 10 The charge characterization of different samples including free emulsion,
emulsion in 0.5% alginate beads, and emulsion in 1% alginate beads after each digestion
stage.
4.2.3.3 Influence of GIT conditions on particle size and microstructure
β-carotene-loaded emulsion droplets. The particle size distribution of the lipid
droplets in the initial emulsion had a single broad peak with a diameter around 0.15µm
(Table 4.2, Fig. 4.11), and the droplets were evenly distributed throughout the system as
shown from the confocal microscope images (Fig. 4.12). It can be deduced that the WPI-
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coated lipid droplets were relatively small and stable to aggregation in the initial
condition. After passing through the mouth phase, the particle size distributions of these
emulsions became bimodal, with a slight increase in mean particle diameter (d32≈
0.29µm). The confocal microscopy images indicated that extensive droplet aggregation
occurred in mouth phase. It could be attributed either bridging or depletion flocculation
induced by the presence of mucin in the simulated saliva, which is also in agreement with
our previous study 254. Bridging flocculation occurs because of the binding of mucin
molecules to the surfaces of oil droplets, whereas depletion flocculation occurs due to the
increase in the osmotic attractive forces between the droplets generated by non-adsorbed
mucin molecules 253. After exposure to the stomach phase, these emulsions showed an
appreciable increase in mean particle diameter (d32≈ 33.31µm), and a further droplet
aggregation could be observed from the confocal microscopy measurements (Fig.4.12). It
has been reported that protein-stabilized emulsions was prone to aggregation under
gastric conditions because of hydrolysis of adsorbed proteins, weakening of electrostatic
repulsion, and depletion or bridging flocculation induced by mucin 230. After passing
through the small intestinal stage, the emulsions still contained relatively large size
droplets (d32≈ 6.58µm) as detected by both light scattering and confocal microscopy
methods. Presumably, there were many colloidal particles present in the digesta including
undigested lipid droplets, undigested protein aggregates, micelles, vesicles, and insoluble
calcium salts.
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Figure 4. 11 Particle size distribution of different samples (a) Free emulsion, (b)
Emulsion in 0.5% alginate beads, and (c) Emulsion in 1% alginate beads after each
digestion stage.

Filled hydrogel beads. The particle size and microstructure of the filled hydrogel
beads depended on the alginate concentration used for the beads formation. Initially,
these beads fabricated with higher concentration of alginate showed larger size, which
has been mentioned in the previous section. The reason could be attributed to the alginate
property and the beads formation mechanism used by the instrument (Encapsulator). The
alginate solution could form polymer flows when being pumped through the nozzle of the
Encapsulator. After obtaining the electrical charge from the equipment, the polymer
flows could be separated with each other due to the electrical repulsion, and then form
small size droplets injected into cross-link agent solution (Ca2+). High concentration of
alginate tends to form high viscous polymer solution, which is hardly separated by
electrical repulsion force and form small size droplets. High concentration polymers
therefore can potentially form larger size beads using the Encapsulator methods.
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Figure 4. 12 Microstructures of different samples including free emulsion, emulsion in
0.5% alginate beads, and emulsion in 1% alginate beads after exposing to different
regions of a simulated GIT model (Scale bar is 20 µm).

For both concentrations of the alginate beads, the general shape of the particle size
distribution remained relatively similar during the whole digestion process. In addition,
the confocal microscope images showed the similar structure (e.g., shape) of the beads
after each digestion steps, indicating that they remained intact after exposure to the
different GIT phases. There was an appreciable increase and then decrease in the mean
particle diameter of the alginate beads when they were moved from the initial to mouth,
and then from mouth to stomach phase. Presumably, it could be attributed to increase in
the electrostatic repulsion between the alginate molecules in the mouth phase, and a
reduction in the electrostatic repulsion below the pKa value of the carboxyl groups in the
stomach phase. Previous studies have also reported that calcium alginate beads tend to
swell when placed in higher pH solutions, while shrink under highly acidic gastric
conditions 255-256. We can expect that the closer packing of the β-carotene within the
alginate-based beads under stomach conditions may be useful for protecting encapsulated
β-carotene from the harsh gastric environment. After intestinal digestion, the inner red
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fluorescence dye of hydrogel beads faded to black, and there were aggregated particles
surrounding the hydrogel beads observed from the confocal microscope images
(Fig.4.12). These results suggested that lipids digestion occurred in intestine phase and
colloidal particles were released from the beads after digestion. These particles may have
been undigested lipid droplets or mixed micelles. It is therefore interesting to study the
dynamic digestion process (e.g., the diffusion of lipase and digestion products) of filled
hydrogel beads in the future studies.
4.2.3.4 Influence of delivery system type on lipid digestion
The effect of different delivery system encapsulation on the rate and extent of lipid
digestion was evaluated using an automatic titration (pH stat) method. The fraction of
free fatty acids (FFAs) released from the samples during the digestion process was
calculated from measurements of the volume of NaOH that had to be titrated into the
reaction chamber to maintain a constant pH (7.0) as shown in Fig. 4.13. The free
emulsion was rapidly digested during the first 5 minutes with over 76% of the FFAs
being released, followed by a more gradual digestion until a relatively constant final
value (95.8%) was attained for the remainder of the incubation time. Conversely, the
FFAs release rate was much slower for the filled hydrogel beads, which also depended on
the alginate concentration. Around 22.2% and 36.7% FFA were released within first 5
min of digestion, and around 56.2% and 82.5% FFA had been release after 120min
digestion for the 1% and 0.5% beads respectively. These results indicate that
encapsulation of the lipid droplets within the hydrogel beads was highly effective at
retarding lipid digestion. There are a number of physicochemical phenomena might
account for the decreased digestion rate for the encapsulated oil droplets. Firstly, lipid
digestion only occurs when pancreatic lipase can adsorb to the surfaces of the lipid
droplets and come into proximity with its substrate such as triacylglycerol and
diacylglycerol molecules 238. For the free emulsion, the pancreatic lipase is able to
rapidly move from the aqueous phase to the lipid droplets surfaces and thus initiate
lipolysis. Whereas for the filled hydrogel beads, lipase (and the other GIT components)
has to penetrate into the beads and diffuse through the hydrogel network before they can
reach the lipid droplet surfaces. The diffusion rate to the interior of the beads increases as
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the pore size of the hydrogel matrix decreases and also the diameter of the beads
increases. The 0.5% beads with a smaller beads diameter therefore showed a higher
digestion rate and extent compared with 1% beads. A second possible reason is that long
chain FFAs generated in the digestion process must be removed otherwise the lipolysis
reaction will be retarded 76. These FFAs can be typically removed by being incorporated
into mixed micelles with bile salts and phospholipids, or by forming insoluble salts with
calcium ions 242. For these hydrogel beads, the removal of FFAs away from the lipid
droplet surfaces may be limited because bile salts, phospholipids, and calcium have to
penetrate into the biopolymer matrix of the hydrogel beads. Furthermore, the diffusion of
the FFAs themselves out of the beads may also be inhibited by the presence of the
biopolymer network. Our results indicated that the in vitro digestion fate of lipid droplets
could be modulated by encapsulating them in different hydrogel beads.
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Figure 4. 13 Amount of fatty acids released from different samples including free
emulsion, emulsion in 0.5% alginate beads, and emulsion in 1% alginate beads measured
in a pH-stat in vitro digestion model.
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4.2.3.5 Influence of delivery system type on β-carotene release
It has been mentioned earlier that pure β-carotene typically has a very low
bioavailability because of its poor chemical stability and low solubility in gastrointestinal
fluids. The concentration of β-carotene in the mixed micelle phase, total digesta and
initial phase were thus determined to provide a measure of the amount of β-carotene that
was solubilized and the amount that was not chemically degraded. The bioaccessibility,
transformation, and effective bioavailability of β-carotene were also calculated from the
equations described in section 2.9. It is indicated from the Fig.4.13 that free emulsion
samples had higher bioaccessibility (B*) and effective bioavailability (BA) of
encapsulated β-carotene compared with the hydrogel beads. It can be expected that the
digestion of the lipid droplets lead to the formation of mixed micelles that can solubilize
the high amount of β-carotene molecules (high B* and BA). Previous studies in our
laboratory had also reported that emulsion systems (e.g., emulsion-based delivery
systems and emulsion-based excipient systems) could increase lipophilic bioactive
ingredients bioaccessibility through these mechanisms 257-259. The relatively low B* and
BA of the β-carotene in the filled hydrogel beads in current study can be attributed to
several reasons. Firstly, some of the β-carotene remained within the undigested lipid
droplets inside the hydrogel beads and was not released and solubilized in micelle. The
second reason is that there was less mixed micelles available in the aqueous phase to
solubilize any β-carotene molecules released from the hydrogel beads (Fig. 4.13). Both of
these reasons could be attributed to the low β-carotene concentration in micelle. The
transformation (T*) of β-carotene was also calculated to determine the extent of any
chemical changes during digestion (Fig. 4.15). It was indicated that β-carotene
encapsulated in free emulsion samples showed slightly lower transformation
(CDigesta/CInitial) than hydrogel beads. We can expect that alginate-based hydrogel beads
encapsulation can protect the β-carotene from degradation during digestion. Based on our
preliminary experiments, the slight degradation of β-carotene majorly occurred after
stomach digestion phase, and the reason could be attributed to the protonization of the
methine carbon of β-carotene in high acid stomach phase. There appeared to be a good
correlation between the β-carotene transformation and extent of β-carotene degradation
during evaluated temperature storage, i.e., they followed the completely opposite trend:
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0.5% beads > 1% beads > Free emulsions. These results suggest that β-carotene showed
higher stability after encapsulation in hydrogel beads.
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Figure 4. 14 Bioaccessibility (B*) and effective bioavailability (BA) of β-carotene in
different delivery systems including free emulsion, emulsion in 0.5% alginate beads, and
emulsion in 1% alginate beads measured in a pH-stat in vitro digestion model.
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Figure 4. 15 Transformation (%) of β-carotene in in different delivery systems including
free emulsion, emulsion in 0.5% alginate beads, and emulsion in 1% alginate beads after
full digestion (mouth, stomach and intestine) process.
4.2.4 Conclusions
The influence of types of delivery systems encapsulation on physicochemical
stability and in vitro bioaccessibility of β-carotene was studied in this present study.
Three different delivery systems were prepared including free emulsion, filled hydrogel
beads formed by 0.5% alginate and filled hydrogel beads formed by 1% alginate. The
hydrogel beads formed with different concentration of alginate showed different physical
structure and properties: the 0.5% beads (creamed to the top of the buffer phase) had
much smaller diameter than 1% beads (sedimented to the bottom). The stability studies
indicated that hydrogel beads encapsulation could protect the β-carotene from
degradation. The retention rate of β-carotene in 0.5% beads was higher than that in 1%
beads. In vitro digestion studies indicated that free lipid droplets were digested more
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rapidly and fully than those encapsulated within hydrogel beads. The rate and extent of
lipid digestion in filled hydrogel beads depended on alginate concentration: the 0.5%
beads showed a higher digestion rate and extent compared with 1% beads. Free emulsion
samples showed higher bioaccessibility and effective bioavailability of encapsulated βcarotene than that in the hydrogel beads. While the β-carotene transformation in different
delivery systems followed the following order: 0.5% beads > 1% beads > Free emulsions.
Our results may have important implications for designing hydrogel beads to increase the
stability and oral bioavailability of β-carotene
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CHAPTER 5
ENCAPSULATION, PROTECTION, AND RELEASE OF BIOACTIVE AGENTS
USING HYDROGEL BEADS WITH SELF-REGULATING MICROCLIMATE
PH PROPERTIES

5.1 Confocal fluorescence mapping of pH profile inside hydrogel beads (microgels)
with controllable internal pH values
5.1.1 Introduction
There is growing interest in the design and fabrication of particle-based delivery
systems to load, protect and release bioactive agents in the food, supplement, and
pharmaceutical industries (Badruddoza, Godfrin, Myerson, Trout, & Doyle, 2016; Janes,
Calvo, & Alonso, 2001). A diverse range of bioactive agents with differing molecular,
physicochemical and biological properties need to be encapsulated, including proteins,
peptides, probiotics, prebiotics, vitamins, minerals, nutraceuticals, triacylglycerol oils,
flavors, colors, antimicrobials, and preservatives (Cook, Tzortzis, Charalampopoulos, &
Khutoryanskiy, 2012; Zhu, Mallery, & Schwendeman, 2000). For example, many
bioactive proteins and peptides need to be encapsulated because of their propensity to
cause bitterness or astringency in the mouth, or their susceptibility to denaturation or
degradation in the stomach and small intestine (Liu & Schwendeman, 2012). Similarly,
probiotic bacteria often need to be encapsulated to maintain their viability when exposed
to highly acidic gastric conditions, but then released in the colon where they exhibit their
beneficial actions on colonic microflora (Li, et al., 2017). Many hydrophobic bioactive
agents (such as carotenoids, curcumin and polyphenols) need to be encapsulated to
prevent their chemical degradation within foods and the gastrointestinal tract (GIT)
(Altunbas, Lee, Rajasekaran, Schneider, & Pochan, 2011; Zhang, Zhang, & McClements,
2016).
Numerous studies have shown that particle-based delivery systems can be designed
to improve the handling, dispersibility, stability, and bioavailability of certain bioactive
agents (Keen, Slater, & Routh, 2012; McClements, 2016). However, to be effective these
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delivery systems must be carefully designed based on the molecular and physicochemical
properties of the bioactives, the processing and storage conditions they are exposed to
(such as pH, ionic strength, and temperature), and the desired quality attributes of the
final products (such as optical, rheological, organoleptic, and stability properties). For
certain applications, hydrogel beads are particularly suitable for encapsulation and
delivery of bioactive agents (McClements, 2016). These hydrogel beads are typically
spherical particles whose interiors are comprised of a porous network of cross-linked
hydrophilic polymers. Hydrogel beads are often formed from natural polymers (such as
polysaccharides and proteins) using relatively mild preparation conditions, and so they
usually have little adverse affects on the properties of the encapsulated bioactives (Kim,
Bae, & Okano, 1992; Zhang, Zhang, Zou, & McClements, 2016).
Many bioactive agents are highly susceptible to physical, chemical, or biological
degradation over a certain pH range, but stable at other pH values. For example, some
natural colors fade rapidly under highly acidic pH conditions, but slowly under neutral
conditions (Castañeda-Ovando, Pacheco-Hernández, Páez-Hernández, Rodríguez, &
Galán-Vidal, 2009). Similarly, many probiotics are rapidly inactivated under highly
acidic conditions, but viable under neutral conditions (Anselmo, McHugh, Webster,
Langer, & Jaklenec, 2016; Li, et al., 2016). A major drawback associated with the
utilization of conventional hydrogel beads for encapsulation of pH-labile bioactives is
that they are highly porous (Zhang, Zhang, Chen, Tong, & McClements, 2015), and so
small acidic or basic ions (such as H+ or OH-) can easily diffuse in or out of them,
thereby causing the internal pH to be fairly similar to the external pH. Consequently, pHlabile substances may be rapidly degraded when they are encapsulated in hydrogel beads
that are exposed to destabilizing pH conditions. The pH sensitivity of conventional
hydrogel beads therefore limits their utilization for certain applications in the food,
supplement, and pharmaceutical industries. Attempts have been made to improve the pHstability of bioactive agents in hydrogel beads by delaying the diffusion of acidic or basic
ions into them, e.g., by reducing the pore size of the internal core or the outer shell (Mei,
et al., 2014). Nevertheless, these approaches have had limited success because the pHdetermining ions involved are so small (< 1 nm) that they can rapidly diffuse through
even small pores.
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In the current study, hydrogel beads were fabricated with self-regulating internal pH
microclimates. This was achieved by trapping a basic buffer (magnesium hydroxide) that
was insoluble under neutral conditions but soluble under acidic conditions inside the
beads. Initially, the hydrogel beads are formed under neutral conditions so that the buffer
remains in an insoluble form. However, when the beads are submerged in an acidic
environment some of the magnesium hydroxide dissolves, which releases OH- ions that
can neutralize the H+ ions, thereby maintaining a neutral internal pH (until all the buffer
has dissolved). A quantitative fluorescent method was developed to map the local pH
inside the hydrogel beads when they were exposed to different pH conditions. This
method involved encapsulating a pH-sensitive fluorescent probe inside of the hydrogel
beads. The probe used has two functional groups, one that is pH sensitive and one that is
pH insensitive, so that the pH can be determined quantitatively from the ratio of the
fluorescence intensity of these two groups. Moreover, the probe is attached to a high
molecular weight polymer (dextran) so that it can be successfully trapped within the
biopolymer (alginate) network that makes up the interior of the hydrogel beads.
5.1.2 Materials and methods
5.1.2.1 Materials
Fluorescein tetramethylrhodamine dextran (FRD, average Mr 70,000) was purchased
from Molecular Probes (Eugene, OR). Alginic acid (sodium salt), calcium chloride, and
magnesium hydrate were purchased from the Sigma Chemical Company (St. Louis, MO).
Sodium phosphate was purchased from Fisher Chemical Company (Pittsburgh, PA). All
chemicals used were analytical grade. Double distilled water was used to make all
solutions.
5.1.2.2 Hydrogel beads preparation
Aqueous alginate solutions were prepared by dispersing powdered alginic acid (0.8%,
w/w) into phosphate buffer solution (5 mM, pH 7.0) and then continuously stirring at
60 °C for an hour. The temperature was then reduced to 35 °C and the samples were
continually stirred until the solution became clear indicating that the alginate had fully
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dissolved. 10 mg/mL FRD in phosphate buffer (5 mM, pH 7.0) was then added to the
alginate solution (at a volume ratio of 1:200) with or without 0.3% Mg(OH)2. After
ensuring the sample was homogeneous by stirring, the mixture was injected into a 10%
w/w calcium chloride solution using a commercial encapsulation unit (Encapsulator B390, BUCHI, Switzerland) with a 120 µm vibrating nozzle to prepare the hydrogel beads.
The encapsulation device was operated under fixed conditions: frequency = 800 Hz;
electrode potential = 800 V; and operating pressure = 500 mbar. The alginate beads
formed were kept in the Ca2+ solution for 1 h at ambient temperature to promote crosslinking and bead hardening.
5.1.2.3 Simulated gastric conditions
The impact of exposure of the hydrogel beads to simulated gastric fluid (SGF) on
their internal pH was determined using a method described previously (Zhang, Zhang,
Zhang, Decker, & McClements, 2015). Hydrogel beads (with or without encapsulated
Mg(OH)2) were added at a ratio of 1:4 (w/w) to SGF that had been preheated to 37 °C
and adjusted to pH 2.5. This mixture was then incubated in an incubated shaker for 2 h at
37 °C to mimic stomach conditions.
5.1.2.4 Confocal Laser Scanning Microscopy
Images were obtained using confocal laser scanning microscopy with a 20´ objective
lens (Nikon D-Eclipse C1 80i, Nikon, Melville, NY, USA). The images of the ratiometric
fluorescence dye were obtained using excitation wavelengths of 543 and 488 nm, and
detection wavelengths/bandwidths of 650 nm/LP and 590 nm/50 nm, respectively. All
samples were imaged using an exposure time of 0.5 s and a 12.5% excitation power level
for both channels. The complete images of each sample were typically acquired in less
than 2 min with at least eight measurements. The microstructural images for confocal
microscopy were analyzed using image analysis software (NIS-Elements, Nikon,
Melville, NY, USA).
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5.1.2.5 Standard curve preparation
A stock FRD solution (10 mg/mL) was prepared by dissolving the powdered FRD
dye in phosphate buffer (5 mM, pH 7) solution. 5 µL/ml FRD stock solution at pH 2.5–7
(adjusted by hydrochloric acid) was imaged using confocal microscopy to determine the
linear range of the pH response. Solutions containing different concentrations of FRD
(2.5, 5 and 10 µL/ml) were also used to prepare a standard curve using a SpectraMax
spectrophotometer (Molecular Devices, Sunnyvale, CA) to assess the impact of dye
concentration on the fluorescence intensity ratio used to calculate the local pH.
5.1.2.6 Image processing for pH measurement
The images were analyzed using Image J Software (1.50I, imagej.nih.gov). The ratio
of pixel intensities of two images obtained from two wavelengths (488 and 543 nm) were
calculated and correlated with the pH obtained from the standard curve. The average
intensity was calculated from at least eight measurements. The pH gradient within the
beads was determined by dividing their circular images into a series of same-pixel
thickness concentric rings, and the mean pixel intensity was calculated for each ring from
the number of pixels and individual pixel intensities in the ring.
5.1.3 Results and discussion
5.1.3.1 Development of pH standard curve
In this study, relatively small hydrogel beads (around 200 µm) were fabricated using
a specialized extrusion device (Encapsulator) with a vibrating nozzle (Figure 5.1). The
small dimensions and viscoelastic nature of these beads meant that it was not possible to
measure their internal pH using traditional methods, such as pH electrodes. It was
therefore necessary to develop an alternative method to measure the pH within the beads
so as to confirm the potential of the encapsulated Mg(OH)2 to control their internal pH
profile. A fluorescent probe method was therefore developed to determine the local pH
profile inside the beads. A dextran conjugated fluorescent probe, Fluorescein and
Tetramethylrhodamine (FRD), was used as the pH indicator. This probe was selected
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because it has a relatively high molecular weight (around 70 kDa), which ensures that it
remains trapped inside the porous biopolymer network that makes up the bead interior.
Moreover, this probe is a ratiometric dye that has both pH-dependent (FITC) and pHindependent (TMR) fluorescence groups. For this type of dye, the pH-independent
channel can be used as an internal standard for quantitative pH evaluation (Chen &
Arriaga, 2006; Deriy, et al., 2009). This ratiometric method also eliminates problems
associated with photo-bleaching, variable bead thickness, and non-uniform dye
distribution within the bead (Cope, Hibberd, Whetstone, MacRae, & Melia, 2002; Li &
Schwendeman, 2005).

Figure 5. 1 Schematic diagram showing the fabrication of self-adjusting microclimate pH
hydrogel beads. The beads are formed by injecting alginate and insoluble buffer into a
cross-linking calcium ion solution.

In preliminary confocal microscopy studies, it was observed that the fluorescence
emission intensity was pH-independent when an excitation wavelength of 543 nm was
used, but pH-dependent when an excitation wavelength of 488 nm was used. The pH of a
sample could therefore be obtained independent of dye concentration by taking the ratio
of the emission intensities at these two excitation wavelengths (543 nm/ 488 nm).
Standard curves of fluorescence intensity ratio versus pH were determined using a series
of buffer solutions (pH 2.5-7.0) with dye concentrations of 2.5, 5 and 10 µL/ml of stock
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solution (10 mg/mL). The fluorescence intensity ratio was exponentially related to pH
from pH 2.5 to 7.0 when determined from the confocal microscopy images (Fig. 5.2a),
but linearly related when measured using a microplate reader (Fig. 5.2b). Moreover, the
fluorescence intensity ratio (TMR/FITC) was largely independent of overall dye
concentration across the entire pH range as determined using the microplate reader.
These results suggest that the pH inside the beads can be successfully mapped even
though there may be some local variations in dye concentration within the beads e.g., due
to diffusion of dye outwards. The major advantage of the confocal microscopy approach
is that the local pH can be obtained from the images, whereas only the overall pH of a
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Figure 5. 2 Standard curve of pH versus fluorescence intensity ratio (TMR/FITC) taken
by (a) microplate at concentrations of 2.5, 5 and 10 µL/ml stock solution (10 mg/mL) and
(b) confocal microscopy at 5 µL/ml stock solution (10 mg/mL).
5.1.3.2 Mapping the pH inside the beads
The highly acidic pH of human gastric juices causes an unwanted reduction in the
activity of many orally delivered bioactive agents, such as many enzymes, probiotics, and
nutraceuticals. Consequently, an antacid buffering agent (Mg(OH)2) was encapsulated
inside the hydrogel beads to create an internal pH that was considerably higher than the
external pH, thereby protecting any co-encapsulated acid-sensitive bioactives. Under
neutral pH conditions, Mg(OH)2 forms insoluble solid particles that are retained within
the hydrogel beads. However, when the beads are exposed to acid conditions some of the
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Mg(OH)2 particles will dissolve, thereby releasing OH- ions that will neutralize any H+
ions that diffuse into the hydrogel interior, thereby helping to maintain a high internal pH.
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Figure 5. 3 Differential interference contrast (DIC) and fluorescent microscopy images
of (a) hydrogel beads without Mg(OH)2 encapsulation and (b) with 0.3% Mg(OH)2
encapsulation. These images were taken after the beads were prepared. The images of
the ratio channel were generated using Image J software (imagej.nih.gov) and the color
strip shown on the top right represents the pseudocolor change with pH (intensity of
TMR signal was enhanced using Image J to improve contrast).
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Hydrogel beads were formed by injecting a solution containing gelling agent
(alginate) and fluorescence dye (FRD) in the absence or presence of insoluble buffer
particles (magnesium oxide) into another solution containing a cross-linking agent
(calcium chloride). The initial beads formed by this method had mean diameters of
around 200 µm as determined by confocal fluorescence and optical microscopy (Fig. 5.3
and 5.4). Initially, the average internal pH values of the hydrogel beads determined from
the CLSM images were around pH 6.5 for buffer-free beads and around pH 7.5 for
buffer-loaded beads. The presence of Mg(OH)2 slightly increased the internal pH of the
buffer-loaded hydrogel beads, which can be attributed to the fact that it is a weak base
and some dissolution may have occurred. The confocal images also indicated that the pH
values inside the beads were not uniformly distributed after Mg(OH)2 encapsulation (Fig.
5.3b). There appeared to be microenvironments around the insoluble Mg(OH)2 particles
that had a higher pH that the surrounding solution. The pH gradient distribution analysis
indicated that the pH was relatively uniform throughout the buffer-free hydrogel beads,
being in the range from pH 6.8-7 (Fig. 5.4c). Conversely, the pH was slightly lower at the
edge of the buffer-loaded hydrogel beads than in their interiors, with the local pH values
increasing from around pH 7.2 at the edge to pH 7.6 at the center (Fig. 5.5c). Presumably,
most of the insoluble buffer particles were located in the center rather than at the edge of
the hydrogel beads.

(a)

(b)

(c)
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Figure 5. 4 An illustration of the image processing approach used to generate the pH
gradient profile within buffer-free hydrogel beads. (a) The fluorescence intensity ratio
image with pseudocolor color; (b) concentric rings of similar pixel thickness obtained
from the images of the beads; and (c) the average pH value within each ring as a function
of distance from the bead edge.
5.1.3.3 Monitoring pH changes after exposure to gastric conditions
Many types of bioactive agents are degraded when exposed to the highly acidic
conditions found in the human stomach, and therefore it would be valuable to have
delivery systems that protected them within the gastric fluids. In this section, we
therefore applied the confocal fluorescence pH mapping method to monitor changes in
the internal pH of the hydrogel beads in the absence and presence of encapsulated
magnesium hydroxide. After incubation in simulated gastric fluids (SGF), the
fluorescence intensity inside the buffer-free hydrogel beads rapidly decreased to around
pH 3 (Figs. 5.6 and 5.7). Presumably, the small H+ ions rapidly diffused through the
porous alginate network within the hydrogel beads driven by the concentration gradient
between the inside and outside of the beads. Consequently, the internal pH of the bufferfree beads was fairly similar to that of the external pH of the SGF after 2 h incubation in
the gastric phase. Conversely, the pH value within the Mg(OH)2-loaded hydrogel beads
remained fairly similar to that of the original value (»pH 7.5) after 2 hours of incubation
in the acidic SGF (Figs. 5.6 and 5.7). This result suggests that these antacid hydrogel
beads could be used to protect acid-sensitive bioactives during passage though the
stomach. The confocal fluorescence images suggest that the pH was higher in the center
of the beads than at their edges (Fig. 5.6). This effect is probably because the insoluble
Mg(OH)2 particles in the exterior regions of the beads dissolve first as hydrogen ions
from the SGF diffuse into the beads. To verify this dissolution process, DIC optical
images of the Mg(OH)2-loaded hydrogel beads were taken throughout the simulated
stomach phase (Fig. 5.8). These images clearly indicated that Mg(OH)2 particles slowly
dissolved during the stomach phase incubation, which can be attributed to their
neutralization reaction with hydrogen ions arising from the gastric fluids.
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Figure 5. 5 An illustration of the image processing approach used to generate the pH
gradient profile within Mg(OH)2-loaded hydrogel beads. (a) The fluorescence intensity
ratio image with pseudocolor color; (b) concentric rings of similar pixel thickness
obtained from the images of the beads; and (c) the average pH value within each ring as a
function of distance from the bead edge.
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Figure 5. 6 Confocal fluorescence microscopy images of hydrogel beads without
Mg(OH)2 encapsulation (top) and with 0.3% Mg(OH)2 encapsulation (bottom) after
passage through the stomach phase. The images of the ratio channel were generated using
Image J software and the color strip (top right of images) represents the pseudo-color
change with pH. The intensity of the TMR signal was enhanced using Image J to
improve the contrast.
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Figure 5. 7 The pH value of hydrogel beads without and with Mg(OH)2 encapsulation
during 2h stomach digestion process.
5.1.3.4 Dynamic pH change during incubation
The acid degradation of many bioactives is a rapid process, and so it is important to
determine how long the hydrogel beads can maintain their high internal pH values after
exposure to gastric fluids. Therefore, the internal pH of buffer-free and buffer-loaded
hydrogel beads was periodically determined throughout the stomach phase (Fig. 5.8). In
the presence of buffer, the average pH inside the beads remained fairly constant (pH 6.6
to 7.5) throughout the entire 2 hour incubation period within the SGF (Fig. 5.7). This
result suggested that the amount of Mg(OH)2 inside the beads was sufficient to act as a
local antacid throughout the duration of the gastric phase. On the contrary, the pH value
inside the buffer-free hydrogel beads fell sharply from pH 6.5 to 3.3 within the first 5
minutes, followed by a more gradual decrease at longer incubation times. As mentioned
earlier, small H+ ions can rapidly diffuse into highly porous hydrogel beads, thereby
causing the pH inside the beads to be fairly similar to that outside.
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Figure 5. 8 Differential interference contrast (DIC) images of hydrogel beads containing
encapsulated Mg(OH)2 taken during incubation in the simulated stomach phase.
The amount of time required for hydrogen ions to diffuse into the hydrogel beads can
be estimated from the following expression (Crank, 1975):

M (t )
6
F=
= 1- 2
M (¥ )
p

æ D gel n 2p 2 t ö
1
÷
expç å
2
2
ç
÷
a
n =1 n
è
ø
¥

(1)

Here, F is the fraction of hydrogen ions that have diffused into the hydrogel beads at
time t, M(t) and M(∞) are the hydrogen ion concentrations within the hydrogel beads at
time t and at equilibrium, n is an integer, a is the radius of the hydrogel beads, and Dgel is
the diffusion coefficient of the hydrogen ions through the biopolymer network inside the
beads, which can be estimated using the following expression (Chan & Neufeld, 2009):
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Here, Dw is the diffusion coefficient of the hydrogen ions through pure water, rH is
the hydrodynamic radius of the hydrogen ions, rf is the cross-sectional radius of the
biopolymer chains (alginate) in the hydrogel network, and z is the mesh pore diameter of
the hydrogel network. The following structural parameters have been reported for
alginate hydrogels: pore diameter (z) = 4 to 400 nm; alginate chain radius (rf) = 0.83 nm
(Chan, et al., 2009). The radius of hydration (rH) of the hydrogen ion (actually H3O+) has
been estimated to be 0.1 nm (Marcus, 2012). The diffusion coefficient of hydrogen ions
in water can be estimated from the expression: Dw = kBT/6phrH, where kB is Boltzmann’s
constant, T is absolute temperature, and h is the viscosity of the solvent. The above
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equations were used to estimate the time-dependence of the fraction of hydrogen ions
diffusing into hydrogel beads with different pore sizes after submerging in a more acidic
environment (Figure 5.9). For these calculations, it was assumed that the pore diameter
(z) of the alginate beads was 10 nm. Even assuming this relatively small pore size, the
theoretical predictions suggest that the hydrogen ions would rapidly diffuse into the
hydrogel beads in a few seconds, which supports our experimental results. These
predictions suggest that any acid-sensitive bioactives encapsulated within the hydrogels
beads would be rapidly exposed to highly acid conditions in the stomach in the absence
of a co-encapsulated insoluble buffering agent.
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Figure 5. 9 Predicted time dependence of the fraction of hydrogen ions (H3O+) absorbed
by alginate beads with a diameter of 200 µm and a pore size of 10 nm after submersion in
an acidic environment.
5.1.4. Conclusions
Certain types of bioactive agents are degraded when exposed to highly acidic
conditions, such as probiotics, enzymes, and some nutraceuticals. The development of
microparticle-based delivery systems that are able to control the pH in the immediate
vicinity of these bioactive agents may therefore be useful for improving their stability. In
this study, edible hydrogel beads were fabricated using a simple injection method that
141

were able to maintain an internal pH that was appreciably higher than the pH of the
surrounding solution. A fluorescence method to map the pH profile inside the hydrogel
beads was also developed based on ratiometric imaging with a confocal laser scanning
microscopy. This method showed that the average internal pH of the buffer-free hydrogel
beads was around 6.5, while that of the buffer-loaded beads was around 7.5. In addition,
the method showed that there were some local variations in pH inside the hydrogel beads.
After exposure to simulated gastric fluids, the average pH inside the buffer-loaded beads
remained fairly constant (around pH 6.6 to 7.5), whereas that in the buffer-free beads fell
sharply within the first few minutes (from pH 6.5 to 3.3). The confocal microscopy
method also indicated that the pH was higher in the center of the buffer-loaded beads
than at their edges. These results show that the encapsulated Mg(OH)2 particles acted as
effective buffering agents that inhibited excessive acidification within the beads during
the gastric phase. Overall, the novel hydrogel beads developed in this study may be
suitable for encapsulation and delivery of acid-sensitive bioactives, which may be
advantageous for certain food, supplement, and pharmaceutical applications.
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5.2 Encapsulation of pancreatic lipase in hydrogel beads with self-regulating
internal pH microenvironments: Retention of lipase activity after exposure to
gastric conditions
5.2.1 Introduction
Exocrine pancreatic insufficiency (EPI) is a serious condition occurring accompanied
with a several diseases (e.g., chronic pancreatitis and pancreatic cancer, etc.) 260-261. EPI
happens due to the pancreas of the patients fails to produce and/or secrete sufficient
amounts of digestive enzymes to support digestion of intraluminal nutrients such as fats,
proteins and carbohydrates, which results in the nutritional deficiencies of the patients 262.
The digestive enzymes normally refer to the trypsin, chymotrypsin, amylase and lipase.
Lipase is one of the most important digestive enzymes derived from the pancreas and it
plays a leading role in the digestion of fat, which provide the majority of calories for
human body 263. Enzyme supplementation is an important therapy for pancreatic
insufficiency 264. However, the supplementation of lipase by direct oral intake is
unpractical because this enzyme is extremely susceptible to acidic degeneration during
stomach incubation process. In healthy people, it was reported that just 1% of the lipase
activity can survive through intestinal transit 265. Thus the entrapment strategies are
required for the lipase encapsulation and delivery.
Encapsulation of enzymes within porous polymer matrices have been widely utilized
for many years to improve the stability and recovery of enzymes 6, 266. In this techniques,
the enzymes can be trapped within a porous matrix, which provide the enzyme with
physical isolation from the surrounding medium. Several entrapment methods can be
included for enzymes encapsulation such as physical entrapment, physical bonding,
and/or chemical covalent bonding 267-268. The physical approaches may have potential
advantages over chemical methods because no chemical modification of the enzyme is
required to form a covalent linkage with the hydrogel network. These physical
approaches normally enable the enzymes to interact with the substrate molecules without
causing pronounced changes in enzyme structure and activity, and thus are regarded as
the best strategy for enzyme encapsulation. Hydrogel beads fabricated from biopolymers
are particularly suitable for the enzyme encapsulation, because they often involve mild
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preparation conditions to physical entrap the enzyme without altering their properties 269.
Moreover, the bead matrices can be prepared from food-grade ingredients (e.g.,
polysaccharides and/or proteins), which are more acceptable by majority of people 229.
The hydrogel beads are commonly fabricated using extrusion-gelation method. In this
approach, a biopolymer solution containing the bioactive agents (e.g., enzyme) is injected
into another “harden” solution to promote the biopolymer gelation, and the hydrogel
beads can be formed during this procedure with bioactives trapped inside the biopolymer
matrix 270. One major drawback associated with the use of conventional hydrogel beads
for lipase encapsulation and intestine target delivery is that the polymer matrix of these
beads are highly porous, which allow the acid ions (H+) easily diffuse in and out the
beads network, thereby may hardly inhibit the encapsulated lipase from acid deactivation
during stomach digestion process.

Researches have been carried out to modify the

properties of hydrogel beads to improve the pH-stability of encapsulated enzyme, such as
by crosslinking the hydrogel matrix using specific enzymes or by coating the beads with
one or more layers of biopolymers through electrostatic deposition 271-272. The

mechanism of these approaches are based on delaying the diffusion of pH determining
ions (H+ or OH-) through the bead matrix 273. However, there are several other limitations
associated with these modifications, the most important one is that the function of
encapsulated enzyme can be negatively interfered; because the diffusion of the enzyme
and substrate can also be retarded at the desired site of action, which limit their mutual
contaction and further hydrolysis reaction.
In this study, we fabricated a novel hydrogel beads with an internal pH selfregulating property. Specially, Mg(OH)2 as the buffer agent was co-encapsulated with
lipase into the hydrogel beads formed by alginate crosslinking with calcium chloride.
Mg(OH)2 was used because it was typical insoluble salts at neutral pH condition, which
make it possible to be trapped inside the beads during storage; while it can be dissolved at
acid condition and thus can be used as an antacid agent at low pH conditions. Moreover,
Mg(OH)2 has been regarded as the safe ingredient and widely used as an acid neutralize
agent in food and pharmaceutical industries 274. Alginate was used for hydrogel beads
formation because it is a food-grade ingredient already widely utilized for bioactive agent
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encapsulation. The mild cross-linking conditions of alginate gel are especially suitable for
the enzyme entrapment and encapsulation. Furthermore, the acid insolubility of alginate
gels makes them a good candidate for bioactives encapsulation and target delivery in
harsh acid condition (e.g., the stomach) with improved stability. The digestion
characteristic of lipid by the lipase loaded in the hydrogel beads with/without Mg(OH)2
co-encapsulation was compared. An in vitro model developed in our lab was used to
simulate the digestion conditions in mouth, stomach and small intestine. The
microclimate pH change of the hydrogel beads after going through different digestion
steps was also estimated using a quantitative ratiometric method based on confocal laser
scanning microscopy (CLSM). The results obtained from this study may provide valuable
information for lipase encapsulation and target delivery.
5.2.2 Materials and methods
5.2.2.1 Materials
Fluorescein tetramethylrhodamine dextran (FRD, average Mr 70,000) was obtained
from Molecular Probes (Eugene, OR). Alginic acid (sodium salt), calcium chloride, and
magnesium hydrate were purchased from Sigma Chemical Company (St. Louis, MO).
Lipase was purchased from Sigma-Aldrich (Sigma Chemical Co., St. Louis, MO) and as
reported by the manufacturer the activity was 100-400 units/mg. Mucin from porcine
stomach, porcine bile extract, sodium chloride, monobasic phosphate and dibasic
phosphate, Nile red and fluorescein thiocyanate isomer I (FITC) were obtained from
either Sigma-Aldrich (Sigma Chemical Co., St. Louis, MO) or Fisher Scientific
(Pittsburgh, PA). All chemicals used were analytical grade. Double distilled water was
used to make all solutions.
5.2.2.2 Hydrogel beads preparation
The alginate aqueous solution was prepared by dissolving powdered alginic acid
(1.6%, w/w) in phosphate buffer and continuously stirring at 60 °C for an hour, then
reducing the temperature to 35 °C with continuously stirring until totally dissolved. The
alginate solution was then mixed with lipase solution to obtain a concentration of 0.8%
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alginate and 2.7% lipase mixture with or without 0.15% Mg(OH)2. For the pH mapping,
10 mg/mL FRD in phosphate buffer was added to the 0.8% alginate solution (at a volume
ratio of 1:200) with or without 0.15% Mg(OH)2. After continuously stirring, the mixtures
were injected into 10% calcium chloride solution using a commercial encapsulation unit
(Encapsulator B-390, BUCHI, Switzerland) with a 120 mm vibrating nozzle to prepare
the hydrogel beads. The encapsulation device was operated under fixed conditions:
frequency 800 Hz; electrode 800 V; and pressure 500 mbar. The formed beads were held
in the Ca2+ solution for 30 min at ambient temperature to promote cross-linking.
5.2.2.3 In vitro digestion model
The lipase-loaded hydrogel beads with or without buffer (0.15% Mg(OH)2) coencapsulation were passed through a gastrointestinal tract (GIT) model that simulated the
mouth, stomach and small intestine, which was slightly modified from the one developed
in our lab 230. The free lipase without beads encapsulation was also studied as the control
sample passing through the same digestion model.
Initial system: 7.5 g of the initial systems were placed into a glass beaker in an incubator
shaker at a rotation speed of 100 rpm for 15 min at 37 °C for preheating. Two different
initial lipase-loaded delivery systems were tested: with or without buffer coencapsulation.
Mouth phase: 7.5 g of simulated saliva fluid (SSF) containing 0.03 g/mL mucin was
preheated to 37 °C and then adjusted to pH 6.8. After being mixed with the initial
samples, the mixture was incubated in an incubator shaker for 2 min at 37 °C to mimic
agitation in the mouth.
Stomach phase: 15 g of simulated gastric fluid preheated to 37 °C, and the pH was
adjusted to 2.1. After being mixed with 15 g of the “bolus” sample resulting from the
mouth phase, the initial pH of the mixture was about 2.5 and incubated in the incubator
shaker for 2 h at 37 °C to mimic stomach conditions.
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Small intestine phase: 30 g of “chyme” sample from the stomach phase was placed into a
100 mL glass beaker that was placed into a water bath at 37 °C and then adjusted to pH
7.00. 1.5 g of simulated intestinal fluid was added to the reaction vessel, followed by 3.5
g of bile salt solution with constant stirring. The pH of the reaction system was adjusted
back to 7.00. 2.5 g of 6% (w/w) corn oil-loaded emulsions was then added to the sample
and an automatic titration unit (Metrohm, USA Inc.) was used to monitor the pH and
maintain it at pH 7.0 by titrating 0.1 N NaOH solution into the reaction vessel for 2 h at
37 °C. The amount of free fatty acids released was calculated from the titration curves as
described previously using the following formula:

% FFA = 100 ´ (

VNaOH ´ mNaOH ´ M Lipid
WLipid ´ 2

)
……………………………… (1)

Here VNaOH is the volume of sodium hydroxide required to neutralize the FFAs produced
(mL), mNaOH is the molarity of the sodium hydroxide solution (0.1 N), WLipid is the total
weight of lipid initially present in the reaction vessel (0.15 g), and MLipid is the molecular
weight of the corn oil (800 g/mol).
5.2.2.2.4 Confocal laser scanning microscopy
Images were obtained using a confocal scanning laser microscope with a 20
objective lens (Nikon D-Eclipse C1 80i, Nikon, Melville, NY, USA). The images of
ratiometric dye were emitted at 543 and 488 nm, and detected at 650/LP and 590/50
respectively. All samples were imaged with exposure time of 0.5 s and a 12.5%
excitation power level for both channel. The images for each sample was achieved
typically in less than 2min with at least eight measurements. After intestine digestion, the
oil phase in the digestion phase was dyed with Nile red solution (1 mg/mL ethanol). The
lipase was dyed with FITC solution (1 mg/mL dimethyl sulfoxide) prior to measurements
by incubating the lipase-loaded beads in 0.1 mL of FITC dye solution. The excitation and
emission spectrum for Nile red were 543 nm and 605 nm, respectively and for FITC were
488 nm and 515 nm, respectively. The microstructure images for confocal microscopy
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were taken and analyzed using image analysis software (NIS- Elements, Nikon, Melville,
NY, USA).
5.2.2.2.5 Standard curve preparation
The stock FRD solution (10 mg/mL) was prepared by dissolving the powdered FRD
dye in phosphate buffer (5mM, pH 7) solution. 5 µL/ml FRD stock solution at pH 4–7
(adjusted by hydrochloric acid) was imaged using confocal microscope to determine the
linear range of pH response.
5.2.2.2.6 Image processing for pH measurement
The images were analyzed using the Image J software (1.50I). The ratio of pixel
intensities of two images obtained from two wavelengths (488 nm, 543 nm) were
calculated and correlated with pH from the obtained standard curve. The images were
processed by repeated scan with frame averaging from at least eight measurements.
5.2.2.2.7 Determination of droplet size
The particle size distribution of the hydrogel beads with/without Mg(OH)2 coencapsulation initially and after stomach digestion was determined using a laser
diffraction device (Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire,
UK), which utilizes measurements of the angular scattering pattern of emulsions.
Samples were diluted in aqueous solutions to avoid multiple scattering effects, and then
stirred (1200 rpm) to ensure homogeneity. Phosphate buffer (5 mM, pH 7.0) was used to
dilute the initial samples, while pH 2.5 adjusted distilled water was used to dilute
stomach samples. The average particle sizes are reported as the volume-weighted mean
diameter (d43).
5.2.2.2.8 Statistical analysis
All experiments were performed on at least three freshly prepared samples. The
results are reported as averages and standard deviations. These analyses were carried out
using Excel (Microsoft, Redmond, VA, USA) and a statistical software package (SPSS).
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5.2.3 Results and discussion
5.2.3.1 Development of the standard curve
In this study, mapping the pH values inside the beads is critical for the verification of
antacid effect of our hydrogel beads during the digestion process. Therefore, a
quantitative ratiometric method based on CLSM methods was developed to quantitatively
measure the microclimate pH in the hydrogel bead matrix. Fluorescein and
Tetramethylrhodamine (FRD), as the pH indicator dye, was used to estimate the pH
change inside the beads during the whole digestion process. This fluorescent dye was
selected because it has both pH-dependent (FITC) and pH-independent (TMR)
fluorescence groups within its molecule structure, which enable the quantitatively
measure the pH value based on the fluorescence intensity ratio with the elimination of the
dye concentration effect 275-276. Furthermore, these two fluorescence groups are
conjugated to the dextran with relatively large molecule weight (around 70,000 Da),
which ensures the entrapment of dye inside the beads during the measurement process.
The ratiometric method has also been used for the pH measurements inside the pellets or
microspheres by other studies, it was reported that this ratiometric method can eliminates
the problems associated with variable microsphere or pellet matrix thickness, and nonuniform indicator distribution within the microsphere or pellet because of loading
efficiency variations 277-279.
It was indicated based on the preliminary studies that the emission intensity obtained
from the FITC channel was correspondingly increased for the dye incubated in higher pH
buffer, while the emission intensity of TMR channel remains at a constant value
irrespective of change of stock buffer with different pH values (data not shown). The
corresponding pH can therefore be obtained independent of dye concentration by taking
the ratio of the emission intensities at these two channels (FITC/TMR). In this study, the
standard curve of pH vs. intensity ratio was determined using standard pH buffer
solutions of pH 4-7 (Fig. 5.10). Based on our previous studies, the TMR/FITC value was
almost independent of the dye concentrations across the pH range of 2.5-7. Therefore, it
can be estimated that the pH value inside the beads could still be quantitatively measured
even though the leakage of the dye occurs during the fabrication and incubation.
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Figure 5. 10 Standard curve of pH vs. intensity ratio taken by 5 µL/ml stock solution
(10mg/mL).
5.2.3.2 Mapping the pH inside the beads during digestion
An antacid buffer agent (Mg(OH)2) was encapsulated within the hydrogel beads to
adjust the internal pH inside the beads during the simulated digestion process. It was
estimated that Mg(OH)2 can be retained within the hydrogel beads with its intrinsic solid
state at neutral condition, while partly dissolved and ionized the hydroxide ion (OH-)
when incubated at low pH conditions. Hydrogel beads fabricated at the same conditions
without Mg(OH)2 encapsulation were also studied as the control samples, and the pH
value inside the beads with or without Mg(OH)2 encapsulation during different steps of
digestion process (i.e., mouth stomach and intestine) was measured based on the
developed standard curve described in previous section.
It was indicated that the pH value inside the hydrogel beads remained fairly constant
for the initial samples and the samples after incubation in mouth phase irrespective of
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Mg(OH)2 encapsulation (Fig. 5.11, Fig. 5.12). This result can be attribute to the reason
that pH value in the initial phase and mouth phase was relatively similar with each other
(pH around 7 for initial phase and 6.8 for mouth phase). The averaged internal pH of the
hydrogel beads before and after mouth digestion was evaluated to be around pH 6.74 to
6.29 for buffer-free beads and pH 7.25 to 7.33 for buffer-loaded beads (Table 5.1). The
encapsulated Mg(OH)2 slightly increased the microclimate pH of the hydrogel beads,
which can be attributed to the weak base characteristic of encapsulated Mg(OH)2. The
confocal fluorescent images also showed that the pseudo-color was constantly distributed
within the buffer-free hydrogel beads, which indicated that the pH value was relatively
uniform within these beads matrix (Fig. 5.11). For the Mg(OH)2 encapsulated beads, the
pseudo-color inside the beads was not evenly distributed. The insoluble Mg(OH)2
particles showed higher pH value compared with surrounding solution based on the color
strip (Fig. 5.12). These results again verify the weak base characteristic of encapsulated
Mg(OH)2. After incubation in simulated gastric fluids, the fluorescence intensity sharply
decreased for the hydrogel beads without Mg(OH)2 encapsulation. The pH was estimated
to be acid value (lower than 4) based on the standard curve calculation. This result can be
attributed that the hydrogen ions can diffuse through the pores of the hydrogel beads to
balance the concentration between inside and outside the beads, thus equilibrium state
was finally achieved after 2h stomach digestion process with a low pH value. On the
contrary, it was showed that the pH value inside the buffer-loaded beads still remain
relatively constant compared with initial value (around pH 7.39) after stomach digestion.
It can be expected that Mg(OH)2 particles slowly ionized and neutralized the hydrogen
ions arising from the gastric fluids, which maintain the pH value inside the beads
constant above 7.
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Figure 5. 11 Fluorescent images of hydrogel beads without buffer encapsulation during
the digestion process (intensity of TMR signal was enhanced using Image J to improve
contrast). The images of the TMR channel and FITC channel were emitted at 543 and
488 nm, detected at 650/LP and 590/50 nm respectively.

Table 5. 1 The measured pH value inside beads with/ without buffer co-encapsulation
during digestion process
Without buffer (pH)

Initial
6.74 ± 0.08

Mouth
6.29 ± 0.104

Stomach
pH < 4.0

With buffer (pH)

7.25 ± 0.106

7.33 ± 0.182

7.39 ± 0.15

152

Figure 5. 12 Fluorescent images of hydrogel beads with buffer encapsulation during the
digestion process (intensity of TMR signal was enhanced using Image J to improve
contrast). The images of the TMR channel and FITC channel were emitted at 543 and
488 nm, detected at 650/LP and 590/50 nm respectively.
5.2.3.3 Influence of different beads encapsulation on lipid digestion
In this section, the influence of different beads encapsulation on lipid digestion was
studied using an automatic titration (“pH-stat”) method. Specifically, the lipase-loaded
beads with or without Mg(OH)2 co-encapsulation after the mouth and stomach digestion
were incubated with oil in the simulated intestine phase. The amount of free fatty acids
released over time was then calculated from the volume of NaOH titrated into the
samples to maintain a constant pH value (7.0).
For the buffer free beads and free lipase samples, there is almost no free fatty acids
released during the whole digestion process, which indicated that lipase has been already
deactivated during the stomach digestion process even though encapsulated in the
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hydrogel matrix (Fig. 5.13). The poor lipases activity at low pH has been attributed to the
titration of the active site histidine or to the weakening of the coordination of stabilizing
calcium ions 280. It has been noted that the acid ions (H+) can easily diffuse in the beads
matrix and get access to the active site of lipase during stomach incubation. The lipid
digestion profile of lipase-load beads with Mg(OH)2 co-encapsulation is significantly
different from buffer free one: a rapid increase in free fatty acids (FFAs) release can be
detected within the first 45 min, and then followed by a more gradual increase until a
relatively constant final value was attained. These results indicated the preservation of
lipase activity when the Mg(OH)2 was co-encapsulated into the beads.
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Figure 5. 13 Amount of free fatty acids released from the systems (free lipase and
hydrogel beads with or without buffer co-encapsulation) using a pH-stat in vitro digestion
model.
To visually testify the digestion process in the lipase-loaded beads, lipase was dyed
to green and oil was dyed to red using FITC and Nile red respectively. The confocal
microscopy images indicated that most of lipase molecules were trapped inside the
hydrogel beads, i.e., the green (lipase) fluorescence dyes were mostly located together in
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the spheroid shape beads matrix (Fig. 5.14). It suggested that large amount of lipase can
be successfully delivered to intestine phase using hydrogel beads entrapment. The green
fluorescence intensity can also be detected outside the beads in the surrounding intestine
phase, which suggested that the lipase can partly release from the beads after intestine
digestion. The alginate beads have been reported to swell when placed in higher pH
solutions such as in intestine phase, because the alginate molecules become highly
charged (carboxylate group) and repel with each other causing the hydrogel network to
expand, thus the encapsulated lipase can partly release from the beads during intestine
digestion process 23. Furthermore, compared to the system without buffer, there was a
decrease in the red fluorescence intensity of the surrounding aqueous phase in system
with buffer, which is indicative of a reduction in the amount of lipids present the
surrounding aqueous phase. It can be estimated based on the digestion profiles that the
lipid droplets had been digested by lipase molecules with reserved activity released from
buffer-loaded hydrogel beads. These results also indicated that co-encapsulation of
Mg(OH)2 within the lipase-loaded hydrogel beads can protect the lipase from
deactivation during digestion process.

With buffer

Without buffer

Figure 5. 14 Confocal microscope of lipase-loaded beads with and without buffer
encapsulation after exposure to the small intestine phase for 2 hours. Lipase was dyed
with FITC to show green fluorescence, while the lipid phase was dyed by Nile Red to
show red fluorescence.
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5.2.3.4 The particle size characteristic of beads during digestion
Alginate beads are regarded as a good polymer based acid indicator due to its pH
dependent behavior. Calcium alginate matrix tend to shrink at acid condition because of
the loss of negative charge on the alginate molecules when the carboxyl groups become
protonated (–COOH, pKa=3.5). Conversely, they will swell when incubated in higher pH
solutions because of charge retrieve which has been discussed in the previous section. It
is thus interesting to study the size characteristic of hydrogel beads with/without buffer
co-encapsulation during the digestion process.
Based on the static light scattering measurements, it was indicated that the general
shape of the particle size distribution was relatively similar from initial-to-stomach for
the buffer-loaded bead, exhibiting a major population of large particles with diameters
around 250µm (Fig. 5.15). The mean particle diameter of these beads was slightly
decreased during this process (initial-to-stomach), i.e., from 264.2 to 244.5µm (Fig. 5.16).
For the beads without buffer encapsulation, an obvious size reduction can be detected
from the particle size distribution after stomach digestion, and the mean particle diameter
of alginate beads sharply decreased from 273.5 to 208.5µm. These results indicated that
the alginate beads can undergo swell to shrink transformation when the incubation

pH reduced from neutral to acid (initial-to-stomach). Moreover, the buffer-loaded
hydrogel beads could maintain the pH relatively constant during this digestion process,
which restrained the shrink of hydrogel beads in acid stomach phase.
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Figure 5. 15 Particle size distributions of different samples initially and after the stomach
digestion process.

Mean Particle Diameter (µm)

280

a

b
c

260
240

d

220
200
180
160
Initial with
buffer

Initial
without
buffer

Stomach
with buffer

Stomach
without
buffer

Figure 5. 16 Mean particle diameter (d43) of different samples initially and after the
stomach digestion process.
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5.2.4 Conclusions
It is an important challenge to stabilize lipase inside any carriers during the digestion
process. In this study, alginate based hydrogel beads were fabricated based on injectiongelation method to encapsulate the lipase, the buffer agent (Mg(OH)2) was also coencapsulated in these beads to adjust the microclimate pH inside beads during the
simulated digestion process. The fluorescence pH measurements based on laser scanning
confocal microscope indicated that the pH value inside the buffer free beads was sharped
decreased to acid condition after stomach digestion. For the buffer-loaded beads, the pH
value was measured to be fairly constant from initial-to-stomach. The lipase-loaded beads
with buffer co-encapsulation clearly had a pronounced impact on the rate and extent of
lipid digestion. Conversely, for the lipase-loaded alginate beads without buffer
encapsulation, no lipid digestion occurred by the end of the 2 h digestion period. The
particle size of buffer free beads was greatly reduced during the digestion process (initialto-stomach), while the size remains relatively similar for the buffer-loaded beads. These
results indicated that Mg(OH)2 can work as an effective buffer agent against acidification
in stomach phase, the lipase-loaded hydrogel beads with Mg(OH)2 co-encapsulation can
reserve the activity of lipase during the digestion.
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5.3 Lactase (β-galactosidase) encapsulation in hydrogel beads with controlled
internal pH microenvironments: Impact of bead characteristics on enzyme
activity
5.3.1 Introduction
Lactose intolerance is a common disease in humans that is associated with the
deficiency of a specific enzyme (β-galactosidase) produced within the brush border of the
small intestine 281-282. Individuals with lactose intolerance have a limited ability to digest
and absorb lactose in the small intestine. As a result, this disaccharide enters the colon in
an undigested form where it can promote health problems, such as gut distension,
stomach pain, flatulence, diarrhea, and nausea 283. Individuals who suffer from lactose
intolerance often avoid consuming milk and other dairy products so as to avoid exhibiting
these undesirable symptoms. Several other approaches have also been developed to aid
individuals with lactose intolerance, including creating lactose-free foods and the coingestion of lactase supplements with lactose-containing foods 284. Enzyme supplement
treatments are particularly promising because they do not cause undesirable changes in
food quality or nutritional profile. Typically, a tablet or capsule containing lactase is
taken at the same time as a lactose-containing food, which promotes lactose hydrolysis
within the gastrointestinal tract (GIT). β-galactosidase (β-gal) is the most common form
of lactase used in enzyme supplements, but it cannot simply be delivered in its free form
because it is highly susceptible to denaturation and deactivation under GIT conditions 285.
In particular, lactase is usually deactivated when exposed to the highly acidic gastric
fluids present within the human stomach 286.
The encapsulation of enzymes within porous matrices can improve their stability by
creating a protective microenvironment or by acting as a physical barrier to the external
environment 287-288. At the same time, the porous matrices can be designed to allow small
molecules (such as co-factors, substrates, and products) to easily diffuse into them and
reach the catalytic site of the encapsulated enzyme, which enables the enzyme to
maintain its activity even after encapsulation 6, 289. Enzymes can be encapsulated within
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porous matrices using physical entrapment, physical interactions, or chemical bonding
267-268

. The encapsulation of enzymes in hydrogels is particularly attractive for application

in the food industry because these semi-solid materials can be fabricated from food-grade
ingredients using simple processing operations 270. Enzymes are physically entrapped in
the hydrogel network during the sol-gel transition, which is a relatively mild process that
tends to preserve the structural integrity and activity of the enzymes. After fabrication,
the enzymes can be retained within the hydrogel matrix by ensuring that its pore size is
appreciably smaller than the enzyme dimensions, or by ensuring that there is a
sufficiently strong attraction between the enzymes and the hydrogel matrix.
For many applications it is desirable to utilize hydrogel beads, rather than bulk
hydrogels to encapsulate and deliver bioactive substances 6. Hydrogel beads consist of
small particles (typically from 100 nm to 1000 µm) that can easily be dispersed in
aqueous solutions. These beads can be fabricated from food-grade biopolymers
(typically polysaccharides and/or proteins) using simple processing operations, such as
the injection-gelation method 229, 269, 290-291. Typically, the formation of hydrogel beads
requires two-steps that may occur consecutively or simultaneously: particle-formation
and particle-gelation. For the injection-gelation method, particle-formation is performed
by injecting an aqueous solution containing a biopolymer (gelling agent) and a bioactive
agent (enzyme) into a gas or immiscible liquid, and then particle-gelation is performed by
exposing the particles formed to solution or environmental conditions that promote
biopolymer gelation. This process leads to the formation of hydrogel beads with
bioactives trapped inside a biopolymer matrix 76. A serious limitation of this approach
for the encapsulation of acid-sensitive enzymes (such as lactase) is that small hydrogen
ions (H+) can easily diffuse through the biopolymer network inside the hydrogel beads,
thereby inducing enzyme deactivation. For this reason, a number of research groups have
tried to improve the acid-resistant characteristics of hydrogel beads, e.g., by reducing the
pore size of the biopolymer network or by coating the beads with biopolymer layers 271272

. However, these approaches are often unsuccessful because the hydrogen ions are so

small that they can still easily penetrate through the biopolymer networks that make up
the hydrogel core or shell.
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In the present study, an alternative approach was used to create hydrogel beads that
would protect enzymes from acid-induced deactivation when exposed to gastric
conditions. The enzyme (lactase) was co-encapsulated with magnesium hydroxide (a
basic buffer) inside the hydrogel beads. Mg(OH)2 was selected as a buffering agent
because it is a widely used food-grade antacid, which is insoluble in water at neutral and
basic pH values, but soluble at acidic pH values 274. When these buffer-loaded hydrogel
beads are dispersed in an acidic solution, the pH inside them remains close to neutral for
an extended period. This phenomenon occurs because as hydrogen ions (H+) from the
surrounding aqueous phase diffuse into the hydrogel beads they cause some of the
Mg(OH)2 to dissociate, which generates hydroxyl ions (OH-) that neutralize any pH
changes. Moreover, it has been widely proven that the presence of Mg2+ can also
increase the activity of lactase (Juers, et al., 2009), which should be another advantage of
co-encapsulation with lactase. The hydrogel beads were fabricated by an injectiongelation method using an anionic polysaccharide (κ-carrageenan) as the gelling agent and
a cationic mineral ion (potassium) as a cross-linking agent. This polysaccharide was
selected because it was previously shown that relatively high encapsulation efficiency
(around 63%) can be achieved by the carrageenan beads. In addition, β-gal encapsulated
within potassium-carrageenan beads had a higher activity than the free enzyme due to the
stabilization effects of K+ ions on enzyme structure 266. The ability of the buffer-loaded
hydrogel beads to protect lactase from acid-induced deactivation was demonstrated by
exposing them to simulated gastric conditions. A quantitative ratiometric fluorescence
method based on confocal laser scanning microscopy (CLSM) was also used to map the
pH inside the beads before and after exposure to gastric conditions. This study provides
information that can be used to facilitate the fabrication of hydrogel beads designed to
encapsulate and deliver acid-labile enzymes and other bioactive agents.
5.3.2 Materials and methods
5.3.2.1 Materials
Fluorescein tetramethylrhodamine dextran (FRD) with an average molecule weight
of around 70 kDa was purchased from Molecular Probes (Eugene, OR). Lactase (β-
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galactosidase) with a specific activity of around 2600 U/g was obtained from Sigma
Chemical Co (St. Louis, MO, USA). Carrageenan was kindly donated by FMC
Biopolymer (Viscarin SD 389, Philadelphia, PA). The reagents o-nitrophenol (o-NP) and
o-nitrophenyl-b-d-galactosidase (o-NPG) were obtained from the Sigma Chemical Co.
(St. Louis, MO, USA). All chemicals used were analytical grade. Double distilled water
was used to prepare all solutions.
5.3.2.2 Hydrogel beads preparation
An aqueous κ-carrageenan (2% w/v) solution was prepared by dissolving the
powdered ingredient in distilled water by stirring at 50 °C for an hour, and then reducing
the temperature to room temperature with continuous stirring until fully dissolved. The κcarrageenan solution was then mixed with β-gal solution to obtain a concentration of 1%
κ-carrageenan and 130 U β-gal mixture with or without different amount of Mg(OH)2 coencapsulation. After continuously stirring, the mixtures were injected into 10% potassium
chloride solution using a syringe or a commercial encapsulation unit (Encapsulator B-390,
BUCHI, Switzerland) with a 150 µm vibrating nozzle to prepare the hydrogel beads. The
encapsulation device was operated under the following conditions: frequency 800 Hz;
electrode 750 V; and pressure 450 mbar. The formed beads were held in the K+ solution
for 30 min at ambient temperature to promote bead hardening.
5.3.2.3 Simulated gastric conditions
A simulated stomach model was used to investigate the influence of exposure to
acidic gastric fluids on the internal pH and lactase activity of the hydrogel beads as
described previously 230. Hydrogel beads (with or without Mg(OH)2) were added to
preheated simulated gastric fluids (pH 2.5, 37 °C) at a ratio of 1:4 (w/w). This mixture
was then incubated in an incubated shaker for 2 h at 37 °C to mimic stomach conditions.
5.3.2.4 Local pH determination by confocal laser scanning microscopy
The fluorescence images were obtained using confocal laser scanning microscopy
with a 20 × objective lens (Nikon D-Eclipse C1 80i, Nikon, Melville, NY, USA). The
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images of the fluorescence probe (FRD) were obtained using emission wavelengths of
543 and 488 nm, and detection wavelengths/bandwidths of 650 nm/LP and 590 nm/50
nm, respectively. All samples were imaged using an exposure time of 0.5 s and a 12.5%
excitation power level. The complete images of each sample were typically acquired in
less than 2 min with at least eight measurements. The microstructural images for confocal
microscopy were acquired using image specialized software (NIS-Elements, Nikon,
Melville, NY, USA).
A stock FRD solution (10 mg/mL) was prepared by dissolving powdered FRD dye in
phosphate buffer (5mM, pH 7) solution. 5 µL/ml of FRD stock solution was dissolved in
a series of phosphate buffer solutions with different pH values and imaged using confocal
microscopy to determine the linear range of pH response.
The confocal microscopy images were analyzed using Image J software (1.50I,
imagej.nih.gov). The ratio of pixel intensities of images taken using two wavelength
channels (488 nm, 543 nm) was calculated and correlated to the pH using the standard
curve. Each pH value was estimated from at least eight measurements.
5.3.2.5 Measurement of lactase activity
The relative activity of β-gal encapsulated in hydrogel beads that was retained after
different incubation times in simulated gastric fluids was assayed using a colorimetric test
with o-NPG as a substrate. Filtered beads were added to 2 mL of o-NPG in phosphate
buffer (0.3 mg/ml) to reach a final alginate to o-NPG ratio of 1:40 (v/v). The formation
rate of free o-NP was recorded by measuring the absorbance (l = 420 nm) of solutions
contained in a 1-cm path length cuvette using a UV-visible spectrophotometer. The
relative activity of encapsulated lactase was calculated based on the conversion rate of
the substrate (o-NPG) into the reaction products (o-NP) initially and after stomach phase
incubation. At least three freshly prepared samples were used for the activity
measurements.
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5.3.2.6 Measurement of bead dimensions
The particle size distribution of the small beads was measured using laser diffraction
(Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, UK), which is
based on analysis of the angular scattering pattern of particulate suspensions. Samples
were diluted in aqueous buffer solutions to avoid multiple scattering effects, and then
stirred (1200 rpm) to ensure homogeneity. The diameter of the large beads was measured
using a digital micrometer (0–300 mm, EC10, High Precision Digital Caliper, Tresna
Instruments, Guilin, China). The bead diameter of at least 5 individual beads was
measured, and the mean and standard deviation were calculated from at least three
measurements.
5.3.2.7 Statistical analysis
All experiments were performed on at least three freshly prepared samples. The
results are reported as means and standard deviations. These analyses were carried out
using Excel (Microsoft, Redmond, VA, USA) and a statistical software package (SPSS).
5.3.3. Results and discussion
5.3.2.1 pH Mapping inside the beads
Knowledge of the local pH inside the hydrogel beads is required to better understand
the ability of buffer-loaded beads to protect lactase from acid-induced deactivation in
simulated gastric fluids. A pH-sensitive fluorescence probe (FRD) was therefore used to
estimate the internal pH of the beads using a ratiometric fluorescence method. FRD has
both pH-dependent (FITC) and pH-independent (TMR) fluorescence groups within its
molecular structure 275-276. Consequently, the local pH can be determined by calculating
the ratio of fluorescence intensities arising from the FITC and TMR groups. In this study,
the FRD was conjugated to a large molecular weight dextran (70 kDa) to ensure that the
fluorescence dye remained trapped inside the hydrogel beads.
The confocal fluorescence microscopy measurements indicated that the emission
intensity from the FITC channel (488 nm) decreased when the fluorescent dye was
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incubated in lower pH buffers, while the emission intensity from the TMR channel (543
nm) remained relatively constant (Fig. 5.16). A standard curve of fluorescence intensity
ratio versus pH (from pH 4 to 7) was then obtained by taking the ratio of the emission
intensities for the FITC/TMR channels (data not shown). The pH value inside the
hydrogel beads could then be determined from the confocal fluorescence microscopy
images using this calibration curve.

Figure 5. 17 Fluorescent images of fluorescence probe dispersed in phosphate buffer
solutions with different pH values. The images in the top row (TMR channel) and bottom
row (FITC channel) were represent the fluorescence intensity using emulsion
wavelengths of 543 and 488 nm, and detection wavelengths of 650 and 590 nm,
respectively.
Confocal microscopy images of the hydrogel beads were taken before and after
exposure to simulated gastric fluids (Figs. 5.17 and 5.18). For the buffer-free beads, the
fluorescence intensity of the FITC channel (pH-dependent) changed from relatively
strong before exposure to very weak after exposure, which is indicative of a substantial
reduction in the internal pH of the beads based on the calibration curve (Fig. 5.17). The
interior of the buffer-free beads was calculated to be around pH 6.9 before exposure, and
below the limit of detection (pH < 4) after exposure. These results suggest that the
hydrogen ions (H+) from the acidic gastric fluids rapidly diffused into the hydrogel beads
and decreased their internal pH. Conversely, for the buffer-loaded beads, the fluorescence
intensity of the FITC channel only decreased slightly after incubation in simulated gastric
fluids (Fig. 5.18). Indeed, the interior of the buffer-loaded beads changed from around
pH 7.2 before exposure to around pH 6.6 after exposure. As mentioned earlier, this effect
can be attributed to the fact that the encapsulated Mg(OH)2 is insoluble under neutral
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conditions, but dissolves under acidic conditions. Consequently, when hydrogen ions
from the gastric fluids diffuse into the hydrogel beads, some of the Mg(OH)2 dissolves,
which generates OH- ions that neutralize the H+ ions, thereby maintaining a neutral pH
inside the beads. Presumably, there was sufficient magnesium hydroxide initially present
within the hydrogel beads to counteract all the hydrogen ions arising from the gastric
fluids.

Figure 5. 18 Fluorescent microscopy images of hydrogel beads without Mg(OH)2
encapsulation before and after stomach digestion. The images of the ratio channel were
generated using Image J software (imagej.nih.gov) and the color strip shown on the top
right represents the pseudocolor change with pH (intensity of TMR signal was enhanced
using Image J to improve contrast).
5.3.2.2 Influence of encapsulation on enzyme activity: Spectrophotometric assay
The local pH that lactase experiences within the stomach phase influences its
molecular conformation and enzyme activity. For this reason, the activity of lactase
encapsulated in hydrogel beads containing different amounts of co-encapsulated
Mg(OH)2 was measured after incubation in simulated gastric fluids. The impact of bead
dimensions on enzyme activity were determined by fabricating large and small hydrogel
beads using either a simple syringe or a dedicated encapsulation unit, respectively. The
hydrogel beads were then incubated in simulated gastric fluids for different times, and the
enzyme activity was measured using a spectrophotometric method.
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Figure 5. 19 Fluorescent microscopy images of hydrogel beads containing 0.6%
Mg(OH)2 before and after stomach digestion. The images of the ratio channel were
generated using Image J software (imagej.nih.gov) and the color strip shown on the top
right represents the pseudocolor change with pH (intensity of TMR signal was enhanced
using Image J to improve contrast).

For both sizes of buffer-free beads, lactase activity was completely lost after 5 min
incubation in simulated gastric fluids (Figs. 5.20 and 5.21). Presumably, this type of
hydrogel bead was unable to prevent acid-induced loss of lactase activity because small
H+ ions easily diffuse through the pores in the biopolymer matrix and rapidly reduced the
internal pH 292. Conversely, for the buffer-loaded beads, the activity of the encapsulated
enzyme depended on both the level of Mg(OH)2 present and the bead dimensions (Figs.
5.20 and 5.21). Lactase activity decreased steeply after 5 minutes incubation for large
buffer-loaded beads containing only 0.06% or 0.1% Mg(OH)2, with a complete loss of
enzyme activity after 25 min incubation (Fig. 5.20). These results suggest that there was
insufficient buffer present inside the beads to completely neutralize all the hydrogen ions
(H+) that diffused into them. At 0.15% and 0.3% Mg(OH)2, the enzyme activity within
the large buffer-loaded beads remained > 60% after 120 min incubation (Fig. 5.22),
which indicated that these systems were effective at preventing the acid-denaturation of
lactase. This effect can be attributed to their ability to maintain a relatively high pH inside
the hydrogel beads. For the small buffer-loaded beads, a higher amount (0.6 or 0.8%) of
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Mg(OH)2 was needed to maintain a reasonable level of enzyme activity at the end of the
gastric phase (26 or 42% respectively) (Figs. 5.21 and 5.22). The observed impact of
hydrogel bead dimensions on the activity of the enzyme can be attributed to the shorter
distance that the H+ ions have to diffuse into smaller beads (see later).

Figure 5. 20 The relative activity of β-galactosidase encapsulated in large hydrogel beads
after incubation in simulated gastric fluids for different times. The enzyme was
encapsulated in hydrogel beads containing different amounts of Mg(OH)2 (0 to 0.30%).
Samples designated with different capital letters (a, b) were significantly different
(Duncan, p < 0.05) when compared between different delivery systems for the final point
(120 min).
5.3.2.3 Influence of encapsulation on enzyme activity: Visual appearance
Additional insights into the impact of encapsulation on the stability of lactase was
obtained by measuring changes in the appearance of hydrogel bead suspensions
incubated at pH 2.5 (gastric) and pH 7.0 (intestinal) in the presence of a lactase substrate
(o-NPG). Photographic images of the samples were taken periodically to indicate color
changes during incubation: an increase in the intensity of the yellow color of the samples
is an indication of a higher conversion of o-NPG to galactose o-NP by lactase.
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For the buffer-free beads, the yellow color was evenly distributed within the o-NPG
solution during incubation at pH 7 (Fig. 5.23a), which suggests a high enzyme activity
under these conditions. Conversely, when buffer-free beads were incubated in the o-NPG
solution at pH 2.5, no color change was observed indicating that the enzyme was
completely deactivated under these acidic conditions (Fig. 5.23b). For the buffer-loaded
beads incubated at pH 2.5, the yellowish color first appeared in the hydrogel beads
located at the bottom of the tube, then the external o-NPG solution became yellowish at
longer incubation times (Fig. 5.23c). Presumably, the substrate (o-NPG) initially diffused
into the hydrogel beads where it was hydrolyzed by the encapsulated lactase. At longer
times, some of the reaction products diffused out of the hydrogel beads and into the
surrounding aqueous phase, thereby turning the whole solution yellow. A schematic
diagram of the proposed reactions taking place in these systems is shown in Figure 5.24.
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Figure 5. 21 The relative activity of β-galactosidase encapsulated in small hydrogel
beads after incubation in simulated gastric fluids for different times. The enzyme was
encapsulated in hydrogel beads combined with different amounts of Mg(OH)2 (0 to
0.80%). Samples designated with different capital letters (a, b, c) were significantly
different (Duncan, p < 0.05) when compared between different delivery systems for the
final point (120 min).

Figure 5. 22 The relative activity of β-galactosidase encapsulated in hydrogel beads after
120 minutes incubation in simulated gastric fluids. The enzyme was encapsulated in
hydrogel beads containing different amounts of Mg(OH)2.
5.3.2.4 Impact of bead dimensions on H+ ion diffusion
The experimental studies indicated that the hydrogel bead dimensions had a major
impact on the stability of the encapsulated lactase to acidic environments, which was
attributed to the impact of particle size on the kinetics of H+ ion diffusion into the beads.
In this section, the impact of bead dimensions on hydrogen ion diffusion were therefore
investigated using a mathematical model.
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(a)

(b)

(c)
Figure 5. 23 Visual appearance of the color change of lactase-loaded large beads
incubated in (a) the o-NPG solution at pH 7 without buffer co-encapsulation, (b) the oNPG solution at pH 2.5 without buffer co-encapsulation, and (c) the o-NPG solution at
pH 2.5 with 0.3% Mg(OH)2 co-encapsulation.
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Figure 5. 24 Schematic representation of physicochemical processes occurring in the
lactase-loaded beads incubated in o-NPG solution at pH 2.5 with Mg(OH)2 coencapsulation.
The particle size distributions of suspensions of both small and large hydrogel beads
contained a single peak (Fig. 5.25a). Digital photographs of the samples showed that
they contained fairly uniform size particles that were evenly distributed throughout the
system (Fig. 5.25b). The mean particle diameters of the small and large beads were
around 255 and 2610 µm, respectively.
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Figure 5. 25 (a) Particle size distributions and (b) visual appearances of carrageenan
beads fabricated by syringe (large beads) and Encapsulator (small beads).
The diffusion of hydrogen ions into hydrogel beads with different dimensions can be
predicted using the following equation 293:
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Here, F refers to the fraction of H+ ions that have diffused into the hydrogel beads at time
t, M(t) and M(∞) are the concentrations of H+ ions inside the hydrogel beads at time t and
at equilibrium, n is an integer, a is the hydrogel bead radius, and Dgel is the diffusion
coefficient of the H+ ions through the hydrogel bead matrix, which can be estimated
based on the following expression 239:

(2)
Here, Dw is the diffusion coefficient of the H+ ions through pure water, rH is the
hydrodynamic radius of the H+ ions, rf is the cross-sectional radius of the biopolymer
chains (κ-carrageenan) in the hydrogel network, and z is the mesh pore diameter of the
hydrogel network. The radius (rf) of the carrageenan chain has been reported to be around
0.50 nm 294. Typical pore sizes of biopolymer hydrogels are reported to be in the range 5
to 500 nm 270, and a value of 15 nm was assumed for the purpose of this study. The
hydration (rH) radius of the H+ ions (actually H3O+ ions) has been estimated to be around
0.1 nm 295. The diffusion coefficient of H+ ions in water can be obtained from: Dw =
kBT/6phrH, where kB is Boltzmann’s constant, T is absolute temperature, and h is the
viscosity of the solvent. These equations can be used to estimate the time-dependence of
the fraction of H+ ions diffusing into hydrogel beads with different sizes after incubation
in the stomach phase (Fig. 5.26).
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Figure 5. 26 Predicted time dependence of the fraction of hydrogen ions (H3O+) absorbed
by carrageenan beads with a diameter of 255 µm (small size beads) and 2609 µm (larger
size beads) with a pore size of 15 nm after submersion in an acidic environment.
The calculations highlight the importance of hydrogel bead dimensions on the
diffusion rate of H+ ions into the beads. The predictions show that H+ ions can diffuse
into the small beads much quicker (in a few seconds) than into the large ones, which
would account for the fact that a higher amount of Mg(OH)2 has to be loaded into the
smaller beads to maintain a neutral internal pH. These calculations partly account for the
reason that the smaller beads are less effective at protecting the lactase from acidic
conditions than the larger beads
In practice, smaller hydrogel beads are often preferred for applications in the food
industry because they give products with more desirable optical, rheological, stability,
and mouthfeel characteristics. This study has shown that smaller beads can still be used
to protect lactase from acid-induced degradation, but that a higher level of Mg(OH)2 must
be incorporated into the beads. In addition, it may be possible to further enhance enzyme
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activity by using different types and amounts of biopolymers or cross-linking agents to
control the hydrogel pore size and physical interactions.
5.3.4. Conclusion
In this study, lactase was encapsulated within potassium carrageenan-based hydrogel
beads using the injection-gelation method. The acid-stability of the enzyme could be
improved by co-encapsulating it with a basic buffering agent: Mg(OH)2. This buffer is
insoluble under neutral conditions, but dissolves when hydrogen ions diffuse into the
hydrogel beads, thereby ensuring a neutral internal pH (as long as some buffer remains).
A quantitative ratiometric fluorescence method proved to be highly effective at
determining the local pH inside the beads before and after exposure to simulated gastric
conditions. The interior of the buffer-free beads rapidly decreased from pH 6.9 to < 4
when exposed to the stomach phase, which led to rapid deactivation of the encapsulated
lactase. Conversely, the interior of the buffer-loaded beads remained relatively close to
neutral (pH 6.6) even after 2 hours exposure to simulated gastric fluids, which helped to
retain lactase activity. A higher amount of Mg(OH)2 was required to protect lactase
encapsulated in small beads than in large beads, which was attributed to faster diffusion
of H+ ions into the smaller bead interiors. This study suggests that buffer-loaded
hydrogel beads may be suitable food-grade delivery systems for acid-sensitive enzymes,
such as lactase. However, in vivo animal and human studies are stilled needed to confirm
that buffer-loaded beads can maintain lactase activity under real life conditions.
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5.4 Protection of insulin from gastric conditions by encapsulation in antacid-loaded
biopolymer microgels
5.4.1 Introduction
It has been estimated that there were around 382 million people in the world with
diabetes in 2013, and that this number will increase to around 592 million by 2035 296.
Consequently, diabetes is a global health concern, which reduces the quality of life of
numerous people, and is a major economic burden on society due to increased health
costs and lost economic activity 297-298. Individuals with Type 1 diabetes, as well as those
with advanced Type 2 diabetes, have a chronic health condition in which their pancreases
cannot produce sufficient insulin to properly regulate their blood sugar levels 299-300.
Insulin is a peptide-based hormone that normally regulates the uptake of glucose into
cells where it can be used as an energy source, and so individuals with diabetes need to
receive regular doses of insulin to remain healthy 301. At present, regular subcutaneous
injections are the most common means of administering insulin, which is associated with
local discomfort and the possibility of infection 299, 302-303. Delivery of insulin through the
oral route would be much more preferable, as it would be more convenient and less
painful than injections 304-305.
However, there are a number of challenges that currently hold back the
development of successful oral insulin delivery systems. First, insulin is highly
susceptible to degradation in the stomach due to the high proteolytic activity and acidity
of the gastric fluids 306-307. Second, the fraction of ingested insulin, which is a
hydrophilic peptide, that is actually absorbed by the epithelium cells is relatively low 308.
In the current study, we focus on the first of these challenges – improving the gastric
stability of insulin. One of the most promising strategies for increasing the stability of
insulin within the stomach is to encapsulate it inside colloidal particles, such as
nanoparticles or microparticles 16, 305, 309-310. These colloidal delivery systems may be
assembled from synthetic polymers, natural polymers, lipids, surfactants, or
phospholipids suitable for oral ingestion, using various types of particle preparation
methods. In this study, we examined the possibility of encapsulating insulin within
biopolymer microgels assembled from calcium alginate. These microgels can be
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fabricated using a mild preparation method, simple injection at ambient temperature,
which is important to minimize any loss of insulin activity during the loading procedure
311

.
A number of researchers have examined the efficacy of calcium alginate

microgels for encapsulating, protecting, and delivering insulin. Insulin has been
encapsulated within calcium alginate microgels fabricated using an
emulsification/gelation method, but this system was unable to protect the insulin from
degradation under simulated gastrointestinal conditions 304, presumably because these
simple microgels have relatively large pores and are therefore unable to protect insulin
from the acids and pepsin in the gastric juices. Structural design principles have
therefore been employed to improve the encapsulation and protection properties of
alginate microgels. For instance, the anionic alginate microgels have been coated with
cationic biopolymers such as poly-L-lysine 312 or chitosan 313-314 to form a protective
coating around them. Alternatively, alginate has been used in combination with other
biopolymers to form a mixed hydrogel matrix inside the microgels, such as cellulose
derivatives, pectin, and chitosan 315-317. These studies showed that the insulin could be
successfully entrapped and retained within the microgels, but that it was still susceptible
to degradation under simulated gastrointestinal conditions. Again, the reason for this is
because the pores in biopolymer microgel cores or coatings are still relatively large
compared to the size of small ions (H+) or digestive enzymes (pepsin) in the gastric fluids.
Consequently, these molecular species can easily diffuse into the interior of the microgels
and promote insulin degradation.
In the current study, a different approach was adopted to create alginate microgels
that could protect insulin from acid and pepsin-induced deactivation when exposed to
gastric conditions. In this approach, insulin was co-encapsulated with magnesium
hydroxide inside the microgels. Mg(OH)2 is a widely used food-grade antacid, which is
soluble in water at acidic pH, but insoluble at neutral and basic pH 274. Consequently, the
pH inside antacid-loaded microgels stays close to neutral for an extended time when
dispersed in simulated gastric fluids, because some of the antacid dissolves and releases
hydroxyl ions (OH-) when hydrogen ions (H+) diffuse into them 318-319. It has been
reported that pepsin loses most of its enzyme activity at neutral pH 320. Consequently,
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any gastric pepsin that diffuses into the neutral interior of antacid-loaded microgels may
lose its activity, and therefore be unable to hydrolyze the encapsulated insulin. We
therefore postulated that these antacid-loaded biopolymer microgels could protect insulin
from both acid- and protease-degradation in gastric fluids.

For this reason, we carried

out a series of experiments to determine the effectiveness of the antacid-loaded microgels
for the encapsulation, retention, protection, and release of insulin under simulated
gastrointestinal conditions.
5.4.2 Materials and methods
5.4.2.1 Materials
The pH-sensitive fluorescence probe, fluorescein tetramethylrhodamine dextran
(FRD, average Mr 70,000), was purchased from Molecular Probes (Eugene, OR). L6
cells were from American Type Culture Collection (Manassas, VA). α-minimum Eagle’s
medium (α-MEM) was from Invitrogen (Carlsbad, CA). RIPA buffer, phosphatase
inhibitor and protease inhibitor cocktail were from Thermo Scientific, Rockford, IL).
Protein (or insulin) concentrations were determined with a protein DC assay kit (Bio-Rad
Co., Hercules, CA). Immobilin P membrane was from Millipore (Bedford, MA). Primary
rabbit antibodies including protein kinase B (AKT), phospho-AKT Thr308, phosphorAkt Ser473, β-actin and horseradish peroxidase conjugated goat anti-rabbit IgG were
obtained from Cell Signaling Technology (Danvers, MA). Enhanced chemi-luminescence
detection kit (Bio-Rad Co., Hercules, CA). The following chemicals were purchased
from the Sigma Chemical Company (St. Louis, MO): fetal bovine serum; Penicillin;
Streptomycin; alginic acid (sodium salt); pepsin from porcine gastric mucosa; fluorescein
isothiocynate (FITC) isomer I; calcium chloride dehydrate; and magnesium hydrate.
Sodium phosphate and calcium chloride were purchased from Fisher Chemical Company
(Pittsburgh, PA). All chemicals used were analytical grade. Double distilled water was
used to make all solutions.
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5.4.2.2 Microgels preparation
The microgels were prepared using an injection-gelation method as described
previously 318-319, with some slight modifications. Aqueous alginate solutions were
prepared by dispersing powdered sodium alginate (1%, w/w) into phosphate buffer
solution (5 mM, pH 7.0), and then stirring at 60 °C for 60 min. The temperature was then
reduced to 35 °C with continuous stirring until the alginate was fully dissolved. The
alginate solution was then mixed with powdered 1 mg/mL insulin and either 0% (antacidfree) or 0.15% (antacid-loaded) Mg(OH)2, and then stirred until the system was
homogeneous. Microgels were then prepared by injecting these mixtures through a 120
µm vibrating nozzle into a 5% w/w calcium chloride solution using a dedicated
encapsulation device (Encapsulator B-390, BUCHI, Switzerland). The operating
conditions used for the encapsulation device were as follows: frequency = 800 Hz;
electrode potential = 650 V; and operating pressure = 300 mbar. The biopolymer
microgels formed were held in the Ca2+ solution for 20 min at ambient temperature to
promote hardening before being removed. They were then filtered and washed with
buffer solution to remove any residual hardening solution.
5.4.2.3 Simulated gastrointestinal conditions
The impact of incubation of the microgels in simulated gastric fluid (SGF) on their
internal pH and on insulin activity was determined using a method described previously
319

, with some slight modifications. Specifically, microgels (with or without Mg(OH)2)

were added at a ratio of 1:4 (w/w) to SGF (containing 0.0032 g/mL pepsin) that had been
preheated to 37 °C and adjusted to pH 2.5. The resulting mixture was then incubated
within a shaking device for 2 h at 37 °C to mimic stomach conditions.
After exposure to stomach phase, the microgels were then exposed to simulated
small intestinal conditions by mixing them with phosphate buffer solution (pH 7.0, 37 °C)
at a fixed mass ratio of 1:4, and then the mixture was adjusted to pH 7.0. For the release
experiments, the microgels were incubated in this simulated small intestinal phase for 2 h
at 37 °C.
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5.4.2.4 Confocal laser scanning microscopy
The microstructural analysis of the biopolymer microgels was carried out using a
confocal scanning laser fluorescence microscope with a 20 × objective lens (Nikon DEclipse C1 80i, Nikon, Melville, NY, U.S.). The insulin was dyed using FITC solution
and then stored at 5 °C overnight. The excitation and emission wavelength used for
detection of the FITC-labeled insulin were 488 nm and 515 nm, respectively.
The pH inside the biopolymer microgels was measured using a fluorescence intensity
method described previously 321. A known amount of the pH-sensitive dye (10 mg/mL
FRD) was dissolved in phosphate buffer (5 mM, pH 7.0), and then mixed with alginate
solution (1:200 v/v) with or without 0.15% Mg(OH)2. Microgels were then fabricated
using the encapsulation device described in Section 2.2. Images of the microgels were
acquired using the confocal laser scanning fluorescence microscope with a 20´objective
lens. Images of the pH-sensitive dye were obtained using excitation wavelengths of 543
and 488 nm, and detection wavelengths/bandwidths of 650 nm/LP and 590 nm/50 nm,
respectively 322-323. All samples were imaged using an exposure time of 0.5 s and a 12.5%
excitation power level for both channels. Full images of each sample were typically
acquired in less than 2 min and then stored on the computer using the microscope’s
software (NIS-Elements, Nikon, Melville, NY, USA). The images were then analyzed
using Image J software (1.50I, imagej.nih.gov). The ratio of pixel intensities of the two
images obtained at two different wavelengths (488 and 543 nm) were calculated and
correlated with the pH obtained using a standard curve, as described previously 321. The
average intensity ratio was calculated from at least eight measurements.
5.4.2.5 Particle size characterization
Particle size distributions were carried out using a static light scattering instrument
(Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, UK). Phosphate
buffer (5 mM, pH 7.0) was used for the dilution of the initial samples and acidified
distilled water (pH 2.5) was used to dilute the gastric samples to avoid multiple scattering
effects.
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5.4.2.6 Insulin activity assay with L6 myotubes and immunoblotting
The activity of insulin was assayed by determining its ability to stimulate Akt
phosphorylation in L6 myotubes. L6 cells were maintained in α-MEM with 10% fetal
bovine serum, 100 µg/ml streptomycin, and 100 U/ml penicillin at 37 °C in a humidified
5% CO2 atmosphere. Cells were differentiated into myotubes for 6 days as has been
reported previously 324. Prior to analysis the microgels were dissociated by mixing them
with a calcium chelating agent (EDTA). Filtered microgels were dissolved in 2 mL of 10%
EDTA solution and then immediately diluted with α-minimum Eagle’s medium by 100
times before treating myotubes for 10 minutes. Cells were lysed with RIPA buffer
supplemented with phosphatase inhibitor and protease inhibitor cocktail. Protein
concentrations were measured using a protein DC assay kit. Cell lysates containing 50 µg
of protein were separated with 10 % SDS-polyacrylamide gel and transferred to
Immobilin P membrane and incubated with primary antibodies overnight at 4

C and

then secondary antibodies for 1 hour. Detections were performed with an enhanced
chemi-luminescence detection kit. The images acquired were quantified using the Image
J software described earlier.
5.4.2.7 Statistical analysis
All experiments were performed on at least three freshly prepared samples, and the
results reported as averages and standard deviations calculated using Excel (Microsoft,
Redmond, VA, USA).
5.4.3 Results and discussion
5.4.3.1 Preparation and characterization of insulin-loaded microgels
The ability of the biopolymer microgels to encapsulate insulin and then retain it
within the stomach phase was determined using confocal fluorescence microscopy (Fig.
5.27). Prior to exposure to simulated gastric conditions, the insulin (stained green) was
distributed evenly throughout the interior of the microgels indicating that it had been
successfully encapsulated. After exposure, the interior of the microgels was still stained

182

green, indicating that the insulin was retained within the microgels. However, there was
a significant decrease in the fluorescence intensity of the insulin after exposure to the
stomach phase. This effect can mainly be attributed to the fact that the intensity of the
fluorescence probe used to stain the insulin (FITC) decreases under acidic conditions 321.
It should be noted that the fluorescence measurements only indicate the location of the
insulin within the system, rather than its biological activity, and so this was measured
using another method (described later).

(a)
(b)
Figure 5. 27 Confocal microscopy images of antacid-loaded microgels (a) before and (b)
after exposure to simulated gastric conditions.
The confocal microscopy images indicated that the microgels had a roughly spherical
shape, and remained intact after exposure to the simulated gastric conditions, which is in
agreement with earlier studies 318-319. The light scattering measurements indicated that the
microgels had a monomodal particle size distribution both before and after exposure (Fig.
5.28). In addition, they indicated that there was a slight shrinkage of the microgels after
they were incubated in the gastric fluids, with the mean particle diameter decreasing from
around 280 µm before exposure to 265 µm after exposure. Microgel shrinkage under
highly acidic conditions can be attributed to a decrease in the electrostatic repulsion
between the alginate chains when the carboxyl groups become more protonated: −COO+ H+ « −COOH, pKa = 3.5 319. This phenomenon is advantageous for the retention of
the insulin within the microgels in the stomach, since a cross-linked biopolymer network
with smaller pores will trap the insulin molecules more effectively.
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Figure 5. 28 The particle size distribution of antacid-loaded microgels before and after
exposure to simulated gastric conditions.

5.4.3.2 Mapping the pH inside the microgels
As mentioned earlier, one of the main hurdles to the oral administration of insulin is
its tendency to degrade in the stomach due to the high acidity and protease activity of the
gastric fluids 307, 325. Protection against these effects is therefore an important strategy for
the development of effective oral delivery systems for insulin 326-327. We hypothesized
that antacid-loaded microgels would protect insulin from both acid- and proteasedegradation by maintaining a neutral pH inside them. Insulin is known to degrade under
acidic conditions 325, and therefore keeping the local environment neutral should protect
it from this type of degradation. Moreover, the optimum activity of pepsin has been
reported to be around pH 2 to 3 328, and it is known to be deactivated around pH 7 320.
Consequently, maintaining a neutral environment inside the microgels may also protect
the insulin from protease-induced degradation by reducing the local pepsin activity.
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In this study, an insoluble antacid (Mg(OH)2) was co-encapsulated with the insulin to
control the internal pH of the microgels under gastric conditions. The local pH inside the
microgels was measured using a pH-sensitive fluorescence probe (FRD) based on a
fluorescence intensity ratio method described earlier 321. The FRD probe has both pHdependent (FITC) and pH-independent (TMR) fluorescence groups, and so the pH can be
determined by measuring the FITC-to-TMR fluorescence intensity ratio. In addition, the
FRD probe selected for this study had a polymer chain (dextran) attached to inhibit its
release from the biopolymers microgels.
Antacid-loaded microgels
FITC

TMR

Initial

After
stomach

(a)
Antacid-free microgels
FITC
FITC

TMR
TMR

Initial

After
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(b)
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Figure 5. 29 Fluorescent microscopy images of microgels (a) with or (b) without 0.15%
Mg(OH)2 before and after exposure to simulated gastric conditions. The intensity of the
TMR signal was enhanced using Image J to improve contrast.
Confocal fluorescence microscopy images of the FRD probe within the microgels
was acquired before and after exposure to simulated gastric fluids (Fig. 5.29). For the
antacid-loaded microgels, the fluorescence intensity of the FITC channel (pH-dependent)
was relatively strong both before and after incubation in the stomach phase. Conversely,
for the antacid-free microgels, the fluorescence intensity of the FITC channel changed
from relatively strong before incubation to very weak after incubation. The average
internal pH value was determined to be around pH 7.4 for the antacid-loaded microgels
after exposure to the simulated gastric fluids, but below the limit of detection (pH < 4) for
the antacid-free microgels. These results indicate that the co-encapsulated magnesium
hydroxide was able to maintain a neutral pH inside the microgels, which is in agreement
with our previous studies with lipase- and lactase-loaded alginate microgels 318-319. This
effect has been attributed to the ability of the Mg(OH)2 particles to partially dissolve
when hydrogen ions diffuse into the microgels, thereby releasing OH- ions that neutralize
the H+ ions and maintain a neutral pH.
5.4.3.3 Influence of encapsulation on insulin activity
In this series of experiments, a biological model was used to test the activity of
insulin after it had been exposed to simulated gastric conditions. In its active form,
insulin is known to stimulate Akt phosphorylation in L6 myotubes 324, and so this assay
was used to determine the activity of free and encapsulated insulin. Insulin was
encapsulated in both antacid-free and antacid-loaded microgels to ascertain the impact of
the antacid on its stability under gastric conditions.
The Akt phosphorylation at both Thr308 and Ser473 was significantly higher for
insulin encapsulated in the antacid-loaded microgels, than for free insulin or for insulin
encapsulated in antacid-free microgels (Figs. 5.30 and 5.31). This result suggests that the
microgels containing the antacid protected the insulin under gastric conditions, which can
be attributed to its ability to maintain a neutral pH inside the microgels, thereby inhibiting
both acid- and pepsin-induced degradation.
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Figure 5. 30 Effects of diluted digestion solution with insulin (beads free, encapsulated
in beads and encapsulated in microgels with antacid) on Akt phosphorylation in L6
myotubes. (The diluted digestion solution was obtained by diluting orginal digestion
solution by 100 times with DMEM medium. Protein expression levels were determined
after treatment with or without diluted digestion solution (100 nM) for 15 min).
A number of previous researchers have focused on the impact of encapsulation of
insulin on its activity under gastric conditions. Studies have shown that insulin can be
encapsulated in biopolymer nanoparticles fabricated from alginate and dextran sulfate,
and that its biological activity was retained after encapsulation 329. However, the activity
of the insulin in this study was only tested by injecting insulin-loaded nanoparticles
subcutaneously into diabetic rats. Hence, it is unclear whether the insulin would still
remain active if insulin-loaded nanoparticles were orally administered to the rats. Insulin
has also been successfully loaded into poly(lactic-co-glycolic acid) nanoparticles, which
were shown to protect it from gastric degradation, and to maintain its activity after oral
administration to diabetic rats 330. Alginate-chitosan microgels have also been shown to
be effective at encapsulating insulin, protecting it from degradation under gastrointestinal
conditions, and maintaining its activity after oral administration to diabetic rats 331. Thus,
various types of polymer-based microgels seem to have promise as oral delivery systems
for insulin 332. Each system has its own advantages and disadvantages in terms of the
commercial viability of the ingredients and fabrication processes used to prepare them,
and their functional attributes.
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Figure 5. 31 The ratio of (a) pAkt/T308 and (b) pAkt/Akt S473, representing the
phosphorylation of Akt, which is due to insulin stimulation in muscle cells. The higher
ratio of beads + antacid group suggests that insulin was better protected under gastric
conditions than the other groups.

5.4.3.4 Release of insulin in a simulated small intestine phase
Insulin that survives intact after passage through the stomach has to be absorbed by
the epithelium cells after reaching the small intestine so that it can enter the systemic
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circulation. It has been reported that free insulin can be absorbed by intestinal
enterocytes through various internalization mechanisms 333-334. It is therefore important
to understand the release properties of the insulin from the microgels in the small
intestine.
In this section, we determined the release profile of insulin from the antacid-loaded
microgels during incubation in simulated small intestinal fluids for two hours (Fig. 5.32).
Around 21% of the insulin was released fairly rapidly during the first 30 minutes and
then another 10% was released more gradually over the next 90 minutes. Presumably,
the remainder of the insulin would also be released gradually at longer incubation times,
which may be useful for sustained release applications. The release of insulin from the
biopolymer microgels in the small intestine phase can be attributed to changes in the
electrical properties of the alginate and insulin molecules, as well as alternations in the
structure of the alginate microgels. The insulin and alginate molecules are both
negatively charged in the small intestine phase (pH 7) and so they will electrostatically
repel each other, which promotes insulin release 335. Moreover, alginate microgels swell
when they are moved from acidic to neutral conditions because of the increase in
electrostatic repulsion between the anionic alginate chains 291. This leads to an increase
in hydrogel pore size, which can increase the release of any encapsulated substances 336.
Overall, these results suggest that insulin could be successfully released from the
microgels in the small intestine phase, which would facilitate their subsequent absorption.
Nevertheless, it is also possible that the insulin would still be degraded in the small
intestinal fluids prior to adsorption due to the presence of digestive enzymes, such as
proteases. In addition, it will be important to determine the fraction of insulin that is
actually absorbed and enters the systemic circulation where it can have its beneficial
effects. In future studies, it will therefore be important to test the efficacy of these
antacid-loaded microgels using animal feeding studies, e.g., with diabetic rats.
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Figure 5. 32 The release profile of insulin from antacid-loaded biopolymer microgels
during incubation in a simulated small intestine phase.

5.4.4 Conclusion
In this study, insulin was encapsulated within calcium alginate microgels using an
injection-gelation method. The stability of insulin after exposure to simulated gastric
conditions was improved by co-encapsulating it with a basic antacid: Mg(OH)2. This
antacid is insoluble under neutral conditions, but dissolves when hydrogen ions diffuse
into the microgels, thereby ensuring that a neutral internal pH is maintained (as long as
some antacid remains). Gastric pepsin is rapidly inactivated under neutral pH conditions,
and so encapsulation of insulin in antacid-loaded microgels protects it from both acidand protease-degradation. This study suggests that antacid-loaded microgels may be a
suitable food-grade delivery system for acid and/or pepsin-sensitive bioactive proteins
and peptides. However, in vivo animal and human studies are needed to confirm that
these microgels can maintain their insulin activity under real life conditions. In addition,
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it will be important to establish that the microgels can be fabricated economically on a
sufficiently large scale for commercial applications, and that they can be successfully
incorporated into formulations intended for oral administration.
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CHAPTER 6
CONTROL THE DIGESTION AND RELEASE OF BIOACTIVE PROTEIN
USING HYDROGEL BEADS

6.1 Protein encapsulation in alginate hydrogel beads: Effect of pH on microgel
stability, protein retention and protein release
6.1.1 Introduction
Colloidal delivery systems are finding increasing application for the encapsulation,
protection, and release of bioactive agents in the pharmaceutical, supplement, and food
industries 337-339. Each type of bioactive agent has its own unique molecular and
physicochemical properties, which means that delivery systems typically have to be
specifically designed for each application. Proteins and peptides are commonly used as
bioactive agents because they exhibit a range of biological activities, including nutritional,
antimicrobial, antioxidant, flavor, anti-hypertension, anti-diabetic, and anticancer 128, 130,
227, 340

. Nevertheless, the incorporation of these bioactive proteins into food products is

often challenging because of their sensitivity to chemical or biochemical degradation,
their susceptibility to aggregation, and their potential for causing off-flavors (such as
bitterness or astringency). For this reason, there has been considerable interest in
encapsulating proteins within polymer particles to protect and release them in different
environments 341-344. Studies have shown that proteins encapsulated within polymer
matrices may be protected from unfolding and aggregation 345. Moreover, these proteinloaded polymer particles can be designed to carry bioactive proteins to specific locations
within the gastrointestinal tract (GIT) and release them at a controlled rate or in response
to a particular trigger 227. Consequently, the functional attributes and biological activity
of proteins can be enhanced by encapsulating them within microgels 291, 341.
Many different approaches have been developed to fabricate hydrogel beads
suitable for protein encapsulation, including extrusion, emulsion, molding, and phase
separation methods 228, 346-348. For certain applications, it is important that the fabrication
method used does not promote unfolding or aggregation of the encapsulated proteins, as
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this may lead to a loss of their functional attributes or biological activity. Hydrogel beads
fabricated from biopolymers (proteins and/or polysaccharides) are particularly suitable
for the encapsulation of bioactive proteins because they often involve mild preparation
conditions that do not alter protein properties, and can be prepared using food-grade
ingredients 227-229. The extrusion-gelation method is one of the most commonly used and
effective methods of producing hydrogel beads 291. In this method, a biopolymer solution
containing the bioactive protein is injected into another ‘‘hardening’’ solution that
promotes biopolymer gelation. This procedure results in the formation of hydrogel beads
with bioactive proteins trapped inside a biopolymer matrix.
When designing a suitable hydrogel bead for this type of application it is important
that it has good encapsulation, retention, and release properties 229, 270, 341. There are a
number of potential strategies to control the retention and release properties of hydrogel
beads 270. First, the pore size of the hydrogel matrix can be controlled by manipulating
the amount of biopolymer and cross-linking agent used: larger pores typically lead to
faster release. Second, the overall dimensions of the hydrogel beads can be controlled
using different fabrication methods or preparation conditions: smaller beads typically
lead to faster release. Third, specific interactions between the bioactive agents and
biopolymer molecules in the hydrogel matrix can be utilized, e.g., hydrophobic, hydrogen
bonding, or electrostatic interactions. Fourth, the hydrogel beads can be designed to
dissociate upon exposure to specific environmental conditions, thereby releasing their
payload. Fifth, the hydrogel beads can be coated with layers of biopolymers or other
materials to alter their permeability. The mechanism that is important for a particular
delivery system depends on its composition and structure.
In the current study, we investigated the utilization of alginate as a building block
for creating protein-loaded hydrogel beads that could release encapsulated proteins in
response to pH changes. Alginate is a naturally occurring anionic polymer isolated from
brown algae that has the ability to form strong hydrogels 349. Protein-loaded alginate
beads can be fabricated by extruding a solution of sodium alginate containing the
bioactive protein into a divalent crosslinking solution, such as one containing Ca2+ ions
291

. Biopolymer gelation primarily occurs due to exchange of Na+ ions from carboxylic
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acids on the sodium alginate molecules with Ca2+ ions from the crosslinking solution,
which leads to the formation of cross-links with a characteristic “egg-box” structure 18-19,
21

. The internal environment of alginate hydrogels has been shown to have little impact

on the functional properties of many globular proteins 291. In addition, proteins can be
retained within alginate beads that have sufficiently small pore sizes and/or specific
attractive interactions between the proteins and alginate molecules 76 However, the
proteins can be released when the system conditions are changed to increase the pore size
and/or reduce the attractive interactions.
In the present study, whey protein was incorporated into hydrogel beads fabricated
from calcium alginate using an automated extrusion device with a small vibrating nozzle.
We hypothesized that the retention and release of the protein molecules would depend on
their electrical characteristics because this would influence their interactions with the
alginate molecules in the hydrogel matrix. The solution pH was therefore altered relative
to the isoelectric point (pI) of the whey proteins so as to obtain highly positive (pH 3),
approximately neutral (pH 5) and highly negative (pH 7) proteins. The influence of pH
on the encapsulation, retention and release of the proteins was then measured. The
information obtained from this study may be useful for the rational design of more
effective delivery systems for bioactive proteins in the food and other industries.
6.1.2. Materials and methods
6.1.2.1 Materials
Whey protein isolate (WPI) was kindly provided by Davisco Foods International Inc.
(Le Sueur MN). The company reported that the WPI contained 97.9 wt.% protein and 0.2
wt.% fat. Alginic acid (sodium salt), calcium chloride dihydrate (CaCl2·H2O) and
fluorescein isothiocynate (FITC) isomer I was purchased from the Sigma Chemical
Company (St. Louis, MO). Double distilled water was used to make all solutions.
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6.1.2.2 Methods
6.1.2.2.1. ζ-potential measurements
ζ-potential versus pH profiles of WPI and alginate solutions was measured using a
commercial micro-electrophoresis instrument (Zetasizer Nano ZA series, Malvern
Instruments Ltd. Worcestershire, UK). Samples were diluted using 10 mM phosphate
buffer (at the same pH as the sample) prior to analysis to keep the instrument attenuation
value between 5 and 10.
6.1.2.2.2. Turbidity measurements
Turbidity versus pH profiles of WPI or WPI-alginate solutions was determined
using a UV–visible spectrophotometer at 600 nm (Ultrospec 3000 pro, Biochrom Ltd.,
Cambridge, UK). The samples were contained within 1 cm path length optical cells, and
phosphate buffer (PBS) was used as a control. Turbidity measurements were carried out
on at least two freshly prepared samples.
6.1.2.2.3 Encapsulation of WPI in alginate beads
An aqueous alginate (2% w/v) solution was prepared by dissolving the powdered
ingredient in distilled water, stirring at 60 ºC for an hour, and then reducing the
temperature to 35 ºC. The WPI (2% w/v) and alginate (2% w/v) solutions were then
mixed together (1:1 v/v) for 1 h with continuous stirring to form a uniform solution. And
then the mixture solution was adjusted to different pH (3. 5 and 7) for the different
hydrogel beads formation. WPI-loaded hydrogel beads were prepared using a commercial
encapsulation unit (Encapsulator B-390, BUCHI, Switzerland) to inject the different
WPI/alginate solutions into 10% corresponding pH calcium chloride solution with
continuous stirring. The hydrogel beads were allowed to crosslink with Ca2+ for 1 h at
ambient temperature. The hardened beads were then collected by filtration and
subsequently washed with distilled water and buffer solution to remove any excess Ca2+
from their surfaces.
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6.1.2.2.4 Particle size measurements
The mean particle diameter and particle size distribution of biopolymer mixtures
(WPI and alginate) and hydrogel beads formed at different pH values (3, 5 and 7) were
determined using static light scattering (Mastersizer 2000, Malvern Instruments,
Worcestershire, United Kingdom). This instrument infers the size of the particles from
measurements of their angular scattering pattern. Samples were diluted in 10 mM PBS
buffer (pH 3, 5 and 7) by adding small aliquots into a measurement chamber.
6.1.2.2.5 Encapsulation efficiency and protein release
The ability of hydrogel beads formed at different pH values (pH 3, 5, and 7) to retain
the protein was determined by immersing them within the corresponding phosphate
buffer solutions (pH 3, 5 and 7) at room temperature. The concentration of protein in the
surrounding aqueous phase was then measured at various time intervals by recording the
absorbance at 280 nm using the UV-visible spectrophotometer. The encapsulation
efficiency (%) was determined by dividing the amount of protein remaining in the beads
by the initial protein in the beads. The amount of protein in the beads was taken to be he
difference between the initial protein and that released into the phosphate buffer. In some
cases, the amount of protein released was determined for protein-loaded hydrogel beads
formed at pH 3, and then incubated in solutions at higher pH values for 10 min.
6.1.2.2.6 Microstructure analysis
The microstructure of hydrogel beads formed at different pH values (pH 3, 5 and 7)
was recorded, as well as the impact of pH on protein release from alginate-based beads.
The microstructure of the protein-loaded alginate beads was examined using confocal
scanning laser microscopy with a 20 × objective lens (Nikon D-Eclipse C1 80i, Nikon,
Melville, NY, U.S.). The proteins were dyed prior to hydrogel bead formed by adding 0.1
mL of FITC dye solution (1 mg FITC /mL dimethyl sulfoxide) to 2 mL of sample and
then storing at 5 °C overnight. The excitation and emission wavelength used for FITC
were 488 nm and 515 nm, respectively. Specially, a relatively high gain value was
adjusted in the hydrogel beads (formed at different pH values) detection to facilitate the
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observation of encapsulated protein. The microstructure images for confocal microscopy
were analyzed using image analysis software (NIS-Elements, Nikon, Melville, NY).
6.1.2.3 Statistical analysis
All experiments were carried out in triplicate using freshly prepared samples. Means
and standard deviations were calculated from a minimum of three measurements using
Excel (Microsoft, Redmond, VA, USA).
6.1.3 Results and discussion
6.1.3.1 Electrical characteristics of biopolymer molecules
An encapsulated protein can electrically interact with the charged biopolymer
molecules used to fabricate the hydrogel beads and thereby influence its encapsulation,
retention, and release properties. For this reason, the pH dependence of the ζ-potential of
WPI and alginate solutions was determined using an electrophoresis method. The ζpotential of the WPI solution went from negative at pH 7.0 (≈ -26 mV) to positive at pH
2.0 (≈ +23 mV), with a point of zero charge around pH 4.7 (Fig. 6.1), which can be
attributed to changes in the protonation of acid (-COOH) and basic (-NH2) groups on the
protein molecules with pH. The ζ-potential of the alginate solution remained negative
across the whole pH range studied (from pH 2 to 7), changing from strongly negative (≈ 68 mV) at pH 7 to slightly negative (≈ -10 mV) at pH 2. The magnitude of the negative
charge on the alginate molecules was lower under acidic conditions than neutral
conditions due to partial protonation of the carboxylic acid groups on the mannuronic and
guluronic acid groups: -COO- Þ -COOH (pK ≈ 3.5) 349. The pH dependence of the ζpotential of mixed WPI-alginate solutions was also measured by electrophoresis to obtain
information about the interactions between the two biopolymers (Fig. 6.1). At relatively
high pH values (pH > 5.5), the ζ-potential of the mixed system was between that of the
two individual biopolymers, which suggests that both biopolymers contributed to the
overall ζ-potential. At lower pH values, the ζ-potential of the mixed system tended
towards that of the alginate molecules, which suggests that an electrostatic complex was
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formed between the two biopolymers whose charge characteristics were dominated by
the presence of the anionic alginate molecules.
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Figure 6. 1 Dependence of the ζ-potential on pH for 0.1 wt% WPI solution, 0.1 wt%
sodium alginate solution, and 0.1% WPI + 0.1 wt% sodium alginate solution (10 mM
phosphate buffer).
Based on the electrical characteristics of the two individual biopolymers (Fig.6.1), it
would be expected that alginate and whey protein should be attracted to each other at
low-to-intermediate pH (pH < 4.7) where they have opposite charges, but repel each
other at high pH (pH > 4.7) where they have similar charges (negative charge). However,
the ζ-potential and turbidity measurements on the mixed systems suggest that the two
biopolymers become associated at higher pH values (pH 5.5) even though they have
similar charges (Figs. 6.1 and 6.2), which can be attributed to the binding of anionic
groups on the alginate molecules to cationic patches on the surfaces of the protein
molecules 191. Based on these measurements, we anticipate that whey proteins would be
retained by the beads at relatively low pH values due to electrostatic attraction, but be
released at high pH values due to electrostatic repulsion.
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Figure 6. 2 Turbidity (at 600 nm) as a function of pH for aqueous solutions containing
either 0.1% WPI and 0.1% sodium alginate or 0.1% WPI only.
6.1.3.2 Turbidity characterization of mixed biopolymer systems
The formation of electrostatic complexes in biopolymer solutions can simply be
monitored using turbidity measurements 194. In this section, the turbidity versus pH
profiles of the alginate solution, WPI solution, and WPI-alginate mixture were measured
as a function of pH using a spectrophotometric method. The alginate solution had a very
low turbidity at all pH values (data not shown), indicating that the alginate molecules did
not aggregate. As expected, there was a large increase in the turbidity of the WPI
solution around the protein’s isoelectric point (pI ≈ 4.5) due to protein aggregation
associated with the low electrostatic repulsion between the whey protein molecules (Fig.
6.2). For the alginate-WPI mixtures, the solution turbidity was relatively low at high pH
(5 < pH < 7) due to the high solubility of the individual protein and alginate molecules,
and the fact that there would be a strong electrostatic repulsion between the two types of
biopolymer in this pH range. When the pH was reduced further, there was a gradual
increase in turbidity from pH 5 to 3, followed by a steep increase from pH 3 to a
maximum value at pH 2. This result suggests that electrostatic complexes large enough
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to scatter light strongly were formed at pH values below about 4. As mentioned earlier,
small electrostatic complexes may also be formed under conditions (pH 4.0 to 5.5) where
both the WPI and alginate molecules have net negative charges due to electrostatic
attraction between anionic groups on the polysaccharide and cationic patches on the
protein surfaces 166, 191, 350. As reported in these studies, the presence of an anionic
polysaccharide can suppress the aggregation of globular proteins that normally occurs
around their isoelectric point. This effect can be attributed to the fact that the protein and
polysaccharide molecules form an electrostatic complex, and there is a relatively strong
electrostatic and steric repulsion between the complexes. In summary, these results have
highlighted the fact that the alginate and whey protein molecules should bind strongly to
each other at relatively low pH values due to electrostatic attraction.
6.1.3.3 Particle size characterization of polymer mixtures at different pH
Three different pH values were selected for further study based on the expected
differences in the electrostatic interactions between the whey protein and alginate
molecules: electrostatic repulsion at pH 7; soluble complex formation at pH 5; and,
insoluble complex formation at pH 3. The particle size distributions of biopolymer
mixtures containing alginate and WPI at a ratio of 1:1 (w/w) were measured at different
pH values (Fig. 6.3). At pH 7, the biopolymer mixtures appeared optically transparent,
which suggested that they did not contain particles large enough to scatter light
appreciably, consequently reliable light scattering measurements could not be made. At
pH 5, the particle size distribution of the biopolymer mixtures was bimodal, suggesting
there was a wide range of different-sized colloidal particles present. These particles were
presumably held together by a weak electrostatic attraction between the whey protein and
alginate molecules. Visually, these samples had a turbid appearance, which again
indicated the formation of relatively large complexes in these samples. At pH 3, there
was a monomodal distribution of relatively large particles present (d » 500 µm), which
formed due to the strong electrostatic attraction between the cationic whey protein and
anionic alginate molecules. The colloidal dispersions formed in the mixed systems at pH
3 had a higher lightness (white color) than those formed at pH 5, which suggests that the
former particles scattered light more strongly. This may have occurred because the
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biopolymer molecules were packed more tightly together in the complexes at the lower
pH value 191, which led to a higher refractive index contrast.
6.1.3.4 Hydrogel beads formed at different pH
Relatively large alginate beads (d > 1 mm) are typically formed using the most
commonly used extrusion method, which involves simply injecting an alginate solution
into a calcium bath using a syringe or pipette 252, 351-352. This bead size is too large for
many commercial applications since it adversely impacts the physicochemical or sensory
properties of the products they are incorporated into. In this study, we therefore
fabricated relatively small alginate beads (d < 500 µm) using a specially designed
extrusion device (Encapsulator) that uses a vibrating 120-µm nozzle and a syringe pump.
These smaller beads may have several advantages over larger ones in terms of their
impact on product appearance, rheology, mouthfeel and stability. On the other hand,
smaller beads may have lower retention and higher release rates than large ones because
of the reduced diffusion path of the encapsulated agents through the hydrogel matrix 76. It
is therefore important to design alginate beads so that they satisfy the different
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physicochemical requirements for each application.
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Figure 6. 3 Particle size distribution and appearance of biopolymer mixtures containing
alginate and WPI (1:1 w/w) at pH 3 and 5. The solutions were transparent at pH 7, and
therefore reliable particle size measurements could not be made.
The influence of fabrication pH on the properties of alginate beads was investigated
by injecting WPI-alginate mixtures into Ca2+ solutions at pH 3, 5, and 7. As mentioned
earlier, these three pH values were selected because they led to different electrostatic
interactions between the protein and alginate molecules. The light scattering
measurements indicated that the particle size distribution and mean diameter of the
hydrogel beads was influenced by the fabrication pH: d43 = 288, 471, and 516 µm at pH 7,
5 and 3, respectively (Fig. 6.4). There are a number of factors that may contribute to the
influence of pH on bead dimensions. First, the negative charge on the alginate molecules
decreases with decreasing pH (Fig. 6.1), which may reduce the number of anionic groups
on the alginate molecules that are available for cross-linking with calcium ions. Second,
the charge on the protein molecules varied from negative to positive with decreasing pH
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(Fig. 6.1), which will have altered any interactions between the protein and alginate
molecules. Again, these interactions may also have interfered with the ability of the
calcium ions to cross-link the alginate molecules. As a result of these effects, the kinetics
of alginate gelation, as well as the nature of the gel network formed, may have been
changed, which altered the dimensions of the beads formed.
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Figure 6. 4 Particle size distribution and appearance images of hydrogel beads formed at
different pH (pH 3, 5 and 7).

The appearance of the suspensions of hydrogel beads changed from translucent to a
whitish color when the fabrication pH was reduced from 7 to 3 (Fig. 6.4). In addition,
there appeared to be some visible clumping of the particles at lower pH values. This
result suggests that there may have been some aggregation of the protein-loaded alginate
beads, which may have been due to a reduction in the electrostatic repulsion between the
beads at lower pH values.
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The protein encapsulation efficiency of the alginate beads depended on the pH used
to fabricate them: pH 7 (11.6%) < pH 5 (19.1%) < pH 3 (58.6%) (Fig. 6.5). In addition,
the confocal fluorescence microscopy images of the hydrogel beads indicated that the
protein concentration (fluorescence intensity) within them was higher at the lowest
fabrication pH (Fig. 6.5). This trend is related to the strength of the electrostatic
interactions between the protein and alginate molecules. At pH 5 and 7, there will be a
strong electrostatic repulsion between the anionic protein and anionic alginate molecules
(Fig. 6.1), and therefore the protein molecules may not have been effectively trapped
within the alginate beads during their formation. As mentioned earlier, at pH 5 alginate
and protein molecules may bind together due to the attraction of anionic groups on the
alginate molecules to cationic patches on the protein surfaces (even though both have a
net negative charge). However, the attractive alginate-protein interactions may have been
much weaker than the alginate-calcium interactions, and so the protein was released
when the alginate solution was titrated into the calcium solution. At pH 3, there will have
been a strong electrostatic attraction between the cationic protein and anionic alginate
molecules (Fig. 6.1), and therefore the two biopolymers may be held together more
strongly during the cross-linking process. Consequently, the protein molecules are
retained within the alginate beads during their fabrication at low pH values. It should
also be noted that the pores within the alginate beads must have been sufficiently large to
allow the protein molecules to diffuse through them 291. It is interesting to note that the
particle size of beads observed from these confocal images was slightly inconsistent with
the results of light scattering measurements (Fig.6.4). It may be because the beads
fabricated in this study were not uniform sphere, and then the size characterization
observed by the confocal microscope could be influenced by the viewing angle.
Moreover, all the beads formed at different pH conditions showed the broad particle size
distributions. The confocal images of these beads were taken by random, which cannot
guarantee the obtaining of images of beads with the representative characterization (e.g.,
a mean diameter).
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Figure 6. 5 Confocal images and protein encapsulation efficiency of hydrogel beads
formed at different pH (pH 3, 5 and 7). The WPI (green) was stained with FITC.
6.1.3.5 Protein release during storage
In this section, the rate of protein release from the alginate beads formed at different
fabrication pH values was compared. At pH 5 and 7, there was a relatively rapid release
of protein during the first 30 min of storage, followed by a more gradual release at longer
storage times (Fig. 6.6). On the other hand, at pH 3, the release of protein occurred
relatively slowly throughout the 6-hour storage period. The final amount of protein
released at the end of the incubation period depended strongly on pH: pH 3 (24%) < pH 5
(78.9%) < pH 7 (95.3%). As discussed in the previous section, this effect can be
attributed to differences in the electrostatic interactions of the alginate and protein
molecules at different pH values. At pH 3, the protein and alginate have opposite charges
and are strongly attracted to each other, and so the protein is better retained within the
hydrogel beads. Conversely, at pH 5 and 7 the protein and alginate have similar charges
and therefore tend to electrostatically repel each other, so the protein tends to leach out of
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the hydrogel beads. A similar effect has also been observed with electrically charged
drugs trapped within alginate beads. For example, it has been reported that a cationic
drug (chlorpheniramine maleate) showed a much slower release rate from alginate gels
than an anionic drug (sodium salicylate) 353-354.
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Figure 6. 6 Leakage of WPI from hydrogel beads formed at different pH as a function of
incubation time. The beads were immersed into the according PBS buffer (pH 3, 5 and 7)
at room temperature.
The pH dependence of the protein release rate may also depend on changes in the
structure of the alginate beads under different solution conditions. It was reported that
calcium alginate beads tend to shrink at low pH due to the loss of negative charge on the
alginate molecules when the carboxyl groups become protonated (–COOH, pKa ≈ 3.5) 76.
Conversely, they tend to swell when placed in higher pH solutions due to the fact that the
alginate molecules become highly charged and repel each other 270. Thus, the faster
release of the protein molecules at pH 5 and 7 may have been partly due to the fact that
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the hydrogel network had larger pores at these higher pH values. Nevertheless, further
work is required to measure the pore size of the alginate beads to confirm the importance
of this mechanism, e.g., using electron microscopy or size exclusion methods 291.
6.1.3.6 pH-triggered protein release from hydrogel beads
The change in the electrical properties of the alginate and protein molecules with pH
means that protein-loaded alginate beads may be designed to release the proteins in
response to a pH trigger 270. In this section, protein-loaded alginate beads were initially
fabricated at pH 3 since they had a high loading capacity and good retention properties
(Sections 3.4 and 4.5). The protein release from these hydrogel beads was then measured
after they were stored at different pH values for 10 min. The storage pH of the beads had
a pronounced impact on the amount of protein released, with the amount released
increasing with increasing pH (Fig. 6.7b). For example, around 11% protein was
released from the hydrogel beads after incubation at pH 3.5, whereas around 90% protein
was released when they were incubated at pH 7. These results were confirmed by
confocal fluorescence microscopy images of the hydrogel beads, which showed that the
fluorescence intensity (protein) of the hydrogel beads decreased with increasing pH (Fig.
6.7a), which suggests that some of the whey protein molecules had diffused out of the
hydrogel beads at higher pH values. These results suggest that protein-loaded alginate
beads could be fabricated at relatively low pH values (pH 3) to effectively retain the
protein, and then the protein could be released by increasing the pH of the hydrogel beads
environment. This type of pH-triggered hydrogel bead may be a useful tool for protection
of proteins in the acidic environment of the stomach, and then releasing them in the
neutral environment of the small intestine. If required, the initial hydrogel beads could be
coated with extra layers of biopolymers (e.g., chitosan or polylysine) using an
electrostatic deposition approach to modulate their functional properties, such as stability,
integrity, and permeability 291.
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Figure 6. 7 Protein release characterization from the hydrogel beads by changing pH
from the initial condition (pH 3): (a) confocal images of hydrogel beads at initial and
final pH. (b) WPI release fraction (%) after changing pH condition.
6.1.4 Conclusions
The effect of pH on the encapsulation, retention and release of whey proteins from
alginate-based hydrogel beads was studied. Different pH values (pH 3, 5 and 7) were
chosen to fabricate the hydrogel beads based on differences in the nature of the
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electrostatic interactions (attraction or repulsion) between the alginate and protein
molecules. Protein-loaded hydrogel beads were successfully prepared using an
encapsulation unit with a small vibrating nozzle to inject the whey protein/alginate
mixture into a Ca2+ solution. The protein encapsulation efficiency and retention of the
beads increased with decreasing fabrication pH (pH 7 < pH 5 < pH 3), which was
attributed to the fact that there was a strong electrostatic attraction between the cationic
protein and anionic alginate molecules at pH 3. Consequently, the protein molecules were
held in the alginate beads more strongly. The hydrogel beads prepared in this study could
be designed to release the protein molecules in response to a pH trigger. The amount of
protein released increased as the pH of the surrounding solution was increased from pH 3
to pH 7, which was again attributed mainly to a weakening of the electrostatic attraction
between the encapsulated protein molecules and the alginate hydrogel with increasing pH.
These results have important implications for designing hydrogel beads to encapsulate,
retain, and release of proteins in food products and within the gastrointestinal tract.
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6.2 Fabrication of microgels to encapsulate the protein and control its digestion
properties in GIT
6.2.1 Introduction
Proteins play a number of important roles as nutritional components within the
human diet. They are a source of essential amino acids and bioactive peptides, provide
energy, are potential allergens, and regulate hormonal responses, such as hunger, satiety
and satiation 128, 133, 355-358. The rate, extent, and location of protein hydrolysis within the
human gastrointestinal tract (GIT) impacts many of these attributes. Protein hydrolysis is
typically carried out by digestive enzymes within the stomach and small intestine 133, 359.
In humans, protein digestion begins in the stomach due to the presence of gastric pepsins
that are activated under acidic conditions 360. These enzymes breakdown peptide bonds
within the protein molecule, which results in the formation of a mixture of polypeptides,
oligopeptides, and amino acids. After leaving the stomach, any remaining proteins or
peptides are further hydrolyzed by pancreatic enzymes (such as trypsin, chymotryosin,
elastase and carboxypeptidases A and B) activated in the duodenum 361. Eventually, the
amino acids and small peptides resulting from protein digestion are absorbed by the
epithelium cells and enter the systemic circulation. Protein digestion products impact
various human functions regulated by hormones, including gastrointestinal motility,
gastric emptying time, secretion of acid and pepsinogen, and total protein and energy
intake 362-363. It may therefore be possible to modulate these hormonal responses by
controlling the rate and extent of protein digestion within the GIT.
Structural design of food matrices has been proposed as a method of controlling the
digestion and release of macronutrients within the GIT, and therefore as a means to
modulate their physiological effects 363-364. In the current study, we examined the impact
of encapsulating proteins inside biopolymer microgels on their gastrointestinal fate using
an in vitro digestion model. Our previous studies showed that encapsulation of lipids
inside biopolymer microgels retarded the rate and extent of lipid digestion under
simulated GIT conditions, which was attributed to the ability of the biopolymer network
to restrict interactions between the digestive enzymes and their substrates 76, 365.
Biopolymer microgels are normally fabricated from food-grade proteins and/or
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polysaccharides 270, 366. The substance to be encapsulated is typically mixed with a
biopolymer solution, which is then gelled by adding an appropriate cross-linking agent
(such as an ion, acid, base or enzyme) or by changing environmental conditions (such as
temperature or pressure) 229, 270. Numerous approaches can potentially be used to fabricate
protein-loaded microgels, including injection, templating, and phase separation methods
367-368

. The injection-gelation method is one of the most commonly used approaches for

encapsulating bioactive substances in biopolymer microgels because of its relative
simplicity and low cost. In this approach, an aqueous solution containing the bioactive
agent and a gelling biopolymer is injected into a ‘‘hardening’’ solution to promote
particle formation and biopolymer cross-linking. This procedure results in the formation
of biopolymer microgels with the bioactive agent trapped inside. The GIT fate of the
bioactive agent can be modulated by changing the composition, dimensions, or pore size
of the microgels 270.
In this study, we examined the possibility of control the digestion of proteins under
simulated GIT conditions by encapsulating them inside biopolymer microgels fabricated
from calcium alginate. Our previous studies have shown that native proteins can easily
escape from biopolymer microgels under conditions where there is not a strong attraction
between the biopolymer network and protein molecules, i.e., at pH values above the
isoelectric point of the protein
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. This phenomenon was mainly attributed to the fact

that the pore size of the microgels is appreciably greater than the dimensions of the native
protein molecules. Consequently, the protein molecules can easily diffuse out of the
microgels when there is no electrostatic attraction between them and the biopolymer
network. For this reason, we examined the impact of using a thermal treatment to
promote protein denaturation and aggregation inside the microgels on protein
encapsulation and retention. The resulting protein-loaded microgels were passed through
a simulated GIT that included mouth, stomach, and small intestinal phases. An in vitro
pH-stat method was used to determine the degree of protein hydrolysis in the simulated
stomach and small intestine phases. We hypothesized that the encapsulation of denatured
protein inside the microgels would retard its digestion and release under simulated GIT
conditions. The present work for the first time combined the alginate and WPI crosslinking through the calcium ions within one delivery system and then evaluated the
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digestion fate of protein in this novel system. The information obtained in this study may
be useful for the development of functional foods to regulate gastrointestinal responses,
such as hunger, satiety, and satiation.
6.2.2 Materials and Methods
6.2.2.1 Materials
Whey protein isolate (WPI) was kindly provided by Davisco Foods International
Inc. (Le Sueur MN). The following chemicals were purchased from the Sigma Chemical
Company (St. Louis, MO): alginic acid (sodium salt); pepsin from porcine gastric mucosa;
fluorescein isothiocynate (FITC) isomer I; calcium chloride dehydrate; porcine trypsin
and bovine α-chymotrypsin. All chemicals used were analytical grade. Double distilled
water was used to prepare all solutions. All concentrations are expressed as weight
percentages (% w/w), unless otherwise stated.
6.2.2.2 Heated protein preparation
Protein solutions (10% WPI) were prepared by dissolving powdered whey protein
isolate into phosphate buffer solution at pH 7 with continual stirring. In some cases, the
dissolved protein solutions were heated at 80 °C for 15 min in a water-bath, then rapidly
transferred to an ice-water bath for 10 min, and then stored at room temperature for 24 h.
6.2.2.3 Protein-loaded microgel preparation
For the heated WPI-loaded microgels, an aqueous alginate solution was first
prepared by dissolving powdered sodium alginate (1.6%) in phosphate buffer with
continual stirring until complete dissolution. The heated WPI and alginate solutions were
then mixed together (1:1, v/v) for 1 h with continual stirring to form a uniform solution.
The resulting mixture was then injected into a 10% calcium chloride solution using a
commercial encapsulation unit with a 120 mm vibrating nozzle (Encapsulator B-390,
BUCHI, Switzerland). The microgels formed by this process were then kept in the
calcium chloride solution for 1 h at ambient temperature to promote cross-linking of the
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alginate molecules. For digestion experiments, the calcium alginate beads were collected
by filtration and then washed with phosphate buffer and distilled water to remove any
excess ions from their surfaces. After determining the total weight of the dry beads, they
were stored in a refrigerator for further measurements.
Two control samples were also fabricated to determine the impact of protein state on
protein encapsulation and retention: native WPI-loaded microgels and heated native WPIloaded microgels. The native WPI-loaded microgels were fabricated by encapsulation of
unheated whey protein inside the microgels using the same procedure as described above.
The heated native WPI-loaded microgels were prepared by firstly fabricating the native
WPI-loaded microgels, and then heating them at 80 °C for 15 min in a water-bath. The
resulting microgels were then cooled using an ice-water bath for 10 min, and then stored
at room temperature for 24 h.
6.2.2.4 Gastrointestinal tract model
For the simulated GIT studies, four samples were prepared using the procedures
described in the previous sections: native WPI; heated WPI; heated WPI-loaded beads;
and, heated WPI with beads. The heated WPI with microgels samples were prepared by
mixing a heated WPI solution with un-loaded microgels. All the samples were then
diluted with buffer solution (5 mM phosphate buffer, pH 7) to obtain the same initial
protein amount (0.375g). The diluted samples were then passed through a static GIT
model that simulated the mouth, stomach, and small intestine phases.
Initial system. 7.5 g of the initial samples were preheated in an incubator shaker at a
rotation speed of 100 rpm at 37 °C for 15 min (Innova Incubator Shaker, Model 4080,
New Brunswick Scientc, Edison, NJ).
Mouth phase. 7.5 g of simulated saliva fluid (SSF) was preheated to 37 °C and then
mixed with the initial samples with continual stirring. After being adjusted to pH 6.8, the
mixture was incubated in an incubator shaker (37 °C) for 2 min to mimic agitation in the
mouth.
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Stomach phase. The potential gastric fate of the samples was monitored using a
simulated stomach model based on previously reported standardized in vitro methods 253,
369-370

, with some small modifications. Specifically, 15 g of sample solution resulting

from the mouth phase was placed into a water bath at 37 °C and then adjusted to pH 3.0.
15 g of simulated gastric fluid (containing 0.0032 g/mL pepsin (≥ 250U/mg), preheated
to 37 °C, at pH 3.0) was then added to the reaction vessel with constant stirring. An
automatic titration unit (Metrohm, USA Inc.) was used to monitor the pH and maintain it
at pH 3.0 by titrating 0.05 N HCl solution into the reaction vessel for 2 hours at 37 °C.
The volume of acid added to the stomach phase was recorded over time and used to
calculate the degree of hydrolysis (DH) of the proteins using the following equation 371 (1,
2):
DH = [(VA × NA)/MP] × (1/P) × FPH × 100%

(1)

Here: VA is the volume of acid (HCl) solution (mL) titrated into the reaction vessel, NA is
the normality of the acid (0.05 N), MP is the mass of the protein (0.375 g), P is the total
number of peptide bonds (8.75 mol/g for WPI) and FPH is a correction factor (1.8) that
takes into account that the peptides are only partially ionized at pH 3.0.
Small intestinal phase. Samples from the stomach phase were adjusted to pH 7.00
and then 1.5 mL of simulated intestinal fluid and 3.5 mL of bile salts (bile extract,
porcine) solution was added to the reaction vessel with constant stirring. The resulting
mixture was then adjusted back to pH 7.00 if required. 2 mL of 1.25 mg/mL trypsin
(1000-2000U/mg) and 2 mL of 5 mg/mL α-chymotrypsin (≥ 40U/mg) were added to the
reaction vessel. The quantity of enzymes used in this step based on previously published
values 371-372. The pH was maintained at 7.0 by titrating 0.1 N NaOH solution into the
reaction vessel for 2 hours at 37 °C. The volume of alkali solution added to the small
intestine phase was recorded over time and used to calculate the degree of protein
hydrolysis using the following equation :
DH = [(VB × NB)/MP] × (1/P) × FPH × 100%
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(2)

Where: VB is the volume of base (NaOH) solution (mL) titrated into the reaction vessel,
NB is the normality of the base solution (0.1 N), (1/α = 3.03 at pH 7 at 37°C), MP is the
mass of the protein [0.375g×(1-DHstomach%)], P is the total number of peptide bonds (8.75
mol/g for WPI), and FPH is a correction factor (3.03) that takes into account that the
peptides are only partially ionized at pH 7.0 371.
6.2.2.5 Particle charge
The electrical characteristics (ζ-potential) of the samples were measured using an
electrophoresis instrument (Zetasizer Nano ZA series, Malvern Instruments Ltd.
Worcestershire, UK). Samples were diluted with appropriate pH-adjusted solutions prior
to measurements to avoid multiple scattering effects. Phosphate buffer (5 mM, pH 7.0)
was used to dilute the initial, mouth, and small intestine samples while acidified water
(pH 3) was used for the dilution of stomach samples.
6.2.2.6 Particle size characterization
Particle size distributions of the samples were determined using static light
scattering (Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, UK).
Again, phosphate buffer (5 mM, pH 7.0) was used for the dilution of the initial, mouth
and small intestine samples and acidified water (pH 3) was used to dilute the stomach
samples to avoid multiple scattering effects. The average particle sizes are reported as the
surface-weighted mean diameter (d43).
6.2.2.7 Microstructure analysis
The microstructure of samples was analyzed using confocal scanning fluorescence
laser microscopy with a 20 × objective lens (Nikon D-Eclipse C1 80i, Nikon, Melville,
NY, U.S.). The proteins were dyed by adding 0.1 mL of FITC dye solution (1 mg
FITC/mL dimethyl sulfoxide) to 2 mL of sample and then storing at 5 °C overnight. The
excitation and emission wavelength used for FITC were 488 nm and 515 nm, respectively.
The resulting confocal microstructure images were analyzed using image analysis
software (NIS-Elements, Nikon, Melville, NY).
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6.2.2.8 Statistical analysis
All experiments were performed on at least three freshly prepared samples. The
results are reported as averages and standard deviations. These analyses were carried out
using Excel (Microsoft, Redmond, VA, USA).
6.2.3 Results and discussion
6.2.3.1 Protein-loaded bead preparation and characterization
Three types of whey protein-loaded microgels were fabricated so as to determine
the impact of protein state (native versus denatured) and time of denaturation (before or
after protein loading) on microgel formation and protein retention. The three systems
studied were: (i) native protein microgels (N-MGs); (ii) post-loading denatured protein
microgels (post-D-MGs); and, (iii) pre-loading denatured protein microgels (pre-D-MGs).
For system (ii), native whey proteins were first encapsulated inside microgels, and then
the microgels were heated to denature the proteins. For system (iii), a solution of whey
proteins was first heated to denature the proteins, and then the denatured proteins were
encapsulated inside the microgels.
The visual appearance and confocal fluorescence images of these samples are
shown in Figure 6.8. The microscopy images of the N-MGs showed that the proteins
(stained green) were uniformly distributed throughout the continuous phase surrounding
the microgels, rather than being located within the microgels (Fig. 6.8a). This result can
be attributed to the low encapsulation efficiency of the native whey proteins in the
microgels. Our previous studies have also shown that native proteins leaked out of
alginate microgels when they are incubated in neutral buffer solutions 266, 269. The reason
for this phenomenon can be attributed to the relatively large pore size of the biopolymer
network inside the microgels (tens to hundreds of nanometers) compared to the
dimensions of the protein molecules (a few nanometers). In addition, the protein
molecules and biopolymer network (alginate) are both negatively charged at neutral pH
and so they tend to electrostatically repel each other. Fairly similar results were observed
for the systems in which the proteins were denatured after they had been loaded into the
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microgels, i.e., post-D-MGs (Fig. 6.8b). Again, most of the proteins (stained green) were
present in the continuous phase surrounding the microgels, rather than trapped inside
them. There may have been a number of reasons for this phenomenon. First, the native
proteins may have rapidly diffused out of the microgels prior to heating. Second, the
protein molecules inside the microgels may have been resistant to thermal denaturation or
aggregation, and so they were still small enough to rapidly diffuse out of the microgels.
In contrast, almost all of the proteins appeared to remain trapped inside the microgels
when the proteins were denatured before they were incorporated into the microgels, i.e.,
pre-D-MGs (Fig. 6.8c). In addition, visual observations of these microgels indicated that
they had a whitish color rather than the more translucent appearance of the other two
samples. This effect was probably because the presence of the proteins inside the
microgels increased their refractive index, which led to stronger light scattering 373. These
results suggest that the most effective means of ensuring a high retention of the proteins
under neutral pH conditions is to pre-heat the proteins prior to forming the microgels.
Previous studies have reported that heating aqueous whey protein solutions above
their thermal denaturation temperature at neutral pH leads to the formation of long
filaments 374. Moreover, studies have shown that these anionic protein filaments are
cross-linked in the presence of Ca2+ ions at ambient temperature 375-377. Consequently,
the proteins may have remained within the microgels for the pre-D-MGs because they
were present as large filaments that could not easily diffuse through the biopolymer
network, and because they were cross-linked by the calcium ions during the alginate
gelation process (Fig. 6.9). For this reason, the pre-D-MGs were selected to study the
effect of bead encapsulation on the gastrointestinal fate of the whey proteins in the
remainder of the study.

217

(a)

(b)

(c)

Figure 6. 8 Visual appearance and confocal images of (a) native protein microgels (NMGs), (b) post-loading denatured protein microgels (post-D-MGs), and (c) pre-loading
denatured protein microgels (pre-D-MGs) in the calcium chloride solution.
6.2.3.2 Impact of gastrointestinal passage on electrical characteristics
In this section, four different samples were studied to determine the impact of
denaturation and encapsulation on the gastrointestinal fate of the proteins: native protein
solutions (N-S); denatured protein solutions (D-S); pre-loading denatured protein
microgels (pre-D-MGs); and, denatured protein solutions mixed with microgels (DS+MGs). The electrical characteristics (z-potential) of these samples were measured as
they passed through the various stages of the simulated GIT. The initial ζ-potential values
of all the samples were highly negative: -19.9, -22.8, -26.7 and -21.9 mV for N-S, D-S,
pre-D-MGs and D-S+MGs, respectively (Figure 6.9). The net negative charge of the

218

native and denatured protein solutions can be attributed to the fact that the pH was above
the isoelectric point of the whey proteins. The negative charge on the protein-loaded
microgels (pre-D-MGs) can be attributed to the presence of anionic carboxylic (-COO- )
groups on the mannuronic and guluronic acid monosaccharides that make up the alginate
chains. As expected, the sample containing a mixture of denatured proteins and microgels
(D-S+MGs) also had a negative charged because both the anionic proteins and the
anionic microgels contributed to the overall electrophoretic signal 365.

Figure 6. 9 The schematic of the fabrication and incubation properties of native protein
microgels (N-MGs) and pre-loading denatured protein microgels (pre-D-MGs).
After passing through the simulated mouth phase, there was a slight decrease in the
magnitude of the negative z-potential for all samples (Figure 6.9). This reduction may
have occurred due to the presence of mineral ions in the simulated saliva, which decrease
the magnitude of the ζ-potential due to ion binding and electrostatic screening effects 365.
A large reduction in the magnitude of the ζ-potential occurred on all the samples after
incubation in the simulated stomach phase. Previous studies have attributed this effect to
protonation of ionizable groups and electrostatic screening due to the low pH and high
ionic strength of the simulated gastric fluids 230. Under highly acidic pH conditions, the
proteins should become positively charged, but this charge may have been partially
neutralized by the presence of the anionic mucin molecules from the mouth. The
microgels should also lose much of their negative charge under highly acidic conditions
due to protonation of the carboxyl groups on the alginate chains. After exposure to the
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simulated small intestine phase, all the samples again showed relatively high negative
charges. Under these conditions both the digested proteins and the alginate molecules
should have regained their negative charge since the pH was well above the pKa values of
the anionic carboxyl groups. Moreover, there will have been other types of anionic
species present in the small intestine phase after digestion, such as bile salts, mucin, and
digestive enzymes.
6.2.3.3 Impact of gastrointestinal passage on particle size and microstructure
In this section, the microstructure of the different systems was determined after
exposure to each GIT stage. In addition, the particle size of the samples containing
microgels was measured using static light scattering. The protein solutions could not be
analyzed using light scattering because the particles were too small to detect using this
instrument.
Protein solutions. The confocal microscopy images indicated that the
microstructures of both protein solutions (native and denatured) were fairly similar
throughout the GIT process (Figure 6.11). Initially, the proteins were uniformly
dispersed throughout the samples. Previous studies have reported that heat denatured
proteins tend to form homogenous fine stranded network structures at neutral pH 378.
After exposure to the mouth phase, the proteins were still fairly evenly dispersed
throughout the system, but there did appear to be some evidence of clumping in the
microscopy images. This may have been due to association of the protein molecules with
mucin from the simulated saliva. A significant decrease in fluorescence intensity was
observed when both protein solutions moved from the mouth to the stomach phase. This
decrease can mainly be attributed to the fact that the intensity of the fluorescence probe
used to stain the proteins (FITC) is reduced under highly acidic conditions due to
quenching 275, 292. After passing through the small intestine, some relatively large proteinrich particles were observed in the digesta by confocal microscopy, which were probably
aggregated whey proteins, peptides, or digestive enzymes.
Microgel samples. The general shape of the particle size distributions of the
microgel samples remained monomodal after passing through the different stages of the
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GIT model (Figure 6.10). This suggested that the microgels were resistant to digestion
and disintegration within the GIT, which was confirmed by the confocal microscopy
images (Figure 6.11). These results were also in agreement with the finding in previous
study (3). Nevertheless, appreciable changes in the average dimensions of the microgels
were observed when they were exposed to different GIT phases. As has been reported in
previous studies, the mean diameter of the alginate microgels was slightly smaller in the
highly acidic gastric fluids than in the other phases 379. This result can be attributed to the
fact that the carboxyl groups on the alginate chains are highly charged at neutral pH, and
so there is a relatively strong electrostatic repulsion between the chains that promotes
swelling of the microgels. On the other hand, the carboxyl groups are partially protonated
and so lose their negative charge in acid solutions (i.e., stomach phase), which weakens
the electrostatic repulsion between the chains and promotes shrinking of the microgels.

Figure 6. 10 Electrical properties of the different samples measured after exposure to
different GIT stages. Samples designated with different capital letters (A, B, C and D)
were significantly different (Duncan, p < 0.05) when compared between different GIT
regions. Samples designated with different lower letters (a, b, c) were significantly
different (Duncan, p < 0.05) when compared between different delivery systems. (N-S:
native protein solutions; D-S: denatured protein solutions; pre-D-MGs: pre-loading
denatured protein microgels; and, D-S+MGs: denatured protein solutions mixed with
microgels).
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The confocal microscopy images of the system that contained denatured proteins
mixed with microgels (D-S+MGs) indicated that the proteins in the aqueous phase
behaved in a fairly similar manner to those in the denatured protein solutions (D-S).
Thus, the GIT fate of the denatured proteins did not appear to be significantly altered by
the presence of the alginate microgels (Figure 6.11). The confocal microscopy images of
the system that contained denatured proteins encapsulated within microgels (pre-D-MGs)
indicated that the proteins remained trapped inside the microgels throughout the GIT.

(a)

(b)

Figure 6. 11 Particle size distributions of different samples after exposure to successive
GIT stage: (a) heated WPI in beads (pre-D-MGs) and (b) heated WPI with beads (DS+MGs).
6.2.3.4 Impact of encapsulation on protein digestion
In this series of experiments, an automatic titration (pH stat) method was used to
evaluate the rate and extent of protein digestion in different delivery systems. The
principle of this method is that protein hydrolysis causes a change in pH that depends on
the number of peptide bonds cleaved, which can be determined by measuring the volume
of acid or base solution required to keep the pH constant 371.
Under simulated stomach conditions, there was a rapid digestion of whey protein in
all of the samples during the first 5 minutes, followed by a more gradual digestion
throughout the rest of the incubation period (Figure 6.12). Nevertheless, there were some
differences in the digestion rates between the different samples. For the proteins in
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solution, the native protein (N-S) was digested more slowly than the denatured protein
(D-S). Previous studies have also reported that native whey proteins are more resistant to
gastric digestion than denatured ones 380-381, which was attributed to the fact that the
peptide bonds in the native globular proteins are more difficult for the proteases to access.
Heat treatment induces conformational changes in the protein molecules, which increases
the exposure of peptic cleavage sites and thus increases their susceptibility to pepsin
hydrolysis. The denatured proteins were digested at a similar rate in the protein solutions
(D-S) and in the mixed systems (D-S+MGs), which suggested that the microgels did not
alter their hydrolysis. On the other hand, encapsulation of the denatured proteins inside
the microgels led to an appreciable decrease in their digestion under simulated gastric
conditions (Figure 6.12). Presumably, the microgels were able to restrict the ability of
the proteases from the aqueous phase to come into contact with the encapsulated protein
molecules, thereby reducing their digestion.
Under small intestine conditions, the native protein solution (N-S) showed the
fastest rate of protein hydrolysis, while all the samples containing denatured protein were
digested at a similar slower rate (Figure 6.13). Previous studies have reported that the
digestion of native proteins in the small intestine is facilitated after they pass through the
stomach, which is probably due to partial denaturation of the proteins in the highly acidic
gastric fluids 371. The fact that encapsulation of the denatured proteins within the
microgels did not appear to inhibit their digestion under small intestine conditions,
despite the fact that the proteins appeared to be trapped within the microgels (Figure
6.11), suggests that the digestive enzymes may have been able to penetrate into the
microgels under these conditions. These results suggest that the microgels may be able to
inhibit protein digestion in the stomach phase, but not in the small intestine phase.
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Figure 6. 12 Microstructures of different samples after exposing to different regions of
the simulated GIT (Scale bar is 100 µm). (N-S: native protein solutions; D-S: denatured
protein solutions; pre-D-MGs: pre-loading denatured protein microgels; and, D-S+MGs:
denatured protein solutions mixed with microgels)
Overall, the relatively low extents of protein hydrolysis observed in our study (<
20%), are similar to those reported in other in vitro studies 371. In reality, in vitro GIT
models cannot reproduce the complex conditions that occur in vivo 370. Therefore, animal
and human studies are still needed to verify the impact of encapsulation on protein
digestion in practice.
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Figure 6. 13 The hydrolytic performance of WPI in different samples under simulated
stomach digestion measured using a pH-stat in vitro digestion model. (N-S: native protein
solutions; D-S: denatured protein solutions; pre-D-MGs: pre-loading denatured protein
microgels; and, D-S+MGs: denatured protein solutions mixed with microgels)
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Figure 6. 14 The hydrolytic performance of WPI in different sample after simulated
small intestine digestion measured using a pH-stat in vitro digestion model. (N-S: native
protein solutions; D-S: denatured protein solutions; pre-D-MGs: pre-loading denatured
protein microgels; and, D-S+MGs: denatured protein solutions mixed with microgels)

6.2.4 Conclusion
In the present study, it was shown that protein-loaded microgels could be fabricated
by injecting a mixture heat-denatured whey protein and alginate molecules into a calcium
solution. If the protein molecules were not denatured prior to incorporation into the
microgels, they had a tendency to leach out, presumably because they were small enough
to diffuse through the pores in the biopolymer network that makes up the interior of the
microgels. A simulated GIT method suggested that encapsulation of the denatured
proteins within the microgels inhibited their hydrolysis under stomach conditions, but not
under small intestine conditions. These results suggest that protein encapsulation in
biopolymer microgels may be useful for modulating protein digestion and peptide release
within the gastrointestinal tract. However, animal and human studies are needed to
confirm these findings in real GITs. Moreover, studies are needed to determine whether
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modulating the rate and extent of protein digestion can impact hormonal responses such
as hunger, satiety, and satiation.
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CHAPTER 7
CONTROL THE RELEASE AND DIGESTION OF LIPIDS USING HYDROGEL
BEADS

7.1 Introduction
Triacylglycerols are nutritionally important constituents of the human diet
because they are a major supply of energy, a source of essential fatty acids, and carriers
of lipophilic micronutrients and nutraceuticals 382. The digestion of triacylglycerols
within the human body is usually highly efficient 126, 383, which can be attributed to the
fact that humans evolved in an environment where calories were often scarce. From a
physicochemical point of view, lipid digestion is a highly complicated process involving
various types of colloidal and interfacial processes throughout the gastrointestinal tract
(GIT) 126, 384-385. The triacylglycerols in ingested foods often exist as lipid droplets or
they are converted into lipid droplets during mastication in the mouth or churning in the
stomach 1, 385. In humans, the process of triacylglycerol digestion begins in the stomach
due to the presence of gastric lipase, but is mainly carried out in the small intestine due to
the presence of pancreatic lipase 126, 238. These lipases typically adsorb to the surfaces of
the lipid droplets and convert the triacylglycerols (TGs) into diacylglycerols (DGs),
monoacylglycerols (MGs), and free fatty acids (FFAs). The presence of lipid digestion
products in the small intestine stimulates the release of hormones that regulate
gastrointestinal motility, gastric emptying times, feelings of hunger/satiety/satiation, and
total energy intake 386-388. Consequently, controlling the rate and extent of triacylglycerol
digestion within the GIT may lead to the creation of functional foods that can modulate
food intake, and therefore aid in the fight against problems with overweight and obesity
389

.
Structural design approaches can be used to create emulsion-based foods that can

control lipid digestion within the GIT 62, 385, 390. These approaches are used to change the
size, composition, interfacial properties, aggregation state, or local environment of the
lipid droplets in foods, thereby altering the way they are processed within the GIT 1.
Previous studies have shown that filled hydrogel beads are one of the most effective
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means of retarding lipid digestion under simulated GIT conditions 76. This type of
delivery system consists of lipid droplets trapped within hydrogel beads. Filled hydrogel
beads are typically fabricated using a two-step process: (i) a droplet-loaded biopolymerrich particle is formed; (ii) the biopolymer molecules are cross-linked using a suitable
physical or covalent method. A number of particle formation methods are available,
including injection, coacervation, segregation, antisolvent precipitation, emulsion
templating, and molding methods 270. The injection-gelation method is one of the
simplest and most widely used for encapsulating lipid droplets. An aqueous solution
containing a mixture of lipid droplets and biopolymer is injected into a ‘‘hardening’’
solution that promotes cross-linking and gelation of the biopolymer molecules. This
procedure results in the formation of a hydrogel bead with lipid droplets trapped inside.
Changing the composition, dimensions, or pore size of the hydrogel beads can be used to
modulate the GIT fate of the lipid droplets 76.
Magnetic resonance imaging (MRI) is a potentially powerful tool for the
investigation of filled hydrogel beads in the GI tract as it is non-invasive and
differentially sensitive to meal components without using ionising radiation. MRI can
image fat and water components of model meals separately based on T1 relaxation and
chemical-shift properties. MRI have been previously used to directly visualize the lipids
in alginate beads within the meal in the human GI tract, as well as in simulated GI
conditions. Magnetic resonance spectroscopy (MRS) is a long established MR-based
method and generally considered the clinical gold-standard technique to quantify the fat
fraction in a sample or organ. The method is based on integrating the frequency spectrum
peaks of water and the fat, which is obtained from a small, spatially localized volume of
interest (voxel) within the region of interest.
In this study, we examined the possibility of modulating the rate and extent of
lipid digestion under simulated GIT conditions by mixing together rapidly digesting and
slowly digesting delivery systems. The rapidly digesting delivery systems were
nanoemulsions containing free lipid droplets, whereas the slowly digesting delivery
systems were lipid droplets encapsulated within hydrogel beads. It was hypothesized that
mixing different ratios of free and encapsulated lipid droplets would lead to delivery
systems with different lipid digestion profiles. Moreover, we examined the possibility of
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utilizing MRI and MRS to determine the lipids release properties from hydrogel beads in
simulated gastric conditions. The information obtained in this study may therefore lead to
the development of functional foods that can control triacylglycerol blood levels,
hunger/satiety/satiation responses, and calorie intake by controlling the rate and extent of
lipid digestion. Furthermore, the results obtained from current study may also provide us
the valuable evaluation of novel use of MR-based technology in emulsion based colloidal
delivery system within GIT.
7.2 Materials and methods
7.2.1 Materials
Corn oil was purchased from a local supermarket and used without further
purification. Carrageenan (κ-) was donated by FMC Biopolymer (Viscarin SD 389,
Philadelphia, PA). Tween 80 and alginic acid (sodium salt, from brown algae, medium
viscosity) were purchased from the Sigma Chemical Company (St. Louis, MO). All other
chemicals were analytical grade. Double distilled water was obtained from a waterpurification unit.
7.2.2. Preparation of nanoemulsions
The aqueous phase consisted of 4% (w/w) Tween 80 dispersed in buffer solution (5
mM phosphate buffer, pH 7.0), stirred for 2 hour at ambient temperature, and then stored
overnight at 4 °C. The oil phase consisted of corn oil at ambient temperature.
Coarse emulsions were prepared by blending 40% (w/w) oil phase and 60% (w/w)
aqueous phase using a high-shear mixer (Bamix, Biospec Products, Bartlesville, OK) for
2 min at ambient temperature. Nanoemulsions were prepared by passing the coarse
emulsions through a dual-channel microfluidizer equipped with a Y- and Z-type
interaction chamber (Microfluidics PureNano, Newton, MA, USA) three-times at 12 kpsi.
The Y-type chamber was placed before the Z-type chamber, which facilitate the
formation of small emulsion droplets with high lipid concentration. The resulting
nanoemulsions were then diluted with buffer solution (5 mM phosphate, pH 7.0) to
obtain samples with a range of lipid droplet levels.
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7.2.3. Preparation of filled biopolymer microgels
Aqueous alginate and κ-carrageenan solutions were prepared by dissolving powdered
polysaccharide ingredients in distilled water at evaluated temperature (60 °C), then
reducing the temperature to 35 °C with continuous stirring until totally dissolved.
Nanoemulsions were then mixed with polysaccharide solutions to create a final system
containing 35% lipid droplets (w/w) and 0.5% polysaccharide (w/w). Filled alginate
microgels were formed by using a simple hand-held syringe (BD Safety-Lok 10 mL
Syringe with a 0.6 mm-diameter tip, Franklin Lakes, NJ) to drip nanoemulsion-alginate
mixtures (2s per drop) into 20 mL 5% (w/w) calcium chloride (Ca2+) solutions with
continuous stirring. Similarly, filled carrageenan microgels were prepared by dripping
nanoemulsion-κ-carrageenan mixtures into 5% (w/w) potassium chloride (K+) solutions.
The filled microgels formed were incubated in the cation (Ca2+ or K+) solutions for 20
min at ambient temperature to promote crosslinking. They were then filtered by filtration
paper (Fisher Science, P5) and washed with distilled water and phosphate buffer solution
to remove any excess ions from their surfaces. The particle size of microgels were
determined using a digital caliper (Fowler high Precision, Newton, MA, USA)
7.2.4. Simulated gastric conditions
The effect of simulated gastric conditions on the properties of the filled microgels
was determined using a method described previously 318, with some slight modifications.
Filled alginate or carrageenan microgels were added at a ratio of 1:1 (w/w) to simulated
gastric fluids (SGF) that had been preheated to 37 °C and then adjusted to pH 2.5. The
resulting mixture maintained at 37 °C with continual stirring for 2 h to mimic gastric
peristalsis and digestion

7.2.5. Turbidity measurements
The turbidity of the fluids surrounding the microgels was determined as an indication
of the release of the lipid droplets. The beads were removed by filtration and the
turbidities of residual solution were measured using a UV-visible spectrophotometer at
600 nm (Ultrospec 3000 pro, Biochrom Ltd., Cambridge, UK). Test samples were
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contained within 1-cm path length optical cells and phosphate buffer was used as a
control. Turbidity measurements were carried out on at least two freshly prepared
samples. Changes in the appearance of the samples were also recorded throughout gastric
digestion using a digital camera. A fraction of microgels were taken from the digestion
phase to facilitate their detection.
7.2.6. MRI and MRS analysis
The release of the lipid droplets from the filled microgels during the simulated
stomach digestion period were studied using a MRI instrument (3T, Siemens Skyra).
Samples collected from the stomach phase were loaded into an glass tube with a screwtop. Any air bubbles were completely removed from the samples before sealing to
eliminate deviation

MR imaging and spectroscopy were performed by placing the

samples into the 3T MR instrument with a 15-ch knee RF coil. The tubes were positioned
axially as a bundle of 7 tubes so that the tube axis was aligned with the magnet axis for
the quantitation study in which the lipid content was measured. The tube bundle was also
positioned vertically for the imaging of individual microgel. The tubes were scanned with
a 3-dimensional T1-weighted sequence, i.e., T1 VIBE or water-selected T1 VIBE
sequence, in an axial orientation with TR/TE = 10/4.92 ms, voxel size = 0.8×0.8×4 mm3,
and flip angle = 10 degree. The MR spectra were obtained using a stimulated echo
acquisition mode (STEAM) sequence of a single voxel of 10×10×15 (F/H) mm3,
TR/TE=1200/20 ms, and water suppression 391-392.
7.2.7. Statistical analysis
All experiments were performed on at least two freshly prepared samples. The
results are reported as averages and standard deviations. These analyses were carried out
by T-tests using Excel (Microsoft, Redmond, VA, USA).
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7.3. Results and Discussion
7.3.1. Influence of gastric conditions on characteristics of filled microgels
Filled microgels were prepared by injecting mixtures of lipid droplets and anionic
biopolymers (carrageenan or alginate) into cationic mineral solutions (K+ or Ca2+). These
constituents were selected as the formed microgels showed significantly different
structure and properties. The carrageenan microgels produced had an irregular shape with
rough surfaces, whereas the alginate microgels had spheroid shapes with smooth surfaces
(Fig. 1). The diameter of the carrageenan microgels (» 3 mm) was slightly larger than
that of the alginate ones (» 2.5 mm). These structural differences have previously been
attributed to the different gelation mechanisms of the two polysaccharides. Carrageenan
gelation is induced by crosslinking anionic sulfate groups in different polysaccharide
chains with cationic potassium ions, whereas alginate gelation is the result of crosslinking
of anionic carboxylic groups with cationic calcium ions 233. Gelation of alginate would
be expected to be stronger and faster than carrageenan because divalent calcium ions are
more efficient crosslinking agents than monovalent potassium ions 393.
Initially, all of the lipid droplets were trapped inside the microgels, which could be
deduced from the fact that the microgels looked white while the surrounding solution was
optically clear (Figs. 1 and 2). Thus, both types of microgel could effectively trap the
lipid droplets inside. Presumably, the dimensions of the lipid droplets were greater than
those of the pore size of the biopolymer network inside the microgels, thereby inhibiting
their movement 76.
After exposure to gastric conditions, visual observations showed there was a
progressive reduction in the size and integrity of the carrageenan microgels, as well as an
increase in the cloudiness of the surrounding aqueous phase (Figure 7.1). Indeed, almost
all of the carrageenan microgels had fully dissociated after 120 min exposure to the
simulated stomach phase. Conversely, the alginate microgels remained intact throughout
the entire incubation period in the gastric fluids and there was only a slight increase in the
cloudiness of the surrounding fluids. The turbidity of the solution surrounding the
microgels increased steeply during incubation in the gastric fluids for the carrageenan
system but only slightly for the alginate system (Figure 7.2). Taken together, these
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results indicated that the carrageenan microgels were more unstable in simulated gastric
conditions than the alginate microgels.
0 min
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microgels
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Figure 7. 1 The optical images of two types of microgels after different simulated
stomach digestion period (a fraction of microgels were taken out from the simulated
digestion phase to facilitate the observation).
The disintegration of carrageenan microgels under stomach conditions can be
attributed to the strong acidity, high ionic strength, and mechanical agitation of the
gastric fluids. Presumably, the crosslinks holding the carrageenan molecules together in
the microgels are weaker than those holding the alginate molecules together. As a result,
they are more likely to be disrupted at high ionic strengths because this weakens the
electrostatic attraction between the polysaccharide molecules and the counter-ions. In
particular, the sodium ions in the gastric fluids could displace the potassium ions that
form the crosslinks between the carrageenan molecules, but not the calcium ions that
form the crosslinks between the alginate molecules. Interestingly, the pKa values of the
sulfate groups in carrageenan (around pH 2) are considerably lower than those of the
carboxyl groups in alginate (around pH 3.5). This suggests that deionization of the
anionic groups on the polysaccharide molecules was not a major factor contributing to
differences in their behavior in the acidic gastric fluids.
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Figure 7. 2 The turbidity of residual solution in two types of microgels during different
simulated stomach digestion period (0-120 min).
It has been reported that up to 30-40% of lipid digestion occurs within the human
stomach 394. Our previous study showed that free lipid droplets are digested much more
rapidly than lipid droplets encapsulated within biopolymer microgels, which was
attributed to the restricted diffusion of lipase molecules through the biopolymer matrix 76.
The early release of the lipid droplets from the carrageenan microgels might therefore be
expected to lead to faster lipid digestion under gastrointestinal conditions, which has been
reported in previous studies 395-396.
7.3.2. Development of standard curve for lipid quantification
A major goal of our research was to demonstrate the potential for magnetic
resonance imaging and spectroscopy to non-invasively monitor the release of
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encapsulated lipids from biopolymer microgels. Initially, it was therefore necessary to
establish correlations between lipid droplets levels in the GIT fluids and measurable MRI
parameters. We examined two different approaches for discriminating between the lipid
and water in the samples, one based on measurements of relaxation times and the other
based on chemical shift spectroscopy.
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Figure 7. 3 A transaxial view of the 3-dimensional T1-weighted water-selected images
from tubes filled with emulsions with different lipid concentration. The lipid
concentration of each tube is marked in percentage on or next to each tube. The tube axis
was aligned with the magnet axis and thus the trapped air was seen as signal void on the
top portion of some tubes.
A series of samples with different lipid levels (0-40%) was prepared by diluting the
most concentrated nano emulsions produced by micro fluidization with buffer solutions.
Water-selected T1 weighted images and spectroscopy analysis of the samples were then
carried out using the MRI instrument. The axis of the cylindrical phantom was aligned
parallel to the static magnetic field and positioned in the center of the knee RF coil to
improve magnetic homogeneity and obtain better water excitation images with high
resolution.
Relaxation Measurements: Initially, we consider the use of relaxation measurements
to determine the lipid content of the samples. A water-selected sequence was used to
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discriminate the water phase from the lipid phase in the nanoemulsions 397. Using this
pulse sequence, the water is excited and produces a signal that appears as bright regions
in the images. Conversely, the lipid remains in equilibrium, thereby producing no signal,
which results in dark regions in the images.
Nanoemulsion samples with different lipid contents could clearly be distinguished
using the T1 water-selected images (Figure 7.3). As expected, the images became
brighter as the lipid level decreased, i.e., as the water level increased. For quantitative
analyses, the signal intensity at identical positions within each sample was measured by
selecting a target region of interest (ROI). The mean signal intensity over the ROI was
used to represent the signal of each nanoemulsion sample. The signal intensity decreased
linearly with increasing lipid concentration (Figure 7.4a), with a high negative
correlation (R2 = 0.9882). These results suggest that the MRI relaxation approach is
suitable for determining the lipid content of samples.
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Figure 7. 4 Relationship of the lipid concentration with (a) T1-weighted image intensity
and (b) MR spectral peak amplitude. The dotted line in each graph indicates the linear
regression with the equation denoted in each graph.
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Figure 7. 5 MR spectra of emulsion samples with different lipid concentrations (0-40%).
The peak integral value of the lipid peak is marked with a red rectangle.
Spectroscopy Measurements: A chemical spectroscopy method was also used to
discriminate between the lipid and water phases in the samples (Figure 7.5). The peaks
in the MRI frequency spectrum corresponding to the lipids and water were integrated
from the ROI for each nanoemulsion sample. Previously, the main CH2 (1.6 ppm) peak
has been reported to be particularly useful for determining lipid contents in biological
samples at clinical field strengths 398-399. The area under the curve of the real part of the
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frequency domain signal was used as the integrated signal amplitude to correlate to the
lipid concentration. Our results indicated that the integral values increased linearly with
lipid concentration in the nanoemulsion samples with a high positive correlation (R2 =
0.9755) (Figure 7.4b, Figure 7.5). These results indicate that MR spectroscopy may also
be used to determine the lipid content of samples.
7.3.3. Determination of the release properties of lipid droplets from microgels
In this section, filled carrageenan and alginate microgels were prepared for analysis
using the two MR-based methods. T1-weighted VIBE sequence images and T1-weighted
water-selected images of the microgel dispersions were then acquired after they were
incubated in simulated gastric fluids for different period (0 to 120 min). The phantom
configuration that was set vertically or aligned to the knee of coil to facilitate the
observation or quantitation.
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Figure 7. 6 Digestion periods of two types of microgels: (a) The phantom configuration
that was set vertically inside the knee of coil, (b) T1-weighted MRI and (c) water-selected
T1-weighted MRI. In each image, ‘Car’ and ‘Alg’ denote the carrageenan and alginate
microgels, respectively. The digestion period of each tube is denoted next to each tube in
minute.
For obtaining the T1-weighted images, the tube bundle was positioned vertically
inside the coil and a relatively small voxel size (0.8×0.8×4 mm3) was used to visualize
individual microgels. These images showed that the filled alginate microgels retained
their spherical shape and integrity throughout the incubation period (Figure 7.6b). While
the filled carrageenan microgels exhibited quite different behavior. They progressively
disintegrated when they were dispersed in the gastric fluids, almost completely
disappearing after 60 minutes of incubation (Figure 7.6b). These results agree with our
previous studies, which showed that the digestion of lipid droplets was much slower
when they were encapsulated in alginate microgels rather than carrageenan ones 400.
Again, these effects can be attributed to the fact that the crosslinks between the alginate
molecules in the microgels are much stronger than those between the carrageenan
molecules. As a result, the alginate microgels are more resistant to gastric conditions
than the carrageenan molecules.
The phantom configuration was also set aligned to the knee of coil to improve
magnetic homogeneity. We could observe that the lipid-loaded alginate microgels floated
to the top of the simulated gastric fluids (Figure 7.7b). These results suggest that the
encapsulation of the lipid droplets inside the alginate microgels could delay their gastric
emptying, since they would tend to float on top of the gastric fluids and not easily pass
through the pylorus sphincter 401. This characteristic may be advantageous for certain
applications of microgels in functional foods. For carrageenan microgels, most of them
were dissolved in the simulated stomach phase after 60 minutes of incubation. However,
they still floated to the top of the gastric fluids at shorter incubation times (Figure 7.7b).
We then determined the changes in the water-selected T1-weighted images of the
microgel samples over different simulated digestion time (Figure 7.6c and 7.7c). The
results obtained were very similar to those obtained from the T1-weighted images. The
alginate microgels remained intact throughout the digestion period, whereas the
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carrageenan microgels progressively disintegrated. In addition, the microgels could again
be seen to float to the top of the gastric fluids using this approach.
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Figure 7. 7 Digestion periods of two types of microgels: (a) The phantom configuration
that was set in the knee of coil, (b) T1-weighted MRI and (c) water-selected T1-weighted
MRI. In each image, ‘Car’ and ‘Alg’ denote the carrageenan and alginate microgels,
retrospectively. The digestion period of each tube is denoted next to each tube in minute.
The tube axis was aligned with the magnet axis to improve magnetic homogeneity.
Quantification of Lipid Release: Finally, we compared the effectiveness of the
relaxation and spectroscopy approaches for monitoring lipid droplet release from the
microgels during incubation in the simulated gastric fluids (Figure 7.8, Figure 7.9 and 7.
10). The lipid release profiles were obtained using the standard curves of intensity versus
lipid content (relaxation) or integral value versus lipid content (spectroscopy) described
in the previous section. These measurements were carried out on the fluid phase
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surrounding the microgels in the tubes settled aligned to the magnetic axis. Only the
carrageenan microgels were analyzed in these experiments because there were so few
lipid droplets released from the alginate microgels.
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Figure 7. 8 The release profile of lipid from carrageenan microgels during 2h’ simulated
stomach digestion period. The lipid release fraction were calculated based on the
intensity and integral value of carrageenan microgels samples obtained from T1 weighted
MRI and the MR spectra.
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Figure 7. 9 Image intensities of two types of microgels obtained from the water-selected
T1-weighted MRI. ‘Car’ and ‘Alg’ denote the carrageenan and alginate microgels,
respectively. The digestion period of each tube is denoted next to each tube in minute.
Our results suggest that the release of the lipid droplets from the carrageenan
microgels occurred relatively slowly within the first 30 min, and then became faster after
about 60 min’s incubation (Figure 7.8). This effect can be attributed to the disintegration
of the carrageenan microgels at around the same time, as seen in the MR images (Figure
7.6 and 7.7). The lipid release profiles obtained from intensity and integral values
showed very similar trends, indicating both of these methods can be used to detect
microgel integrity and lipid release in situ. Interestingly, the UV-visible spectroscopy
measurements indicated that the turbidity of the carrageenan microgels increased
immediately after they were incubated in gastric fluids (Figure 7.2). This may have been
because only a very low concentration of lipid droplets is required to increase the
turbidity of a solution, whereas a relatively high concentration is required to be detectable
by MRI. The turbidity measurements are therefore not very useful for quantifying lipid
droplet release at realistic food compositions. Moreover, turbidity measurements would
be problematic in complex food systems that contained other types of particles that can
scatter light.

244

10 min
Car

0 min
Car

Integral value: 0

Integral value: 2.28
60 min
Car

30 min
Car

Integral value: 141
90 min
Car

Integral value: 860
120 min
Car

Integral value: 1560

Integral value: 1570

245

120 min
Alg

Integral value: 0

Figure 7. 10 MR spectra of two types of microgels after different simulated stomach
digestion period. The integral value of the lipid peak is marked with a red rectangle. In
each image, ‘Car’ and ‘Alg’ denote the carrageenan and alginate microgels, respectively.

7.4. Conclusion
This study demonstrates the feasibility of MRI-based approaches to non-invasively
monitor microgel integrity and to quantify lipid droplet release under gastrointestinal
conditions. The MRI techniques used clearly showed that alginate microgels are much
more resistant to gastric conditions than carrageenan microgels. Carrageenan microgels
broken down and released their lipid droplets, whereas alginate microgels stayed intact
and retained their lipid droplets. This phenomenon may have important implications for
the design of functional foods that control the release of bioactive agents within the
human GIT. Carrageenan microgels could be used to slowly release bioactive agents in
the stomach, whereas alginate microgels could be used to deliver them further down the
gastrointestinal tract. One of the advantages of the MRI method is that 3-dimensional
images of the samples can be obtained so it is possible to detect the location of the
microgels over time. In this study, it was found that the lipid-loaded microgels tended to
float on top of the gastric fluids, which would be expected to alter the gastrointestinal fate.
Previous studies have shown that MRI measurements can be carried out in humans to
monitor the gastrointestinal of ingested microgels after a meal. The two signal
246

acquisition approaches developed in the current study may increase the power of MRI for
obtaining detailed information about the behavior of lipids inside humans. These tools
may facilitate the more rational design of functional foods that behave in a controlled
fashion inside our bodies.
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